<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T19:51:46Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:3913909" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:3913909</identifier><datestamp>2014-03-05</datestamp><setSpec>frontimmu</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Front Immunol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Front Immunol</journal-id>
      <journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
      <journal-title-group>
        <journal-title>Frontiers in Immunology</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1664-3224</issn>
      <publisher>
        <publisher-name>Frontiers Media S.A.</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC3913909</article-id>
      <article-id pub-id-type="pmcid">PMC3913909</article-id>
      <article-id pub-id-type="pmc-uid">3913909</article-id>
      <article-id pub-id-type="pmid">24600447</article-id>
      <article-id pub-id-type="doi">10.3389/fimmu.2014.00022</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Immunology</subject>
          <subj-group>
            <subject>Classification Article</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Immunoglobulin and T Cell Receptor Genes: IMGT<sup>Â®</sup> and the Birth and Rise of Immunoinformatics</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Lefranc</surname>
            <given-names>Marie-Paule</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="corresp" rid="cor1">*</xref>
          <uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/32061"/>
        </contrib>
      </contrib-group>
      <aff id="aff1"><sup>1</sup><institution>The International ImMunoGenetics Information System<sup>Â®</sup> (IMGT<sup>Â®</sup>), Laboratoire dâImmunoGÃ©nÃ©tique MolÃ©culaire (LIGM), Institut de GÃ©nÃ©tique Humaine, UPR CNRS, UniversitÃ© Montpellier 2</institution>, <addr-line>Montpellier</addr-line>, <country>France</country></aff>
      <author-notes>
        <fn fn-type="edited-by">
          <p>Edited by: Kendall A. Smith, Weill Cornell Medical College of Cornell University, USA</p>
        </fn>
        <fn fn-type="edited-by">
          <p>Reviewed by: Edward J. Collins, University of North Carolina at Chapel Hill, USA; David K. Cole, Cardiff University, UK</p>
        </fn>
        <corresp content-type="corresp" id="cor1">*Correspondence: Marie-Paule Lefranc, The International ImMunoGenetics Information System<sup>Â®</sup> (IMGT<sup>Â®</sup>), Laboratoire dâImmunoGÃ©nÃ©tique MolÃ©culaire (LIGM), Institut de GÃ©nÃ©tique Humaine, UPR CNRS, UniversitÃ© Montpellier 2, 1142, 141 rue de la Cardonille, 34396 Montpellier Cedex 5, France e-mail: <email>marie-paule.lefranc@igh.cnrs.fr</email></corresp>
        <fn fn-type="other" id="fn001">
          <p>This article was submitted to T Cell Biology, a section of the journal Frontiers in Immunology.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub">
        <day>05</day>
        <month>2</month>
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2014</year>
      </pub-date>
      <volume>5</volume>
      <elocation-id>22</elocation-id>
      <history>
        <date date-type="received">
          <day>17</day>
          <month>12</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>15</day>
          <month>1</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright Â© 2014 Lefranc.</copyright-statement>
        <copyright-year>2014</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>IMGT<sup>Â®</sup>, the international ImMunoGeneTics information system<sup>Â®</sup><sup>1</sup>, (CNRS and UniversitÃ© Montpellier 2) is the global reference in immunogenetics and immunoinformatics. By its creation in 1989, IMGT<sup>Â®</sup> marked the advent of immunoinformatics, which emerged at the interface between immunogenetics and bioinformatics. IMGT<sup>Â®</sup> is specialized in the immunoglobulins (IG) or antibodies, T cell receptors (TR), major histocompatibility (MH), and proteins of the IgSF and MhSF superfamilies. IMGT<sup>Â®</sup> has been built on the IMGT-ONTOLOGY axioms and concepts, which bridged the gap between genes, sequences, and three-dimensional (3D) structures. The concepts include the IMGT<sup>Â®</sup> standardized keywords (concepts of identification), IMGT<sup>Â®</sup> standardized labels (concepts of description), IMGT<sup>Â®</sup> standardized nomenclature (concepts of classification), IMGT unique numbering, and IMGT Colliers de Perles (concepts of numerotation). IMGT<sup>Â®</sup> comprises seven databases, 15,000 pages of web resources, and 17 tools, and provides a high-quality and integrated system for the analysis of the genomic and expressed IG and TR repertoire of the adaptive immune responses. Tools and databases are used in basic, veterinary, and medical research, in clinical applications (mutation analysis in leukemia and lymphoma) and in antibody engineering and humanization. They include, for example IMGT/V-QUEST and IMGT/JunctionAnalysis for nucleotide sequence analysis and their high-throughput version IMGT/HighV-QUEST for next-generation sequencing (500,000 sequences per batch), IMGT/DomainGapAlign for amino acid sequence analysis of IG and TR variable and constant domains and of MH groove domains, IMGT/3Dstructure-DB for 3D structures, contact analysis and paratope/epitope interactions of IG/antigen and TR/peptide-MH complexes and IMGT/mAb-DB interface for therapeutic antibodies and fusion proteins for immune applications (FPIA).</p>
      </abstract>
      <kwd-group>
        <kwd>IMGT</kwd>
        <kwd>immunogenetics</kwd>
        <kwd>immunoinformatics</kwd>
        <kwd>IMGT-ONTOLOGY</kwd>
        <kwd>IMGT Collier de Perles</kwd>
        <kwd>immunoglobulin</kwd>
        <kwd>T cell receptor</kwd>
        <kwd>major histocompatibility</kwd>
      </kwd-group>
      <counts>
        <fig-count count="6"/>
        <table-count count="9"/>
        <equation-count count="0"/>
        <ref-count count="106"/>
        <page-count count="22"/>
        <word-count count="17328"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec id="S1">
      <title>IMGT<sup>Â®</sup>: The Birth of Immunoinformatics</title>
      <p>IMGT<sup>Â®</sup>, the international ImMunoGeneTics information sys- tem<sup>Â®</sup><xref ref-type="fn" rid="fn1"><sup>1</sup></xref>
(<xref rid="B1" ref-type="bibr">1</xref>), was created in 1989 by Marie-Paule Lefranc at Montpellier, France (CNRS and UniversitÃ© Montpellier 2). The founding of IMGT<sup>Â®</sup> marked the advent of immunoinformatics, a new science, which emerged at the interface between immunogenetics and bioinformatics. For the first time, immunoglobulin (IG) or antibody and T cell receptor (TR) variable (V), diversity (D), joining (J), and constant (C) genes were officially recognized as âgenesâ as well as the conventional genes (<xref rid="B2" ref-type="bibr">2</xref>â<xref rid="B5" ref-type="bibr">5</xref>). This major breakthrough allowed genes and data of the complex and highly diversified adaptive immune responses to be managed in genomic databases and tools.</p>
      <p>The adaptive immune response was acquired by jawed vertebrates (or <italic>gnathostomata</italic>) more than 450 million years ago and is found in all extant jawed vertebrate species from fishes to humans. Understanding the basis for adaptive immunity, at the level of cell populations, individual cells, and molecules, has been a major focus of immunology in the past century (<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B7" ref-type="bibr">7</xref>). The adaptive immune response is characterized by a remarkable immune specificity and memory, which are the properties of the B and T cells owing to an extreme diversity of their antigen receptors. The specific antigen receptors comprise the immunoglobulins (IG) or antibodies of the B cells and plasmocytes (<xref rid="B2" ref-type="bibr">2</xref>) (Figure <xref ref-type="fig" rid="F1">1</xref>), and the T cell receptors (TR) (<xref rid="B3" ref-type="bibr">3</xref>) (Figure <xref ref-type="fig" rid="F2">2</xref>). The IG recognize antigens in their native (unprocessed) form, whereas the TR recognize processed antigens, which are presented as peptides by the highly polymorphic major histocompatibility (MH, in humans HLA for human leukocyte antigens) proteins (Figure <xref ref-type="fig" rid="F2">2</xref>).</p>
      <fig id="F1" position="float">
        <label>Figure 1</label>
        <caption>
          <p><bold>An immunoglobulin (IG) or antibody</bold>. <italic>In vivo</italic>, an IG or antibody is anchored in the membrane of a B cell as part of a signaling B cell receptor (BcRâ=âmembrane IG+CD79) or, as shown here, is secreted (<xref rid="B2" ref-type="bibr">2</xref>). An IG is made of two identical heavy (H, for IG-HEAVY) chains and two identical light (L, for IG-LIGHT) chains (<xref rid="B2" ref-type="bibr">2</xref>). An IG comprises 12 domains (for example, IgG1, shown here) or 14 domains (IgM or IgE). The V-DOMAIN of each chain and the C-DOMAIN, one for each L chain and three for each H chain are highlighted. The light chain (here, L-KAPPA) is made of a variable domain (V-DOMAIN, here, V-KAPPA) at the N-terminal end and a constant domain (C-DOMAIN, here, C-KAPPA) at the C-terminal end. The heavy chain (here, H-GAMMA-1) is made of a VH (at the N-terminal end) and of three CH (four for H-MU or H-EPSILON) (Table <xref ref-type="table" rid="T1">1</xref>) (<xref rid="B2" ref-type="bibr">2</xref>). The structure is that of the antibody b12, an IgG1-kappa, and so far the only complete human IG crystallized [1hzh from IMGT/3Dstructure-DB (<uri xlink:type="simple" xlink:href="http://www.imgt.org">http://www.imgt.org</uri>)].</p>
        </caption>
        <graphic xlink:href="fimmu-05-00022-g001"/>
      </fig>
      <fig id="F2" position="float">
        <label>Figure 2</label>
        <caption>
          <p><bold>A T cell receptor (TR)/peptide-major histocompatibility 1 (pMH1) complex</bold>. A TR (here, TR-alpha_beta) is shown (on top, upside down) in complex with an MH (here, MH1) presenting a peptide in its groove. <italic>In vivo</italic>, a TR is anchored in the membrane of a T cell as part of the signaling T cell receptor (TcRâ=âTR+CD3). A TR is made of two chains, each comprising a variable domain (V-DOMAIN) at the N-terminal end and a constant domain (C-DOMAIN) at the C-terminal end (<xref rid="B3" ref-type="bibr">3</xref>). The domains are V-ALPHA and C-ALPHA for the TR-ALPHA chain, V-BETA and C-BETA for the TR-BETA chain (Table <xref ref-type="table" rid="T2">2</xref>) (<xref rid="B3" ref-type="bibr">3</xref>). An MH1 is made of the I-ALPHA chain with two G-DOMAIN (G-ALPHA1 and G-ALPHA2) and a C-LIKE-DOMAIN (C-LIKE), non-covalently associated with the B2M (a C-LIKE-DOMAIN) (<xref rid="B8" ref-type="bibr">8</xref>). The TR/pMH1 complex structure is 3qfj from IMGT/3Dstructure-DB (<uri xlink:type="simple" xlink:href="http://www.imgt.org">http://www.imgt.org</uri>).</p>
        </caption>
        <graphic xlink:href="fimmu-05-00022-g002"/>
      </fig>
      <p>The potential antigen receptor repertoire of each individual is estimated to comprise about 2âÃâ10<sup>12</sup> different IG and TR, and the limiting factor is only the number of B and T cells that an organism is genetically programed to produce (<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B3" ref-type="bibr">3</xref>). This huge diversity results from the complex molecular synthesis of the IG and TR chains and more particularly of their variable domains (V-DOMAIN) which, at their N-terminal end, recognize and bind the antigens (<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B3" ref-type="bibr">3</xref>). The IG and TR synthesis includes several unique mechanisms that occur at the DNA level: combinatorial rearrangements of the V, D, and J genes that code the V-DOMAIN [the Vâ(D)âJ being spliced to the C gene that encodes the C-REGION in the transcript], exonuclease trimming at the ends of the V, D, and J genes and random addition of nucleotides by the terminal deoxynucleotidyl transferase (TdT) that creates the junctional N-diversity regions, and later during B cell differentiation, for the IG, somatic hypermutations and class or subclass switch (<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B3" ref-type="bibr">3</xref>).</p>
      <p>IMGT<sup>Â®</sup> manages the diversity and complexity of the IG and TR and the polymorphism of the MH of humans and other vertebrates. IMGT<sup>Â®</sup> is also specialized in the other proteins of the immunoglobulin superfamily (IgSF) and MH superfamily (MhSF) and related proteins of the immune system (RPI) of vertebrates and invertebrates (<xref rid="B1" ref-type="bibr">1</xref>). IMGT<sup>Â®</sup> provides a common access to standardized data from genome, proteome, genetics, two-dimensional (2D), and three-dimensional (3D) structures. IMGT<sup>Â®</sup> is the acknowledged high-quality integrated knowledge resource in immunogenetics for exploring immune functional genomics. IMGT<sup>Â®</sup> comprises seven databases (for sequences, genes and 3D structures) (<xref rid="B9" ref-type="bibr">9</xref>â <xref rid="B14" ref-type="bibr">14</xref>), 17 online tools (<xref rid="B15" ref-type="bibr">15</xref>â <xref rid="B30" ref-type="bibr">30</xref>), and more than 15,000 pages of web resources [e.g., IMGT Scientific chart, IMGT Repertoire, IMGT Educationâ&gt;âAide-mÃ©moire (<xref rid="B31" ref-type="bibr">31</xref>), the IMGT Medical page, the IMGT Veterinary page, the IMGT Biotechnology page, the IMGT Immunoinformatics page] (<xref rid="B1" ref-type="bibr">1</xref>). IMGT<sup>Â®</sup> is the global reference in immunogenetics and immunoinformatics (<xref rid="B32" ref-type="bibr">32</xref>â<xref rid="B47" ref-type="bibr">47</xref>). Its standards have been endorsed by the World Health OrganizationâInternational Union of Immunological Societies (WHOâIUIS) Nomenclature Committee since 1995 (first IMGT<sup>Â®</sup> online access at the Ninth International Congress of Immunology, San Francisco, CA, USA) (<xref rid="B48" ref-type="bibr">48</xref>, <xref rid="B49" ref-type="bibr">49</xref>) and the WHOâInternational Nonproprietary Names (INN) Programme (<xref rid="B50" ref-type="bibr">50</xref>, <xref rid="B51" ref-type="bibr">51</xref>).</p>
      <p>The accuracy and the consistency of the IMGT<sup>Â®</sup> data are based on IMGT-ONTOLOGY (<xref rid="B52" ref-type="bibr">52</xref>â<xref rid="B54" ref-type="bibr">54</xref>), the first, and so far, unique ontology for immunogenetics and immunoinformatics (<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B52" ref-type="bibr">52</xref>â<xref rid="B70" ref-type="bibr">70</xref>). IMGT-ONTOLOGY manages the immunogenetics knowledge through diverse facets that rely on seven axioms: IDENTIFICATION, DESCRIPTION, CLASSIFICATION, NUMEROTATION, LOCALIZATION, ORIENTATION, and OBTENTION (<xref rid="B53" ref-type="bibr">53</xref>, <xref rid="B54" ref-type="bibr">54</xref>, <xref rid="B58" ref-type="bibr">58</xref>). The concepts generated from these axioms led to the elaboration of the IMGT<sup>Â®</sup> standards that constitute the IMGT Scientific chart: e.g., IMGT<sup>Â®</sup> standardized keywords (IDENTIFICATION) (<xref rid="B59" ref-type="bibr">59</xref>), IMGT<sup>Â®</sup> standardized labels (DESCRIPTION) (<xref rid="B60" ref-type="bibr">60</xref>), IMGT<sup>Â®</sup> standardized gene and allele nomenclature (CLASSIFICATION) (<xref rid="B61" ref-type="bibr">61</xref>), IMGT unique numbering (<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B62" ref-type="bibr">62</xref>â<xref rid="B66" ref-type="bibr">66</xref>), and its standardized graphical 2D representation or IMGT Colliers de Perles (<xref rid="B67" ref-type="bibr">67</xref>â<xref rid="B70" ref-type="bibr">70</xref>) (NUMEROTATION).</p>
      <p>The fundamental information generated from these IMGT-ONTOLOGY concepts, which led to the IMGT Scientific chart rules is reviewed. The major IMGT<sup>Â®</sup> tools and databases used for IG and TR repertoire analysis, antibody humanization, and IG/Ag and TR/pMH structures are briefly presented: IMGT/V-QUEST (<xref rid="B15" ref-type="bibr">15</xref>â<xref rid="B20" ref-type="bibr">20</xref>) for the analysis of rearranged nucleotide sequence with the results of the integrated IMGT/JunctionAnalysis (<xref rid="B21" ref-type="bibr">21</xref>, <xref rid="B22" ref-type="bibr">22</xref>), IMGT/Automat (<xref rid="B23" ref-type="bibr">23</xref>, <xref rid="B24" ref-type="bibr">24</xref>) and IMGT/Collier-de-Perles tool (<xref rid="B29" ref-type="bibr">29</xref>), IMGT/HighV-QUEST, the high-throughput version for next-generation sequencing (NGS) (<xref rid="B20" ref-type="bibr">20</xref>, <xref rid="B25" ref-type="bibr">25</xref>, <xref rid="B26" ref-type="bibr">26</xref>), IMGT/DomainGapAlign (<xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B27" ref-type="bibr">27</xref>, <xref rid="B28" ref-type="bibr">28</xref>) for amino acid (AA) sequence analysis, IMGT/3Dstructure-DB for 3D structures (<xref rid="B11" ref-type="bibr">11</xref>â<xref rid="B13" ref-type="bibr">13</xref>) and its extension, IMGT/2Dstructure-DB (for antibodies and other proteins for which the 3D structure is not available). IMGT<sup>Â®</sup> tools and databases run against IMGT reference directories built from sequences annotated in IMGT/LIGM-DB (<xref rid="B9" ref-type="bibr">9</xref>), the IMGT<sup>Â®</sup> nucleotide database (175,406 sequences from 346 species in November 2013) and from IMGT/GENE-DB (<xref rid="B10" ref-type="bibr">10</xref>), the IMGT<sup>Â®</sup> gene database (3,117 genes and 4,732 alleles from 17 species, of which 695 genes and 1,420 alleles for <italic>Homo sapiens</italic> and 868 genes and 1,318 alleles for <italic>Mus musculus</italic> in November 2013).</p>
      <p>An interface, IMGT/mAb-DB (<xref rid="B14" ref-type="bibr">14</xref>), has been developed to provide an easy access to therapeutic antibody AA sequences (links to IMGT/2Dstructure-DB) and structures (links to IMGT/3Dstructure-DB, if 3D structures are available). IMGT/mAb-DB data include monoclonal antibodies (mAb, INN suffix -mab; a -mab is defined by the presence of at least an IG variable domain) and fusion proteins for immune applications (FPIA, INN suffix -cept) (a -cept is defined by a receptor fused to an Fc) from the WHOâINN Programme (<xref rid="B50" ref-type="bibr">50</xref>, <xref rid="B51" ref-type="bibr">51</xref>). This database also includes a few composite proteins for clinical applications (CPCA) (e.g., protein or peptide fused to an Fc for only increasing their half-life, identified by the INN prefix ef-) and some related proteins of the immune system (RPI) used, unmodified, for clinical applications. The unified IMGT<sup>Â®</sup> approach is of major interest for bridging knowledge from IG and TR repertoire in normal and pathological situations (<xref rid="B71" ref-type="bibr">71</xref>â<xref rid="B74" ref-type="bibr">74</xref>), IG allotypes and immunogenicity (<xref rid="B75" ref-type="bibr">75</xref>â<xref rid="B77" ref-type="bibr">77</xref>), NGS repertoire (<xref rid="B25" ref-type="bibr">25</xref>, <xref rid="B26" ref-type="bibr">26</xref>), antibody engineering, and humanization (<xref rid="B35" ref-type="bibr">35</xref>, <xref rid="B42" ref-type="bibr">42</xref>â<xref rid="B44" ref-type="bibr">44</xref>, <xref rid="B46" ref-type="bibr">46</xref>, <xref rid="B78" ref-type="bibr">78</xref>â<xref rid="B82" ref-type="bibr">82</xref>).</p>
    </sec>
    <sec id="S2">
      <title>IMGT-Ontology Concepts</title>
      <sec id="S2-1">
        <title>IDENTIFICATION: IMGT<sup>Â®</sup> standardized keywords</title>
        <p>More than 325 IMGT<sup>Â®</sup> standardized keywords (189 for sequences and 137 for 3D structures) were precisely defined (<xref rid="B59" ref-type="bibr">59</xref>). They represent the controlled vocabulary assigned during the annotation process and allow standardized search criteria for querying the IMGT<sup>Â®</sup> databases and for the extraction of sequences and 3D structures. They have been entered in BioPortal at the National Center for Biomedical Ontology (NCBO) in 2010<xref ref-type="fn" rid="fn2"><sup>2</sup></xref>
.</p>
        <p>Standardized keywords are assigned at each step of the molecular synthesis of an IG. Those assigned to a nucleotide sequence are found in the âDEâ (definition) and âKWâ (keyword) lines of the IMGT/LIGM-DB files (<xref rid="B9" ref-type="bibr">9</xref>). They characterize for instance the gene type, the configuration type and the functionality type (<xref rid="B59" ref-type="bibr">59</xref>). There are six gene types: variable (V), diversity (D), joining (J), constant (C), conventional-with-leader, and conventional-without-leader. Four of them (V, D, J, and C) identify the IG and TR genes and are specific to immunogenetics. There are four configuration types: germline (for the V, D, and J genes before DNA rearrangement), rearranged (for the V, D, and J genes after DNA rearrangement), partially-rearranged (for D gene after only one DNA rearrangement) and undefined (for the C gene and for the conventional genes that do not rearrange). The functionality type depends on the gene configuration. The functionality type of genes in germline or undefined configuration is functional (F), open reading frame (ORF), or pseudogene (P). The functionality type of genes in rearranged or partially-rearranged configuration is either productive [no stop codon in the Vâ(D)âJ-region and in-frame junction] or unproductive [stop codon(s) in the Vâ(D)âJ-region, and/or out-of-frame junction].</p>
        <p>The 20 usual AA have been classified into 11 IMGT physicochemical classes (IMGT<sup>Â®</sup>, see footnote text 1, IMGT Educationâ&gt;âAide-mÃ©moireâ&gt;âAmino acids). The AA changes are described according to the hydropathy (3 classes), volume (5 classes), and IMGT physicochemical classes (11 classes) (<xref rid="B31" ref-type="bibr">31</xref>). For example, Q1â&gt;âE (+â+ââ) means that in the AA change (Qâ&gt;âE), the two AA at codon 1 belong to the same hydropathy (+) and volume (+) classes but to different IMGT physicochemical properties (â) classes (<xref rid="B31" ref-type="bibr">31</xref>). Four types of AA changes are identified in IMGT<sup>Â®</sup>: very similar (+â+â+), similar (+â+ââ, +âââ+), dissimilar (ââââ+, ââ+ââ, +ââââ), and very dissimilar (âââââ).</p>
      </sec>
      <sec id="S2-2">
        <title>DESCRIPTION: IMGT<sup>Â®</sup> standardized labels</title>
        <p>More than 560 IMGT<sup>Â®</sup> standardized labels (277 for sequences and 285 for 3D structures) were precisely defined (<xref rid="B60" ref-type="bibr">60</xref>). They are written in capital letters (no plural) to be recognizable without creating new terms. Standardized labels assigned to the description of sequences are found in the âFTâ (feature) lines of the IMGT/LIGM-DB files (<xref rid="B9" ref-type="bibr">9</xref>). Querying these labels represents a big plus compared to the generalist nucleotide databases [GenBank/European Nucleotide Archive (ENA)/DNA Data Bank of Japan (DDBJ)]. Thus it is possible to query for the âCDR3-IMGTâ of the human rearranged productive sequences of IG-Heavy-Gamma (e.g., 1733 CDR3-IMGT obtained, with their sequences at the nucleotide or AA level). The core labels include V-REGION, D-REGION, J-REGION, and C-REGION, which correspond to the coding region of the V, D, J, and C genes. IMGT structure labels for chains and domains and their correspondence with sequence labels are shown for human IG (Table <xref ref-type="table" rid="T1">1</xref>), for human TR (Table <xref ref-type="table" rid="T2">2</xref>), and for MH (<xref rid="B8" ref-type="bibr">8</xref>) (Table <xref ref-type="table" rid="T3">3</xref>). These labels are necessary for a standardized description of the IG, TR, and MH sequences and structures in databases and tools (<xref rid="B60" ref-type="bibr">60</xref>).</p>
        <table-wrap id="T1" position="float">
          <label>Table 1</label>
          <caption>
            <p><bold>Immunoglobulin (IG) receptor, chain, and domain structure labels and correspondence with sequence labels</bold>.</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th align="center" colspan="4" rowspan="1">IG structure labels (IMGT/3Dstructure-DB)<hr/></th>
                <th align="left" rowspan="1" colspan="1">Sequence labels (IMGT/LIGM-DB)<hr/></th>
              </tr>
              <tr>
                <th align="left" rowspan="1" colspan="1">Receptor<xref ref-type="table-fn" rid="tfn1"><sup>a</sup></xref></th>
                <th align="left" rowspan="1" colspan="1">Chain<xref ref-type="table-fn" rid="tfn2"><sup>b</sup></xref></th>
                <th align="center" rowspan="1" colspan="1">Domain description type</th>
                <th align="left" rowspan="1" colspan="1">Domain<xref ref-type="table-fn" rid="tfn3"><sup>c</sup></xref></th>
                <th align="left" rowspan="1" colspan="1">Region</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" rowspan="1" colspan="1">IG-GAMMA-1_KAPPA</td>
                <td align="left" rowspan="1" colspan="1">L-KAPPA</td>
                <td align="center" rowspan="1" colspan="1">V-DOMAIN</td>
                <td align="left" rowspan="1" colspan="1">V-KAPPA</td>
                <td align="left" rowspan="1" colspan="1">VâJ-REGION</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="center" rowspan="1" colspan="1">C-DOMAIN</td>
                <td align="left" rowspan="1" colspan="1">C-KAPPA</td>
                <td align="left" rowspan="1" colspan="1">C-REGION</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">H-GAMMA-1</td>
                <td align="center" rowspan="1" colspan="1">V-DOMAIN</td>
                <td align="left" rowspan="1" colspan="1">VH</td>
                <td align="left" rowspan="1" colspan="1">VâDâJ-REGION</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="center" rowspan="1" colspan="1">C-DOMAIN</td>
                <td align="left" rowspan="1" colspan="1">CH1</td>
                <td align="left" rowspan="1" colspan="1">C-REGION<xref ref-type="table-fn" rid="tfn4"><sup>d</sup></xref></td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="center" rowspan="1" colspan="1">C-DOMAIN</td>
                <td align="left" rowspan="1" colspan="1">CH2</td>
                <td align="left" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="center" rowspan="1" colspan="1">C-DOMAIN</td>
                <td align="left" rowspan="1" colspan="1">CH3</td>
                <td align="left" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">IG-MU_LAMBDA</td>
                <td align="left" rowspan="1" colspan="1">L-LAMBDA</td>
                <td align="center" rowspan="1" colspan="1">V-DOMAIN</td>
                <td align="left" rowspan="1" colspan="1">V-LAMBDA</td>
                <td align="left" rowspan="1" colspan="1">VâJ-REGION</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="center" rowspan="1" colspan="1">C-DOMAIN</td>
                <td align="left" rowspan="1" colspan="1">C-LAMBDA-1</td>
                <td align="left" rowspan="1" colspan="1">C-REGION</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">H-MU</td>
                <td align="center" rowspan="1" colspan="1">V-DOMAIN</td>
                <td align="left" rowspan="1" colspan="1">VH</td>
                <td align="left" rowspan="1" colspan="1">VâDâJ-REGION</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="center" rowspan="1" colspan="1">C-DOMAIN</td>
                <td align="left" rowspan="1" colspan="1">CH1</td>
                <td align="left" rowspan="1" colspan="1">C-REGION<xref ref-type="table-fn" rid="tfn4"><sup>d</sup></xref></td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="center" rowspan="1" colspan="1">C-DOMAIN</td>
                <td align="left" rowspan="1" colspan="1">CH2</td>
                <td align="left" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="center" rowspan="1" colspan="1">C-DOMAIN</td>
                <td align="left" rowspan="1" colspan="1">CH3</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="center" rowspan="1" colspan="1">C-DOMAIN</td>
                <td align="left" rowspan="1" colspan="1">CH4<xref ref-type="table-fn" rid="tfn5"><sup>e</sup></xref></td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="tfn1">
              <p><italic><sup>a</sup>Labels are shown for two examples of IG (<italic>Homo sapiens</italic> IgG1-kappa and IgM-lambda). An IG (âReceptorâ) (Figure <xref ref-type="fig" rid="F1">1</xref>) is made of two identical heavy (H, for IG-HEAVY) chains and two identical light (L, for IG-LIGHT) chains (âChainâ) and usually comprises 12 (e.g., IgG1) or 14 (e.g., IgM) domains. Each chain has an N-terminal V-DOMAIN (or Vâ(D)âJ-REGION, encoded by the rearranged Vâ(D)âJ genes), whereas the remaining of the chain is the C-REGION (encoded by a C gene). The IG C-REGION comprises one C-DOMAIN (C-KAPPA or C-LAMBDA) for the L chain, or several C-DOMAIN (CH) for the H chain (<xref rid="B2" ref-type="bibr">2</xref>)</italic>.</p>
            </fn>
            <fn id="tfn2">
              <p><italic><sup>b</sup>The kappa (L-KAPPA) or lambda (L-LAMBDA) light chains may associate to any heavy chain isotype (e.g., H-GAMMA-1, H-MU). In humans, there are nine isotypes, H-MU, H-DELTA, H-GAMMA-3, H-GAMMA-1, H-ALPHA-1, H-GAMMA-2, H-GAMMA-4, H-EPSILON, H-ALPHA-2 (listed in the order 5â²â3â² in the IGH locus of the IGHC genes, which encode the constant region of the heavy chains (<xref rid="B2" ref-type="bibr">2</xref>) (IMGT<sup>Â®</sup><uri xlink:type="simple" xlink:href="http//www.imgt.org">http//www.imgt.org</uri>, IMGT Repertoire)</italic>.</p>
            </fn>
            <fn id="tfn3">
              <p><italic><sup>c</sup>The IG V-DOMAIN includes VH (for the IG heavy chain) and VL (for the IG light chain). In higher vertebrates, the VL is V-KAPPA or V-LAMBDA, whereas in fishes, the VL is V-IOTA. The C-DOMAIN includes CH [for the IG heavy chain, the number of CH per chain depending on the isotype (<xref rid="B2" ref-type="bibr">2</xref>)] and CL (for the IG light chain). In higher vertebrates, the CL is C-KAPPA or C-LAMBDA, whereas in fishes, the CL is C-IOTA</italic>.</p>
            </fn>
            <fn id="tfn4">
              <p><italic><sup>d</sup>The heavy chain C-REGION also includes the HINGE-REGION for the H-ALPHA, H-DELTA, and H-GAMMA chains and, for membrane IG (mIG), the CONNECTING-REGION (CO), TRANSMEMBRANE-REGION (TM) and CYTOPLASMIC-REGION (CY); for secreted IG (sIG), the C-REGION includes CHS instead of CO, TM, and CY</italic>.</p>
            </fn>
            <fn id="tfn5">
              <p><italic><sup>e</sup>For H-MU and H-EPSILON</italic>.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <table-wrap id="T2" position="float">
          <label>Table 2</label>
          <caption>
            <p><bold>T cell receptor (TR), chain, and domain structure labels and correspondence with sequence labels</bold>.</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th align="center" colspan="4" rowspan="1">TR structure labels (IMGT/3Dstructure-DB)<hr/></th>
                <th align="left" rowspan="1" colspan="1">Sequence labels (IMGT/LIGM-DB)<hr/></th>
              </tr>
              <tr>
                <th align="left" rowspan="1" colspan="1">Receptor<xref ref-type="table-fn" rid="tfn6"><sup>a</sup></xref></th>
                <th align="left" rowspan="1" colspan="1">Chain</th>
                <th align="center" rowspan="1" colspan="1">Domain description type</th>
                <th align="left" rowspan="1" colspan="1">Domain<xref ref-type="table-fn" rid="tfn7"><sup>b</sup></xref></th>
                <th align="left" rowspan="1" colspan="1">Region</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" rowspan="1" colspan="1">TR-ALPHA_BETA</td>
                <td align="left" rowspan="1" colspan="1">TR-ALPHA</td>
                <td align="center" rowspan="1" colspan="1">V-DOMAIN</td>
                <td align="left" rowspan="1" colspan="1">V-ALPHA</td>
                <td align="left" rowspan="1" colspan="1">VâJ-REGION</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="center" rowspan="1" colspan="1">C-DOMAIN</td>
                <td align="left" rowspan="1" colspan="1">C-ALPHA</td>
                <td align="left" rowspan="1" colspan="1">Part of C-REGION<xref ref-type="table-fn" rid="tfn8"><sup>c</sup></xref></td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">TR-BETA</td>
                <td align="center" rowspan="1" colspan="1">V-DOMAIN</td>
                <td align="left" rowspan="1" colspan="1">V-BETA</td>
                <td align="left" rowspan="1" colspan="1">VâDâJ-REGION</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="center" rowspan="1" colspan="1">C-DOMAIN</td>
                <td align="left" rowspan="1" colspan="1">C-BETA</td>
                <td align="left" rowspan="1" colspan="1">Part of C-REGION<xref ref-type="table-fn" rid="tfn8"><sup>c</sup></xref></td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">TR-GAMMA_DELTA</td>
                <td align="left" rowspan="1" colspan="1">TR-GAMMA</td>
                <td align="center" rowspan="1" colspan="1">V-DOMAIN</td>
                <td align="left" rowspan="1" colspan="1">V-GAMMA</td>
                <td align="left" rowspan="1" colspan="1">VâJ-REGION</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="center" rowspan="1" colspan="1">C-DOMAIN</td>
                <td align="left" rowspan="1" colspan="1">C-GAMMA</td>
                <td align="left" rowspan="1" colspan="1">Part of C-REGION<xref ref-type="table-fn" rid="tfn8"><sup>c</sup></xref></td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">TR-DELTA</td>
                <td align="center" rowspan="1" colspan="1">V-DOMAIN</td>
                <td align="left" rowspan="1" colspan="1">V-DELTA</td>
                <td align="left" rowspan="1" colspan="1">VâDâJ-REGION</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="center" rowspan="1" colspan="1">C-DOMAIN</td>
                <td align="left" rowspan="1" colspan="1">C-DELTA</td>
                <td align="left" rowspan="1" colspan="1">Part of C-REGION<xref ref-type="table-fn" rid="tfn8"><sup>c</sup></xref></td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="tfn6">
              <p><italic><sup>a</sup>A TR (âReceptorâ) (<xref rid="B3" ref-type="bibr">3</xref>) (Figure <xref ref-type="fig" rid="F2">2</xref>) is made of two chains (alpha and beta, or gamma and delta) (âChainâ) and comprises four domains. Each chain has an N-terminal V-DOMAIN [or Vâ(D)âJ-REGION, encoded by the rearranged Vâ(D)âJ genes (<xref rid="B3" ref-type="bibr">3</xref>)] whereas the remaining of the chain is the C-REGION (encoded by a C gene). The TR C-REGION comprises one C-DOMAIN (<xref rid="B3" ref-type="bibr">3</xref>). TR receptor, chain, and domain structure labels, and correspondence with sequence labels, are shown for two examples of TR (<italic>Homo sapiens</italic> TR-alpha_beta and TR-gamma_delta)</italic>.</p>
            </fn>
            <fn id="tfn7">
              <p><italic><sup>b</sup>The TR V-DOMAIN includes V-ALPHA, V-BETA, V-GAMMA, and V-DELTA. The TR C-DOMAIN includes C-ALPHA, C-BETA, C-GAMMA, and C-DELTA (there are two isotypes for the TR-BETA and TR-GAMMA chains in humans, TR-BETA-1 and TR-BETA-2, and TR-GAMMA-1 and TR-GAMMA-2, the C-REGION of these chains being encoded by the TRBC1 and TRBC2 genes, and TRGC1 and TRGC2 genes, respectively) (IMGT<sup>Â®</sup><uri xlink:type="simple" xlink:href="http://www.imgt.org">http://www.imgt.org</uri>, IMGT Repertoire) (<xref rid="B3" ref-type="bibr">3</xref>)</italic>.</p>
            </fn>
            <fn id="tfn8">
              <p><italic><sup>c</sup>The TR chain C-REGION also includes the CONNECTING-REGION (CO), the TRANSMEMBRANE-REGION (TM), and the CYTOPLASMIC-REGION (CY), which are not present in 3D structures</italic>.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <table-wrap id="T3" position="float">
          <label>Table 3</label>
          <caption>
            <p><bold>Major histocompatibility (MH) receptor, chain, and domain structure labels and correspondence with sequence labels</bold>.</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th align="left" rowspan="1" colspan="1">MH group</th>
                <th align="center" colspan="5" rowspan="1">MH structure labels (IMGT/3Dstructure-DB)<hr/></th>
                <th align="left" rowspan="1" colspan="1">Sequence labels (IMGT/LIGM-DB)</th>
              </tr>
              <tr>
                <th align="left" rowspan="1" colspan="1"/>
                <th align="left" rowspan="1" colspan="1">Receptor<xref ref-type="table-fn" rid="tfn9"><sup>a</sup></xref></th>
                <th align="left" rowspan="1" colspan="1">Chain</th>
                <th align="center" rowspan="1" colspan="1">Domain description type<xref ref-type="table-fn" rid="tfn10"><sup>b</sup></xref></th>
                <th align="left" rowspan="1" colspan="1">Domain</th>
                <th align="left" rowspan="1" colspan="1">Domain number</th>
                <th align="left" rowspan="1" colspan="1">Region</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" rowspan="1" colspan="1">MH1</td>
                <td align="left" rowspan="1" colspan="1">MH1-ALPHA_B2M</td>
                <td align="left" rowspan="1" colspan="1">I-ALPHA</td>
                <td align="center" rowspan="1" colspan="1">G-DOMAIN</td>
                <td align="left" rowspan="1" colspan="1">G-ALPHA1</td>
                <td align="left" rowspan="1" colspan="1">[D1]</td>
                <td align="left" rowspan="1" colspan="1">Part of REGION<xref ref-type="table-fn" rid="tfn11"><sup>c</sup></xref></td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="center" rowspan="1" colspan="1">G-DOMAIN</td>
                <td align="left" rowspan="1" colspan="1">G-ALPHA2</td>
                <td align="left" rowspan="1" colspan="1">[D2]</td>
                <td align="left" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="center" rowspan="1" colspan="1">C-LIKE-DOMAIN</td>
                <td align="left" rowspan="1" colspan="1">C-LIKE</td>
                <td align="left" rowspan="1" colspan="1">[D3]</td>
                <td align="left" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">B2M</td>
                <td align="center" rowspan="1" colspan="1">C-LIKE-DOMAIN</td>
                <td align="left" rowspan="1" colspan="1">C-LIKE</td>
                <td align="left" rowspan="1" colspan="1">[D]</td>
                <td align="left" rowspan="1" colspan="1">REGION</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">MH2</td>
                <td align="left" rowspan="1" colspan="1">MH2-ALPHA_BETA</td>
                <td align="left" rowspan="1" colspan="1">II-ALPHA</td>
                <td align="center" rowspan="1" colspan="1">G-DOMAIN</td>
                <td align="left" rowspan="1" colspan="1">G-ALPHA</td>
                <td align="left" rowspan="1" colspan="1">[D1]</td>
                <td align="left" rowspan="1" colspan="1">Part of REGION<xref ref-type="table-fn" rid="tfn11"><sup>c</sup></xref></td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="center" rowspan="1" colspan="1">C-LIKE-DOMAIN</td>
                <td align="left" rowspan="1" colspan="1">C-LIKE</td>
                <td align="left" rowspan="1" colspan="1">[D2]</td>
                <td align="left" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">II-BETA</td>
                <td align="center" rowspan="1" colspan="1">G-DOMAIN</td>
                <td align="left" rowspan="1" colspan="1">G-BETA</td>
                <td align="left" rowspan="1" colspan="1">[D1]</td>
                <td align="left" rowspan="1" colspan="1">Part of REGION<xref ref-type="table-fn" rid="tfn11"><sup>c</sup></xref></td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="center" rowspan="1" colspan="1">C-LIKE-DOMAIN</td>
                <td align="left" rowspan="1" colspan="1">C-LIKE</td>
                <td align="left" rowspan="1" colspan="1">[D2]</td>
                <td align="left" rowspan="1" colspan="1"/>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="tfn9">
              <p><italic><sup>a</sup>An MH (âReceptorâ) (<xref rid="B8" ref-type="bibr">8</xref>) depending on the MH group is made of one chain (I-ALPHA) non-covalently associated to the beta2-microglobulin (B2M) (MH1 group, in the literature MHC class I) (Figure <xref ref-type="fig" rid="F2">2</xref>) or of two chains (II-ALPHA and II-BETA) (MH2 group, in the literature MHC class II). The I-ALPHA chain has two G-DOMAIN whereas each II-ALPHA and II-BETA has one G-DOMAIN. MH receptor, chain, and domain structure labels, and correspondence with sequence labels, are shown for examples of members of the MH1 and MH2 groups</italic>.</p>
            </fn>
            <fn id="tfn10">
              <p><italic><sup>b</sup>The domain description type shows that the MH proteins belong to the MhSF by their G-DOMAIN and to the IgSF by their C-LIKE-DOMAIN. The B2M associated to the I-ALPHA chain in MH1 has only a single C-LIKE-DOMAIN and only belongs to the IgSF</italic>.</p>
            </fn>
            <fn id="tfn11">
              <p><italic><sup>c</sup>The REGION of the I-ALPHA, II-ALPHA, and II-BETA chains also includes the CONNECTING-REGION (CO), the TRANSMEMBRANE-REGION (TM), and the CYTOPLASMIC-REGION (CY), which are not present in 3D structures</italic>.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>Highly conserved AA at a given position in a domain have IMGT labels (<xref rid="B60" ref-type="bibr">60</xref>). Thus three AA labels are common to the V and C-domains: 1st-CYS (cysteine C at position 23), CONSERVED-TRP (tryptophan W at position 41), and 2nd-CYS (C at position 104) (<xref rid="B62" ref-type="bibr">62</xref>â<xref rid="B66" ref-type="bibr">66</xref>). Two other labels are characteristics of the IG and TR V-DOMAIN and correspond to the first AA of the canonical F/WâGâXâG motif (where F is phenylalanine, W tryptophan, G glycine, and X any AA) encoded by the J-REGION: J-PHE or J-TRP (F or W at position 118) (<xref rid="B62" ref-type="bibr">62</xref>â<xref rid="B64" ref-type="bibr">64</xref>, <xref rid="B66" ref-type="bibr">66</xref>).</p>
      </sec>
      <sec id="S2-3">
        <title>CLASSIFICATION: IMGT<sup>Â®</sup> standardized genes and alleles</title>
        <p>The IMGT-ONTOLOGY CLASSIFICATION axiom was the trigger of immunoinformaticsâ birth. Indeed the IMGT<sup>Â®</sup> concepts of classification allowed, for the first time, to classify the antigen receptor genes (IG and TR) for any locus [e.g., immunoglobulin heavy (IGH), T cell receptor alpha (TRA)], for any gene configuration (germline, undefined, or rearranged), and for any species (from fishes to humans). In higher vertebrates, there are seven IG and TR major loci (other loci correspond to chromosomal orphon sets, genes of which are orphons, not used in the IG or TR chain synthesis). The IG major loci include the IGH, and for the light chains, the immunoglobulin kappa (IGK), and the immunoglobulin lambda (IGL) in higher vertebrates, and the immunoglobulin iota (IGI) in fishes (IMGT<sup>Â®</sup>, see footnote text 1, IMGT Repertoire).</p>
        <p>Since the creation of IMGT<sup>Â®</sup> in 1989, at New Haven during the Tenth Human Genome Mapping Workshop (HGM10), the standardized classification and nomenclature of the IG and TR of humans and other vertebrate species have been under the responsibility of the IMGT Nomenclature Committee (IMGT-NC). IMGT<sup>Â®</sup> gene and allele names are based on the concepts of classification of âGroup,â âSubgroup,â âGene,â and âAlleleâ (<xref rid="B61" ref-type="bibr">61</xref>). âGroupâ allows to classify a set of genes that belong to the same multigene family, within the same species or between different species. For example, there are 10 groups for the IG of higher vertebrates: IGHV, IGHD, IGHJ, IGHC, IGKV, IGKJ, IGKC, IGLV, IGLJ, IGLC. âSubgroupâ allows to identify a subset of genes, which belong to the same group, and which, in a given species, share at least 75% identity at the nucleotide level, e.g., <italic>Homo sapiens</italic> IGHV1 subgroup. Subgroups, genes, and alleles are always associated to a species name. An allele is a polymorphic variant of a gene, which is characterized by the mutations of its sequence at the nucleotide level, identified in its core sequence and compared to the gene allele reference sequence, designated as allele *01. For example, <italic>Homo sapiens</italic> IGHV1-2*01 is the allele *01 of the <italic>Homo sapiens</italic> IGHV1-2 gene that belongs to the <italic>Homo sapiens</italic> IGHV1 subgroup, which itself belongs to the IGHV group. For the IGH locus, the constant genes are designated by the letter (and eventually number) corresponding to the encoded isotypes (IGHM, IGHD, IGHG3â¦), instead of using the letter C. IG and TR genes and alleles are not italicized in publications. IMGT-ONTOLOGY concepts of classification have been entered in the NCBO BioPortal.</p>
        <p>The IMGT<sup>Â®</sup> IG and TR gene names (<xref rid="B2" ref-type="bibr">2</xref>â<xref rid="B5" ref-type="bibr">5</xref>) were approved by the Human Genome Organisation (HUGO) Nomenclature Committee (HGNC) in 1999 (<xref rid="B83" ref-type="bibr">83</xref>, <xref rid="B84" ref-type="bibr">84</xref>) and were endorsed by the WHOâIUIS Nomenclature Subcommittee for IG and TR (<xref rid="B48" ref-type="bibr">48</xref>, <xref rid="B49" ref-type="bibr">49</xref>). The IMGT<sup>Â®</sup> IG and TR gene names are the official international reference and, as such, have been entered in IMGT/GENE-DB (<xref rid="B10" ref-type="bibr">10</xref>), in the Genome Database (GDB) (<xref rid="B85" ref-type="bibr">85</xref>), in LocusLink at the National Center for Biotechnology Information (NCBI) USA (<xref rid="B86" ref-type="bibr">86</xref>), in Entrez Gene (NCBI) when this database (now designated as âGeneâ) superseded LocusLink (<xref rid="B87" ref-type="bibr">87</xref>), in NCBI MapViewer, in Ensembl at the European Bioinformatics Institute (EBI) (<xref rid="B88" ref-type="bibr">88</xref>), and in the Vertebrate Genome Annotation (Vega) Browser (<xref rid="B89" ref-type="bibr">89</xref>) at the Wellcome Trust Sanger Institute (UK). HGNC, Gene NCBI, Ensembl, and Vega have direct links to IMGT/GENE-DB (<xref rid="B10" ref-type="bibr">10</xref>). IMGT<sup>Â®</sup> human IG and TR genes were also integrated in IMGT-ONTOLOGY on the NCBO BioPortal and, on the same site, in the HUGO ontology and in the National Cancer Institute (NCI) Metathesaurus. AA sequences of human IG and TR constant genes (e.g., <italic>Homo sapiens</italic> IGHM, IGHG1, IGHG2) were provided to UniProt in 2008. Since 2007, IMGT<sup>Â®</sup> gene and allele names have been used for the description of the therapeutic mAb and FPIA of the WHOâINN Programme (<xref rid="B50" ref-type="bibr">50</xref>, <xref rid="B51" ref-type="bibr">51</xref>).</p>
        <p>The basis for the nomenclature of the MH of newly sequenced genomes has been set up on the same concepts. In IMGT<sup>Â®</sup>, MHC refers to the locus, which indeed is a complex of genes, particularly in the higher vertebrates. In contrast the letter âCâ is dropped when referring to individual genes and proteins. Thus, the class I genes are designated as MH1 whereas the class II genes are designated as MH2. The IMGT nomenclature, with the MH1 and MH2 groups, has been used for the first time with the <italic>Oncorhynchus mykiss</italic> genes [see footnote text 1, IMGT Repertoire (MH)â&gt;âLocus and genesâ&gt;âGene tables]. It can also be applied to the human genes in databases, which deal with humans and other vertebrate species (for example, <italic>Homo sapiens</italic> MH1-A for HLA-A).</p>
      </sec>
      <sec id="S2-4">
        <title>NUMEROTATION: IMGT unique numbering and IMGT Collier de Perles</title>
        <p>The IMGT-ONTOLOGY NUMEROTATION axiom is acknowledged as the âIMGT<sup>Â®</sup> Rosetta stoneâ that has bridged the biological and computational spheres in bioinformatics (<xref rid="B40" ref-type="bibr">40</xref>). The IMGT<sup>Â®</sup> concepts of numerotation comprise the IMGT unique numbering (<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B62" ref-type="bibr">62</xref>â<xref rid="B66" ref-type="bibr">66</xref>) and its graphical 2D representation the IMGT Collier de Perles (<xref rid="B67" ref-type="bibr">67</xref>â<xref rid="B70" ref-type="bibr">70</xref>). Developed for and by the âdomain,â these concepts integrate sequences, structures, and interactions into a standardized domain-centric knowledge for functional genomics. The IMGT unique numbering has been defined for the variable V-domain (V-DOMAIN of the IG and TR, and V-LIKE-DOMAIN of IgSF other than IG and TR) (<xref rid="B62" ref-type="bibr">62</xref>â<xref rid="B64" ref-type="bibr">64</xref>), the constant C-domain (C-DOMAIN of the IG and TR, and C-LIKE-DOMAIN of IgSF other than IG and TR) (<xref rid="B65" ref-type="bibr">65</xref>), and the groove G-domain (G-DOMAIN of the MH, and G-LIKE-DOMAIN of MhSF other than MH) (<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B90" ref-type="bibr">90</xref>, <xref rid="B91" ref-type="bibr">91</xref>). Thus the IMGT unique numbering and IMGT Collier de Perles provide a definitive and universal system across species including invertebrates, for the sequences and structures of the V, C, and G-domains of IG, TR, MH, IgSF, and MhSF (<xref rid="B66" ref-type="bibr">66</xref>, <xref rid="B70" ref-type="bibr">70</xref>, <xref rid="B92" ref-type="bibr">92</xref>, <xref rid="B93" ref-type="bibr">93</xref>).</p>
        <sec id="S2-4-1">
          <title>V-domain IMGT<sup>Â®</sup> definitive system</title>
          <sec id="S2-4-1-1">
            <title>V-domain definition and main characteristics</title>
            <p>In the IMGT<sup>Â®</sup> definitive system, the V-domain includes the V-DOMAIN of the IG and of the TR, which corresponds to the VâJ-REGION or VâDâJ-REGION encoded by Vâ(D)âJ rearrangements (<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B3" ref-type="bibr">3</xref>), and the V-LIKE-DOMAIN of the IgSF other than IG and TR. The V-domain description of any receptor, any chain, and any species is based on the IMGT unique numbering for V-domain (V-DOMAIN and V-LIKE-DOMAIN) (<xref rid="B62" ref-type="bibr">62</xref>â<xref rid="B64" ref-type="bibr">64</xref>, <xref rid="B66" ref-type="bibr">66</xref>).</p>
            <p>A V-domain (Figure <xref ref-type="fig" rid="F3">3</xref>) comprises about 100 AA and is made of nine antiparallel beta strands (A, B, C, Câ², Câ³, D, E, F, and G) linked by beta turns (AB, CCâ², Câ³D, DE, and EF), and three loops (BC, Câ²Câ³, and FG), forming a sandwich of two sheets [ABED] [GFCCâ²Câ³] (<xref rid="B62" ref-type="bibr">62</xref>â<xref rid="B64" ref-type="bibr">64</xref>, <xref rid="B66" ref-type="bibr">66</xref>). The sheets are closely packed against each other through hydrophobic interactions giving a hydrophobic core, and joined together by a disulfide bridge between a first highly conserved cysteine (1st-CYS) in the B strand (in the first sheet) and a second equally conserved cysteine (2nd-CYS) in the F strand (in the second sheet) (<xref rid="B62" ref-type="bibr">62</xref>â<xref rid="B64" ref-type="bibr">64</xref>, <xref rid="B66" ref-type="bibr">66</xref>).</p>
            <fig id="F3" position="float">
              <label>Figure 3</label>
              <caption>
                <p><bold>Variable (V) domain</bold>. An IG VH (V-DOMAIN) is shown as an example. <bold>(A)</bold> 3D structure ribbon representation with the IMGT strand and loop delimitations (<xref rid="B64" ref-type="bibr">64</xref>). <bold>(B)</bold> IMGT Collier de Perles on two layers with hydrogen bonds. The IMGT Collier de Perles on two layers show, in the forefront, the GFCCâCâ strands (forming the sheet located at the interface VH/VL of the IG) and, in the back, the ABED strands. The IMGT Collier de Perles with hydrogen bonds (green lines online, only shown here for the GFCCâ²Câ³ sheet) is generated by the IMGT/Collier-de-Perles tool integrated in IMGT/3Dstructure-DB, from experimental 3D structure data (<xref rid="B11" ref-type="bibr">11</xref>â<xref rid="B13" ref-type="bibr">13</xref>). <bold>(C)</bold> IMGT Collier de Perles on two layers generated from IMGT/DomainGapAlign (<xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B27" ref-type="bibr">27</xref>, <xref rid="B28" ref-type="bibr">28</xref>). Pink circles (online) indicate amino acid (AA) changes compared to the closest genes and alleles from the IMGT reference directory. <bold>(D)</bold> IMGT Collier de Perles on one layer. AA are shown in the one-letter abbreviation. All proline (P) are shown online in yellow. IMGT anchors are in square. Hatched circles are IMGT gaps according to the IMGT unique numbering for V-domain (<xref rid="B64" ref-type="bibr">64</xref>, <xref rid="B66" ref-type="bibr">66</xref>). Positions with bold (online red) letters indicate the four conserved positions that are common to a V-domain and to a C-domain: 23 (1st-CYS), 41 (CONSERVED-TRP), 89 (hydrophobic), 104 (2nd-CYS) (<xref rid="B62" ref-type="bibr">62</xref>â<xref rid="B66" ref-type="bibr">66</xref>), and the fifth conserved position, 118 (J-TRP or J-PHE), which is specific to a V-DOMAIN and belongs to the motif F/W-G-X-G that characterizes the J-REGION (<xref rid="B64" ref-type="bibr">64</xref>, <xref rid="B66" ref-type="bibr">66</xref>) (Table <xref ref-type="table" rid="T4">4</xref>). The hydrophobic AA (hydropathy index with positive value: I, V, L, F, C, M, A) and tryptophan (W) (<xref rid="B31" ref-type="bibr">31</xref>) found at a given position in more than 50% of sequences are shown (online with a blue background color). Arrows indicate the direction of the beta strands and their designations in 3D structures. IMGT color menu for the CDR-IMGT of a V-DOMAIN indicates the type of rearrangement, VâDâJ (for a VH here, red, orange, and purple) or VâJ (for V-KAPPA or V-LAMBDA (not shown), blue, green, and greenblue) (<xref rid="B2" ref-type="bibr">2</xref>). The identifier of the chain to which the VH domain belongs is 1n0x_H (from the <italic>Homo sapiens</italic> b12 Fab) in IMGT/3Dstructure-DB (<uri xlink:type="simple" xlink:href="http://www.imgt.org">http://www.imgt.org</uri>). The CDR-IMGT lengths of this VH are [8.8.20] and the FR-IMGT are [25.17.38.11]. The 3D ribbon representation was obtained using PyMOL (<uri xlink:type="simple" xlink:href="http://www.pymol.org">http://www.pymol.org</uri>) and âIMGT numbering comparisonâ of 1n0x_H (VH) from IMGT/3Dstructure-DB (<uri xlink:type="simple" xlink:href="http://www.imgt.org">http://www.imgt.org</uri>).</p>
              </caption>
              <graphic xlink:href="fimmu-05-00022-g003"/>
            </fig>
          </sec>
          <sec id="S2-4-1-2">
            <title>V-domain strands and loops (FR-IMGT and CDR-IMGT)</title>
            <p>The V-domain strands and loops and their delimitations and lengths, based on the IMGT unique numbering for V-domain (<xref rid="B62" ref-type="bibr">62</xref>â<xref rid="B64" ref-type="bibr">64</xref>, <xref rid="B66" ref-type="bibr">66</xref>), are shown in Table <xref ref-type="table" rid="T4">4</xref>. In the IG and TR V-DOMAIN, the three hypervariable loops BC, Câ²Câ³, and FG involved in the ligand recognition (native antigen for IG and pMH for TR) are designated complementarity determining regions (CDR-IMGT), whereas the strands form the framework region (FR-IMGT), which includes FR1-IMGT, FR2-IMGT, FR3-IMGT, and FR4-IMGT (Table <xref ref-type="table" rid="T4">4</xref>). In the IMGT<sup>Â®</sup> definitive system, the CDR-IMGT have accurate and unambiguous delimitations in contrast to the CDR described in the literature. Correspondences between the IMGT unique numbering with other numberings, e.g., Kabat (<xref rid="B94" ref-type="bibr">94</xref>) or Chothia (<xref rid="B95" ref-type="bibr">95</xref>), are available in the IMGT Scientific chart. The correspondences with these previous and heterogenous numberings are useful for the interpretation of previously published data but nowadays the usage of these numberings has become obsolete owing to the development of immunoinformatics based on the IMGT<sup>Â®</sup> standards (<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B62" ref-type="bibr">62</xref>â<xref rid="B70" ref-type="bibr">70</xref>) (IMGT<sup>Â®</sup>, see footnote text 1, IMGT Scientific chartâ&gt;âNumberingâ&gt;âCorrespondence between V numberings).</p>
            <table-wrap id="T4" position="float">
              <label>Table 4</label>
              <caption>
                <p><bold>V-domain strands and loops, IMGT positions, and lengths, based on the IMGT unique numbering for V-domain (V-DOMAIN and V-LIKE-DOMAIN)</bold>.</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th align="left" rowspan="1" colspan="1">V-domain strands and loops<xref ref-type="table-fn" rid="tfn12"><sup>a</sup></xref></th>
                    <th align="left" rowspan="1" colspan="1">IMGT positions<xref ref-type="table-fn" rid="tfn13"><sup>b</sup></xref></th>
                    <th align="left" rowspan="1" colspan="1">Lengths<xref ref-type="table-fn" rid="tfn14"><sup>c</sup></xref></th>
                    <th align="left" rowspan="1" colspan="1">Characteristic IMGT Residue@Position<xref ref-type="table-fn" rid="tfn15"><sup>d</sup></xref></th>
                    <th align="left" rowspan="1" colspan="1">V-DOMAIN FR-IMGT and CDR-IMGT</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">A-STRAND</td>
                    <td align="left" rowspan="1" colspan="1">1â15</td>
                    <td align="left" rowspan="1" colspan="1">15 (14 if gap at 10)</td>
                    <td align="left" rowspan="1" colspan="1"/>
                    <td align="left" rowspan="1" colspan="1">FR1-IMGT</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">B-STRAND</td>
                    <td align="left" rowspan="1" colspan="1">16â26</td>
                    <td align="left" rowspan="1" colspan="1">11</td>
                    <td align="left" rowspan="1" colspan="1">1st-CYS 23</td>
                    <td align="left" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">BC-LOOP</td>
                    <td align="left" rowspan="1" colspan="1">27â38</td>
                    <td align="left" rowspan="1" colspan="1">12 (or less)</td>
                    <td align="left" rowspan="1" colspan="1"/>
                    <td align="left" rowspan="1" colspan="1">CDR1-IMGT</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">C-STRAND</td>
                    <td align="left" rowspan="1" colspan="1">39â46</td>
                    <td align="left" rowspan="1" colspan="1">8</td>
                    <td align="left" rowspan="1" colspan="1">CONSERVED-TRP 41</td>
                    <td align="left" rowspan="1" colspan="1">FR2-IMGT</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">Câ²-STRAND</td>
                    <td align="left" rowspan="1" colspan="1">47â55</td>
                    <td align="left" rowspan="1" colspan="1">9</td>
                    <td align="left" rowspan="1" colspan="1"/>
                    <td align="left" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">Câ²Câ³-LOOP</td>
                    <td align="left" rowspan="1" colspan="1">56â65</td>
                    <td align="left" rowspan="1" colspan="1">10 (or less)</td>
                    <td align="left" rowspan="1" colspan="1"/>
                    <td align="left" rowspan="1" colspan="1">CDR2-IMGT</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">Câ³-STRAND</td>
                    <td align="left" rowspan="1" colspan="1">66â74</td>
                    <td align="left" rowspan="1" colspan="1">9 (or 8 if gap at 73)</td>
                    <td align="left" rowspan="1" colspan="1"/>
                    <td align="left" rowspan="1" colspan="1">FR3-IMGT</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">D-STRAND</td>
                    <td align="left" rowspan="1" colspan="1">75â84</td>
                    <td align="left" rowspan="1" colspan="1">10 (or 8 if gaps at 81, 82)</td>
                    <td align="left" rowspan="1" colspan="1"/>
                    <td align="left" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">E-STRAND</td>
                    <td align="left" rowspan="1" colspan="1">85â96</td>
                    <td align="left" rowspan="1" colspan="1">12</td>
                    <td align="left" rowspan="1" colspan="1">Hydrophobic 89</td>
                    <td align="left" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">F-STRAND</td>
                    <td align="left" rowspan="1" colspan="1">97â104</td>
                    <td align="left" rowspan="1" colspan="1">8</td>
                    <td align="left" rowspan="1" colspan="1">2nd-CYS 104</td>
                    <td align="left" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">FG-LOOP</td>
                    <td align="left" rowspan="1" colspan="1">105â117</td>
                    <td align="left" rowspan="1" colspan="1">13 (or less, or more)</td>
                    <td align="left" rowspan="1" colspan="1"/>
                    <td align="left" rowspan="1" colspan="1">CDR3-IMGT</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">G-STRAND</td>
                    <td align="left" rowspan="1" colspan="1">118â128</td>
                    <td align="left" rowspan="1" colspan="1">11 (or 10)</td>
                    <td align="left" rowspan="1" colspan="1">V-DOMAIN J-PHE 118 or J-TRP 118<xref ref-type="table-fn" rid="tfn16"><sup>e</sup></xref></td>
                    <td align="left" rowspan="1" colspan="1">FR4-IMGT</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="tfn12">
                  <p><italic><sup>a</sup>IMGT<sup>Â®</sup> labels (concepts of description) are written in capital letters (no plural) (<xref rid="B60" ref-type="bibr">60</xref>). Beta turns (AB, CCâ², Câ³D, DE, or EF) are individualized only if they have additional AA compared to the standard description. If not, they are included in the strands</italic>.</p>
                </fn>
                <fn id="tfn13">
                  <p><italic><sup>b</sup>Based on the IMGT unique numbering for V-domain (V-DOMAIN and V-LIKE-DOMAIN) (<xref rid="B62" ref-type="bibr">62</xref>â<xref rid="B64" ref-type="bibr">64</xref>, <xref rid="B66" ref-type="bibr">66</xref>)</italic>.</p>
                </fn>
                <fn id="tfn14">
                  <p><italic><sup>c</sup>In number of AA (or codons)</italic>.</p>
                </fn>
                <fn id="tfn15">
                  <p><italic><sup>d</sup>IMGT Residue@Position is a given residue (usually an AA) or a given conserved property AA class, at a given position in a domain, based on the IMGT unique numbering (<xref rid="B66" ref-type="bibr">66</xref>)</italic>.</p>
                </fn>
                <fn id="tfn16">
                  <p><italic><sup>e</sup>In the IG and TR V-DOMAIN, the G-STRAND (or FR4-IMGT) is the C-terminal part of the J-REGION, with J-PHE or J-TRP 118, and the canonical motif F/WâGâXâG at positions 118â121 (<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B3" ref-type="bibr">3</xref>). The JUNCTION refers to the CDR3-IMGT plus the two anchors 2nd-CYS 104 and J-PHE or J-TRP 118 (<xref rid="B63" ref-type="bibr">63</xref>, <xref rid="B64" ref-type="bibr">64</xref>). The JUNCTION (positions 104â118) is therefore two AA longer than the corresponding CDR3-IMGT (positions 105â117) (<xref rid="B63" ref-type="bibr">63</xref>, <xref rid="B64" ref-type="bibr">64</xref>)</italic>.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p>For a V-domain, the BC loop (or CDR1-IMGT in a V-DOMAIN) encompasses positions 27â38, the Câ²Câ³ loop (or CDR2-IMGT in a V-DOMAIN) positions 56â65, and the FG loop (or CDR3-IMGT) positions 105â117. In a V-DOMAIN, the CDR3-IMGT encompasses the Vâ(D)âJ junction that results from a VâJ or VâDâJ rearrangement (<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B3" ref-type="bibr">3</xref>) and is more variable in sequence and length than the CDR1-IMGT and CDR2-IMGT that are encoded by the V gene region only. For CDR3-IMGT of length &gt;13 AA, additional IMGT positions are added at the top of the loop between 111 and 112 (Table <xref ref-type="table" rid="T5">5</xref>).</p>
            <table-wrap id="T5" position="float">
              <label>Table 5</label>
              <caption>
                <p><bold>IMGT additional positions for CDR3-IMGT</bold>.</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th align="left" rowspan="1" colspan="1">CDR3-IMGT lengths</th>
                    <th align="center" colspan="10" rowspan="1">IMGT additional positions for CDR3-IMGT length &gt;13 AA<xref ref-type="table-fn" rid="tfn17"><sup>a</sup></xref></th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">21</td>
                    <td align="center" rowspan="1" colspan="1">111</td>
                    <td align="center" rowspan="1" colspan="1">111.1</td>
                    <td align="center" rowspan="1" colspan="1">111.2</td>
                    <td align="center" rowspan="1" colspan="1">111.3</td>
                    <td align="center" rowspan="1" colspan="1">111.4</td>
                    <td align="center" rowspan="1" colspan="1">112.4</td>
                    <td align="center" rowspan="1" colspan="1">112.3</td>
                    <td align="center" rowspan="1" colspan="1">112.2</td>
                    <td align="center" rowspan="1" colspan="1">112.1</td>
                    <td align="center" rowspan="1" colspan="1">112</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">20</td>
                    <td align="center" rowspan="1" colspan="1">111</td>
                    <td align="center" rowspan="1" colspan="1">111.1</td>
                    <td align="center" rowspan="1" colspan="1">111.2</td>
                    <td align="center" rowspan="1" colspan="1">111.3</td>
                    <td align="center" rowspan="1" colspan="1">â</td>
                    <td align="center" rowspan="1" colspan="1">112.4</td>
                    <td align="center" rowspan="1" colspan="1">112.3</td>
                    <td align="center" rowspan="1" colspan="1">112.2</td>
                    <td align="center" rowspan="1" colspan="1">112.1</td>
                    <td align="center" rowspan="1" colspan="1">112</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">19</td>
                    <td align="center" rowspan="1" colspan="1">111</td>
                    <td align="center" rowspan="1" colspan="1">111.1</td>
                    <td align="center" rowspan="1" colspan="1">111.2</td>
                    <td align="center" rowspan="1" colspan="1">111.3</td>
                    <td align="center" rowspan="1" colspan="1">â</td>
                    <td align="center" rowspan="1" colspan="1">â</td>
                    <td align="center" rowspan="1" colspan="1">112.3</td>
                    <td align="center" rowspan="1" colspan="1">112.2</td>
                    <td align="center" rowspan="1" colspan="1">112.1</td>
                    <td align="center" rowspan="1" colspan="1">112</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">18</td>
                    <td align="center" rowspan="1" colspan="1">111</td>
                    <td align="center" rowspan="1" colspan="1">111.1</td>
                    <td align="center" rowspan="1" colspan="1">111.2</td>
                    <td align="center" rowspan="1" colspan="1">â</td>
                    <td align="center" rowspan="1" colspan="1">â</td>
                    <td align="center" rowspan="1" colspan="1">â</td>
                    <td align="center" rowspan="1" colspan="1">112.3</td>
                    <td align="center" rowspan="1" colspan="1">112.2</td>
                    <td align="center" rowspan="1" colspan="1">112.1</td>
                    <td align="center" rowspan="1" colspan="1">112</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">17</td>
                    <td align="center" rowspan="1" colspan="1">111</td>
                    <td align="center" rowspan="1" colspan="1">111.1</td>
                    <td align="center" rowspan="1" colspan="1">111.2</td>
                    <td align="center" rowspan="1" colspan="1">â</td>
                    <td align="center" rowspan="1" colspan="1">â</td>
                    <td align="center" rowspan="1" colspan="1">â</td>
                    <td align="center" rowspan="1" colspan="1">â</td>
                    <td align="center" rowspan="1" colspan="1">112.2</td>
                    <td align="center" rowspan="1" colspan="1">112.1</td>
                    <td align="center" rowspan="1" colspan="1">112</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">16</td>
                    <td align="center" rowspan="1" colspan="1">111</td>
                    <td align="center" rowspan="1" colspan="1">111.1</td>
                    <td align="center" rowspan="1" colspan="1">â</td>
                    <td align="center" rowspan="1" colspan="1">â</td>
                    <td align="center" rowspan="1" colspan="1">â</td>
                    <td align="center" rowspan="1" colspan="1">â</td>
                    <td align="center" rowspan="1" colspan="1">â</td>
                    <td align="center" rowspan="1" colspan="1">112.2</td>
                    <td align="center" rowspan="1" colspan="1">112.1</td>
                    <td align="center" rowspan="1" colspan="1">112</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">15</td>
                    <td align="center" rowspan="1" colspan="1">111</td>
                    <td align="center" rowspan="1" colspan="1">111.1</td>
                    <td align="center" rowspan="1" colspan="1">â</td>
                    <td align="center" rowspan="1" colspan="1">â</td>
                    <td align="center" rowspan="1" colspan="1">â</td>
                    <td align="center" rowspan="1" colspan="1">â</td>
                    <td align="center" rowspan="1" colspan="1">â</td>
                    <td align="center" rowspan="1" colspan="1">â</td>
                    <td align="center" rowspan="1" colspan="1">112.1</td>
                    <td align="center" rowspan="1" colspan="1">112</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">14</td>
                    <td align="center" rowspan="1" colspan="1">111</td>
                    <td align="center" rowspan="1" colspan="1">â</td>
                    <td align="center" rowspan="1" colspan="1">â</td>
                    <td align="center" rowspan="1" colspan="1">â</td>
                    <td align="center" rowspan="1" colspan="1">â</td>
                    <td align="center" rowspan="1" colspan="1">â</td>
                    <td align="center" rowspan="1" colspan="1">â</td>
                    <td align="center" rowspan="1" colspan="1">â</td>
                    <td align="center" rowspan="1" colspan="1">112.1</td>
                    <td align="center" rowspan="1" colspan="1">112</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="tfn17">
                  <p><italic><sup>a</sup>For CDR3-IMGT length &gt;13 AA, IMGT additional positions are created between positions 111 and 112 at the top of the CDR3-IMGT loop in the following order 112.1, 111.1, 112.2, 111.2, 112.3, 111.3, etc., and as many positions can be added as necessary for very long CDR3-IMGT. For CDR3-IMGT length &lt;13 AA (not shown), IMGT gaps are created classically from the top of the loop, in the following order 111, 112, 110, 113, 109, 114, etc. (IMGT<sup>Â®</sup><uri xlink:type="simple" xlink:href="http://www.imgt.org">http://www.imgt.org</uri>, IMGT Scientific chartâ&gt;âNumbering)</italic>.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </sec>
          <sec id="S2-4-1-3">
            <title>IMGT Colliers de Perles</title>
            <p>The loop and strands are visualized in the IMGT Colliers de Perles (<xref rid="B67" ref-type="bibr">67</xref>â <xref rid="B70" ref-type="bibr">70</xref>), which can be displayed on one layer (closer to the AA sequence) or on two layers (closer to the 3D structure) (Figure <xref ref-type="fig" rid="F3">3</xref>). The three loops, BC, Câ²Câ³, and FG (or CDR1-IMGT, CDR2-IMGT, and CDR3-IMGT for a V-DOMAIN) are delimited by the IMGT anchors, which are shown in square in the IMGT Colliers de Perles. IMGT anchors are positions, which belong to strands and represent anchors for the loops of the V-domains. IMGT anchors are the key and original concept of IMGT<sup>Â®</sup>, which definitively solved the ambiguous situation of different CDR lengths and delimitations found in the literature. The six anchors of a V-domain are positions 26 and 39 (anchors of the BC loop or CDR1-IMGT in V-DOMAIN), 55 and 66 (anchors of the Câ²âCâ³ loop or CDR2-IMGT in V-DOMAIN), 104 and 118 (anchors of the FG loop or CDR3-IMGT in V-DOMAIN). The CDR3-IMGT anchors are highly conserved, they are C104 (2nd-CYS, in F strand) and F118 or W118 (J-PHE or J-TRP in G strand). The JUNCTION of an IG or TR V-DOMAIN includes the anchors 104 and 118, and is therefore two AA longer than the corresponding CDR3-IMGT (positions 105â117).</p>
            <p>In biological data, the lengths of the loops and strands are given by the number of occupied positions [unoccupied positions or âIMGT gapsâ are represented with hatches in the IMGT Colliers de Perles (Figure <xref ref-type="fig" rid="F3">3</xref>) or by dots in alignments]. The CDR-IMGT lengths are given in number of AA (or codons), into brackets and separated by dots: for example [9.6.9] means that the BC, Câ²Câ³, and FG loops (or CDR1-IMGT, CDR2-IMGT, and CDR3-IMGT for a V-DOMAIN) have a length of 9, 6, and 9 AA (or codons), respectively. Similarly [25.17.38.11] means that the FR1-IMGT, FR2-IMGT, FR3-IMGT, and FR4-IMGT have a length of 25, 17, 38, and 11 AA (or codons), respectively. Together, the four FR of a VH domain usually comprise 91 AA and the individual FR-IMGT lengths are [25.17.38.11], whereas the four FR of a VL domain usually comprise 89 AA and the individual FR-IMGT lengths are [26.17.36.10].</p>
          </sec>
          <sec id="S2-4-1-4">
            <title>Conserved AA</title>
            <p>A V-domain has five characteristic AA at given positions (positions with bold (online red) letters in the IMGT Colliers de Perles). Four of them are highly conserved and hydrophobic (<xref rid="B31" ref-type="bibr">31</xref>) and are common to the C-domain: 23 (1st-CYS), 41 (CONSERVED-TRP), 89 (hydrophobic), and 104 (2nd-CYS). These AA contribute to the two major features shared by the V and C-domain: the disulfide bridge (between the two cysteines 23 and 104) and the internal hydrophobic core of the domain (with the side chains of tryptophan W41 and AA 89). The fifth position, 118, is an anchor of the FG loop. It is occupied, in the V-domains of IgSF other than IG or TR, by AA with diverse physicochemical properties (<xref rid="B31" ref-type="bibr">31</xref>). In contrast, in IG and TR V-DOMAIN, the position 118 is occupied by remarkably conserved AA, which consist in a phenylalanine or a tryptophan encoded by the J-REGION and therefore designated J-TRP or J-PHE 118. The bulky aromatic side chains of J-TRP and J-PHE are internally orientated and structurally contribute to the V-DOMAIN hydrophobic core (<xref rid="B64" ref-type="bibr">64</xref>).</p>
          </sec>
          <sec id="S2-4-1-5">
            <title>Genomic delimitation</title>
            <p>A last criterion used in the IMGT<sup>Â®</sup> definitive system for the characterization of a V-domain is its delimitation taking into account the exon delimitations, whenever appropriate. The exon rule is not used for the delimitation of the 5â² end of the first N-terminal domain of proteins with a leader (this includes the V-DOMAIN of the IG and TR chains). In those cases, the 5â²end of the first N-terminal domain of the chain corresponds to the proteolytic site between the leader (L-REGION) and the coding region of the mature protein. The IG and TR V-DOMAIN is therefore delimited in 5â² by a proteolytic site and in 3â² at the genomic level by the splicing site of the J-REGION (<xref rid="B60" ref-type="bibr">60</xref>). This IMGT<sup>Â®</sup> genomic approach integrates the strands A and G, in contrast to structural alignments that usually lack these strands due to their poor structural conservation, and thus bridges the gap between genomic data (exon) and 3D structure (domain).</p>
          </sec>
        </sec>
        <sec id="S2-4-2">
          <title>C-domain IMGT<sup>Â®</sup> definitive system</title>
          <sec id="S2-4-2-6">
            <title>C-domain definition and main characteristics</title>
            <p>In the IMGT<sup>Â®</sup> definitive system, the C-domain includes the C-DOMAIN of the IG and of the TR (<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B3" ref-type="bibr">3</xref>) and the C-LIKE-DOMAIN of the IgSF other than IG and TR. The C-domain description of any receptor, any chain, and any species is based on the IMGT unique numbering for C-domain (C-DOMAIN and C-LIKE-DOMAIN) (<xref rid="B65" ref-type="bibr">65</xref>, <xref rid="B66" ref-type="bibr">66</xref>).</p>
            <p>A C-domain (Figure <xref ref-type="fig" rid="F4">4</xref>) comprises about 90â100 AA and is made of seven antiparallel beta strands (A, B, C, D, E, F, and G), linked by beta turns (AB, DE, and EF), a transverse strand (CD) and two loops (BC and FG), and forming a sandwich of two sheets (ABED) (GFC) (<xref rid="B65" ref-type="bibr">65</xref>, <xref rid="B66" ref-type="bibr">66</xref>). A C-domain has a topology and a three-dimensional structure similar to that of a V-domain but without the Câ² and Câ³ strands and the Câ²Câ³ loop, which is replaced by a transverse CD strand (<xref rid="B65" ref-type="bibr">65</xref>).</p>
            <fig id="F4" position="float">
              <label>Figure 4</label>
              <caption>
                <p><bold>Constant (C) domain</bold>. An IG CH (C-DOMAIN) is shown as an example. <bold>(A)</bold> 3D structure ribbon representation with the IMGT strand and loop delimitations (<xref rid="B65" ref-type="bibr">65</xref>). <bold>(B)</bold> IMGT Collier de Perles on two layers with hydrogen bonds. The IMGT Colliers de Perles on two layers show, in the forefront, the GFC strands and, in the back, the ABED strands (located at the interface CH1/CL of the IG), linked by the CD transverse strand. The IMGT Collier de Perles with hydrogen bonds (green lines online, only shown here for the GFC sheet) is generated by the IMGT/Collier-de-Perles tool integrated in IMGT/3Dstructure-DB, from experimental 3D structure data (<xref rid="B11" ref-type="bibr">11</xref>â<xref rid="B13" ref-type="bibr">13</xref>). <bold>(C)</bold> IMGT Collier de Perles on two layers from IMGT/DomainGapAlign (<xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B27" ref-type="bibr">27</xref>, <xref rid="B28" ref-type="bibr">28</xref>). <bold>(D)</bold> IMGT Colliers de Perles on one layer. Amino acids are shown in the one-letter abbreviation. All proline (P) are shown online in yellow. IMGT anchors are in square. Hatched circles are IMGT gaps according to the IMGT unique numbering for C-domain (<xref rid="B65" ref-type="bibr">65</xref>, <xref rid="B66" ref-type="bibr">66</xref>). Positions with bold (online red) letters indicate the four conserved positions that are common to a V-domain and to a C-domain: 23 (1st-CYS), 41 (CONSERVED-TRP), 89 (hydrophobic), 104 (2nd-CYS) (<xref rid="B62" ref-type="bibr">62</xref>â<xref rid="B66" ref-type="bibr">66</xref>) (Table <xref ref-type="table" rid="T6">6</xref>), and position 118, which is only conserved in V-DOMAIN. The identifier of the chain to which the CH domain belongs is 1n0x_H (from the <italic>Homo sapiens</italic> b12 Fab, in IMGT/3Dstructure-DB, <uri xlink:type="simple" xlink:href="http://www.imgt.org">http://www.imgt.org</uri>). The 3D ribbon representation was obtained using PyMOL and âIMGT numbering comparisonâ of 1n0x_H (CH1) from IMGT/3Dstructure-DB (<uri xlink:type="simple" xlink:href="http://www.imgt.org">http://www.imgt.org</uri>).</p>
              </caption>
              <graphic xlink:href="fimmu-05-00022-g004"/>
            </fig>
          </sec>
          <sec id="S2-4-2-7">
            <title>C-domain strands and loops</title>
            <p>The C-domain strands, turns, and loops and their delimitations and lengths, based on the IMGT unique numbering for C-domain (<xref rid="B65" ref-type="bibr">65</xref>, <xref rid="B66" ref-type="bibr">66</xref>), are shown in Table <xref ref-type="table" rid="T6">6</xref>. Correspondences between the IMGT unique numbering with other numberings (Eu, Kabat) are available in the IMGT Scientific chart. The correspondences with these previous numberings are useful for the interpretation of previously published data but, as for the V-domain, the usage of these previous numberings has become obsolete owing to the development of immunoinformatics based on the IMGT<sup>Â®</sup> standards (<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B62" ref-type="bibr">62</xref>â<xref rid="B70" ref-type="bibr">70</xref>) (IMGT<sup>Â®</sup>, see footnote text 1, IMGT Scientific chartâ&gt;âNumberingâ&gt;âCorrespondence between C numberings).</p>
            <table-wrap id="T6" position="float">
              <label>Table 6</label>
              <caption>
                <p><bold>C-domain strands, turns, and loops, IMGT positions, and lengths, based on the IMGT unique numbering for C-domain (C-DOMAIN and C-LIKE-DOMAIN)</bold>.</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th align="left" rowspan="1" colspan="1">C-domain strands, turns, and loops<xref ref-type="table-fn" rid="tfn18"><sup>a</sup></xref></th>
                    <th align="left" rowspan="1" colspan="1">IMGT positions<xref ref-type="table-fn" rid="tfn19"><sup>b</sup></xref></th>
                    <th align="left" rowspan="1" colspan="1">Lengths<xref ref-type="table-fn" rid="tfn20"><sup>c</sup></xref></th>
                    <th align="left" rowspan="1" colspan="1">Characteristic IMGT Residue@Position<xref ref-type="table-fn" rid="tfn21"><sup>d</sup></xref></th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">A-STRAND</td>
                    <td align="left" rowspan="1" colspan="1">1â15</td>
                    <td align="left" rowspan="1" colspan="1">15 (14 if gap at 10)</td>
                    <td align="left" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">AB-TURN</td>
                    <td align="left" rowspan="1" colspan="1">15.1â15.3</td>
                    <td align="left" rowspan="1" colspan="1">0â3</td>
                    <td align="left" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">B-STRAND</td>
                    <td align="left" rowspan="1" colspan="1">16â26</td>
                    <td align="left" rowspan="1" colspan="1">11</td>
                    <td align="left" rowspan="1" colspan="1">1st-CYS 23</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">BC-LOOP</td>
                    <td align="left" rowspan="1" colspan="1">27â31</td>
                    <td align="left" rowspan="1" colspan="1">10 (or less)</td>
                    <td align="left" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1"/>
                    <td align="left" rowspan="1" colspan="1">34â38</td>
                    <td align="left" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">C-STRAND</td>
                    <td align="left" rowspan="1" colspan="1">39â45</td>
                    <td align="left" rowspan="1" colspan="1">7</td>
                    <td align="left" rowspan="1" colspan="1">CONSERVED-TRP 41</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">CD-STRAND</td>
                    <td align="left" rowspan="1" colspan="1">45.1â45.9</td>
                    <td align="left" rowspan="1" colspan="1">0â9</td>
                    <td align="left" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">D-STRAND</td>
                    <td align="left" rowspan="1" colspan="1">77â84</td>
                    <td align="left" rowspan="1" colspan="1">8 (or 7 if gap at 82)</td>
                    <td align="left" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">DE-TURN</td>
                    <td align="left" rowspan="1" colspan="1">84.1â84.7</td>
                    <td align="left" rowspan="1" colspan="1">0â14</td>
                    <td align="left" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1"/>
                    <td align="left" rowspan="1" colspan="1">85.1â85.7</td>
                    <td align="left" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">E-STRAND</td>
                    <td align="left" rowspan="1" colspan="1">85â96</td>
                    <td align="left" rowspan="1" colspan="1">12</td>
                    <td align="left" rowspan="1" colspan="1">Hydrophobic 89</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">EF-TURN</td>
                    <td align="left" rowspan="1" colspan="1">96.1â96.2</td>
                    <td align="left" rowspan="1" colspan="1">0â2</td>
                    <td align="left" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">F-STRAND</td>
                    <td align="left" rowspan="1" colspan="1">97â104</td>
                    <td align="left" rowspan="1" colspan="1">8</td>
                    <td align="left" rowspan="1" colspan="1">2nd-CYS 104</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">FG-LOOP</td>
                    <td align="left" rowspan="1" colspan="1">105â117</td>
                    <td align="left" rowspan="1" colspan="1">13 (or less, or more)</td>
                    <td align="left" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">G-STRAND</td>
                    <td align="left" rowspan="1" colspan="1">118â128</td>
                    <td align="left" rowspan="1" colspan="1">11 (or less)</td>
                    <td align="left" rowspan="1" colspan="1"/>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="tfn18">
                  <p><italic><sup>a</sup>IMGT<sup>Â®</sup> labels (concepts of description) are written in capital letters (no plural) (<xref rid="B60" ref-type="bibr">60</xref>)</italic>.</p>
                </fn>
                <fn id="tfn19">
                  <p><italic><sup>b</sup>Based on the IMGT unique numbering for C-domain (C-DOMAIN and C-LIKE-DOMAIN) (<xref rid="B65" ref-type="bibr">65</xref>, <xref rid="B66" ref-type="bibr">66</xref>)</italic>.</p>
                </fn>
                <fn id="tfn20">
                  <p><italic><sup>c</sup>In number of amino acids (AA) (or codons)</italic>.</p>
                </fn>
                <fn id="tfn21">
                  <p><italic><sup>d</sup>IMGT Residue@Position is a given residue (usually an AA) or a given conserved property AA class, at a given position in a domain, based on the IMGT unique numbering (<xref rid="B66" ref-type="bibr">66</xref>)</italic>.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </sec>
          <sec id="S2-4-2-8">
            <title>IMGT Colliers de Perles</title>
            <p>The lengths of the strands and loops are visualized in the IMGT Colliers de Perles (<xref rid="B68" ref-type="bibr">68</xref>â<xref rid="B70" ref-type="bibr">70</xref>), on one layer and two layers (Figure <xref ref-type="fig" rid="F4">4</xref>). There are six IMGT anchors in a C-domain (four of them identical to those of a V-domain): positions 26 and 39 (anchors of the BC loop), 45 and 77 [by extension, anchors of the CD strand as there is no Câ²âCâ³ loop in a C-domain (<xref rid="B65" ref-type="bibr">65</xref>)], and 104 and 118 (anchors of the FG loop).</p>
          </sec>
          <sec id="S2-4-2-9">
            <title>Conserved AA</title>
            <p>A C-domain has five characteristic AA at given positions [positions with bold (online red) letters in the IMGT Colliers de Perles]. Four of them are highly conserved and hydrophobic (<xref rid="B31" ref-type="bibr">31</xref>) and are common to the V-domain: 23 (1st-CYS), 41 (CONSERVED-TRP), 89 (hydrophobic), and 104 (2nd-CYS). As mentioned above, these AA contribute to the two major features shared by the V and C-domain: the disulfide bridge (between the two cysteines 23 and 104) and the internal hydrophobic core of the domain (with the side chains of tryptophan W41 and AA 89). The fifth position, 118, is diverse and is characterized as being an FG loop anchor.</p>
          </sec>
          <sec id="S2-4-2-10">
            <title>Genomic delimitation</title>
            <p>In the IMGT<sup>Â®</sup> definitive system, the C-domains (C-DOMAIN and C-LIKE-DOMAIN) are delimited taking into account the exon delimitation, whenever appropriate. As for the V-domain, this IMGT<sup>Â®</sup> genomic approach integrates the strands A and G, which are absent of structural alignments.</p>
          </sec>
        </sec>
        <sec id="S2-4-3">
          <title>G-domain IMGT<sup>Â®</sup> definitive system</title>
          <sec id="S2-4-3-11">
            <title>G-domain definition and main characteristics</title>
            <p>In the IMGT<sup>Â®</sup> definitive system, the G-domain includes the G-DOMAIN of the MH (Figure <xref ref-type="fig" rid="F5">5</xref>) (<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B66" ref-type="bibr">66</xref>) and the G-LIKE-DOMAIN of the MhSF other than MH or RP1-MH1Like (there is no âRPI-MH2Likeâ identified so far) (<xref rid="B96" ref-type="bibr">96</xref>, <xref rid="B97" ref-type="bibr">97</xref>). The RPI-MH1Like in humans comprise (<xref rid="B97" ref-type="bibr">97</xref>): AZGP1 (that regulates fat degradation in adipocytes), CD1A to CD1E proteins (that display phospholipid antigens to T cells and participate in immune defense against microbian pathogens), FCGRT (that transports maternal immunoglobulins through placenta and governs neonatal immunity), HFE (that interacts with transferring receptor and takes part in iron homeostasis by regulating iron transport through cellular membranes), MICA and MICB (that are induced by stress and involved in tumor cell detection), MR1 (that regulates mucosal immunity), PROCR, previously EPCR (that interacts with activated C protein and is involved in the blood coagulation pathway), RAET1E, RAET1G, and RAET1L (that are inducible by retinoic acid and stimulate cytokine/chemokine production and cytotoxic activity of NK cells), and ULBP1, ULBP2, and ULBP3 (that are ligands for NKG2D receptor). The G-domain description of any receptor, any chain, and any species is based on the IMGT unique numbering for G-domain (G-DOMAIN and G-LIKE-DOMAIN) (<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B66" ref-type="bibr">66</xref>).</p>
            <fig id="F5" position="float">
              <label>Figure 5</label>
              <caption>
                <p><bold>Groove (G) domain</bold>. <bold>(A)</bold> 3D structure ribbon representation of the two G-domains. The two domains form a groove with a âfloorâ (four strands from each domain) and two âwallsâ (one helix from each domain) (<xref rid="B8" ref-type="bibr">8</xref>). The G-domains characterize the proteins of the MhSF, which comprises the MH (MH1 and MH2) and the RPI-MH1Like (MhSF other than MH) (<xref rid="B8" ref-type="bibr">8</xref>). The two G-DOMAIN of an MH1 are shown as an example. The view is from above the cleft with the G-ALPHA1 (on top) and G-ALPHA2 (on bottom). <bold>(B)</bold> IMGT Colliers de Perles of the two G-DOMAIN of an MH1. G-ALPHA1 (on top) and G-ALPHA2 (on bottom) belong to the I-ALPHA chain (<xref rid="B8" ref-type="bibr">8</xref>). <bold>(C)</bold> IMGT Colliers de Perles of the two G-DOMAIN of an MH2. G-ALPHA (on top) and G-BETA (on bottom) to the II-ALPHA chain and to the II-BETA chain, respectively (<xref rid="B8" ref-type="bibr">8</xref>). <bold>(D)</bold> IMGT Colliers de Perles of the two G-LIKE-DOMAIN of a RPI-MH1Like. G-ALPHA1-LIKE (on top) and G-ALPHA2-LIKE (on bottom) belong to the I-ALPHA-LIKE chain. Helices are moved outside of the floor to make it visible. Amino acids (AA) are shown in the one-letter abbreviation. All proline (P) are shown online in yellow. Hatched circles are IMGT gaps according to the IMGT unique numbering for G-domain (<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B66" ref-type="bibr">66</xref>). The 3D ribbon representation was obtained using PyMOL and âIMGT numbering comparisonâ of 3qfj_A (G-ALPHA1 and G-ALPHA2) in IMGT/3Dstructure-DB (<uri xlink:type="simple" xlink:href="http://www.imgt.org">http://www.imgt.org</uri>). IMGT Colliers de Perles AA sequences are from 3qfj_A for MH1 (<italic>Homo sapiens</italic> HLA-A*0201), 1j8h_A and 1j8h_B for MH2 (<italic>Homo sapiens</italic> HLA-DRA*0101 and HLA-DRB1*0401, respectively) and 3huj_A for RPI-MH1Like (<italic>Homo sapiens</italic> CD1D). The IMGT Colliers de Perles were generated using the IMGT/Collier-de-Perles tool integrated in IMGT/3Dstructure-DB (<uri xlink:type="simple" xlink:href="http://www.imgt.org">http://www.imgt.org</uri>) (<xref rid="B11" ref-type="bibr">11</xref>â<xref rid="B13" ref-type="bibr">13</xref>).</p>
              </caption>
              <graphic xlink:href="fimmu-05-00022-g005"/>
            </fig>
          </sec>
          <sec id="S2-4-3-12">
            <title>G-domain strands and helix</title>
            <p>A G-domain (Figure <xref ref-type="fig" rid="F5">5</xref>) comprises about 90 AA and is made of four antiparallel beta strands (A, B, C, and D) linked by turns (AB, BC, and CD), and of a helix (<xref rid="B98" ref-type="bibr">98</xref>, <xref rid="B99" ref-type="bibr">99</xref>); the helix sits on the beta strands, its axis forming an angle of about 40Â° with the strands (<xref rid="B90" ref-type="bibr">90</xref>, <xref rid="B91" ref-type="bibr">91</xref>). Two G-domains are needed to form the MhSF groove made of a âfloorâ and two âwallsâ (<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B66" ref-type="bibr">66</xref>). Each G-domain contributes by its four strands and turns to half of the groove floor and by its helix to one wall of the groove (<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B66" ref-type="bibr">66</xref>, <xref rid="B90" ref-type="bibr">90</xref>, <xref rid="B91" ref-type="bibr">91</xref>). The MH groove in which the peptide binds is made of two G-DOMAIN belonging to a single chain or to two chains, depending on the MH group, MH1 or MH2, respectively. In the MH1, the groove is made of two G-DOMAIN (G-ALPHA1 and G-ALPHA2), which belong to the same chain I-ALPHA, whereas in the MH2, the groove is made of two G-DOMAIN (G-ALPHA and G-BETA), which belong to two different chains, II-ALPHA and II-BETA, respectively (<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B66" ref-type="bibr">66</xref>). For the RPI-MH1Like, the two G-LIKE-DOMAIN also belong, as for the MH1, to the same chain (I-ALPHA-LIKE) (<xref rid="B96" ref-type="bibr">96</xref>, <xref rid="B97" ref-type="bibr">97</xref>).</p>
          </sec>
          <sec id="S2-4-3-13">
            <title>IMGT Colliers de Perles</title>
            <p>The G-domain strands, turns, and helix and their delimitations and lengths, based on the IMGT unique numbering for G-domain (<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B66" ref-type="bibr">66</xref>) are shown in Table <xref ref-type="table" rid="T7">7</xref>. The strands and helix of each domain are visualized in the IMGT Collier de Perles (<xref rid="B68" ref-type="bibr">68</xref>â<xref rid="B70" ref-type="bibr">70</xref>, <xref rid="B90" ref-type="bibr">90</xref>, <xref rid="B91" ref-type="bibr">91</xref>) (Figure <xref ref-type="fig" rid="F5">5</xref>). The views are from above the cleft (with the helices displaced to show the floor) and with on top and on bottom, respectively, G-ALPHA1 and G-ALPHA2 (MH1), G-ALPHA and G-BETA (MH2), and G-ALPHA1-LIKE and G-ALPHA2-LIKE (RPI-MH1Like). There is no link between G-ALPHA and G-BETA because they belong to different chains (II-ALPHA and II-BETA).</p>
            <table-wrap id="T7" position="float">
              <label>Table 7</label>
              <caption>
                <p><bold>G-domain strands, turns, and helix, IMGT positions, and lengths, based on the IMGT unique numbering for G-domain (G-DOMAIN and G-LIKE-DOMAIN)</bold>.</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th align="left" rowspan="1" colspan="1">G-domain strands, turns, and helix<xref ref-type="table-fn" rid="tfn22"><sup>a</sup></xref></th>
                    <th align="left" rowspan="1" colspan="1">IMGT positions<xref ref-type="table-fn" rid="tfn23"><sup>b</sup></xref></th>
                    <th align="left" rowspan="1" colspan="1">Lengths<xref ref-type="table-fn" rid="tfn24"><sup>c</sup></xref></th>
                    <th align="left" rowspan="1" colspan="1">Characteristic IMGT Residue@Position<xref ref-type="table-fn" rid="tfn25"><sup>d</sup></xref> and additional positions<xref ref-type="table-fn" rid="tfn26"><sup>e</sup></xref></th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">A-STRAND</td>
                    <td align="left" rowspan="1" colspan="1">1â14</td>
                    <td align="left" rowspan="1" colspan="1">14</td>
                    <td align="left" rowspan="1" colspan="1">7A, CYS-11</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">AB-TURN</td>
                    <td align="left" rowspan="1" colspan="1">15â17</td>
                    <td align="left" rowspan="1" colspan="1">3 (or 2 or 0)</td>
                    <td align="left" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">B-STRAND</td>
                    <td align="left" rowspan="1" colspan="1">18â28</td>
                    <td align="left" rowspan="1" colspan="1">11 (or 10<xref ref-type="table-fn" rid="tfn27"><sup>f</sup></xref>)</td>
                    <td align="left" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">BC-TURN</td>
                    <td align="left" rowspan="1" colspan="1">29â30</td>
                    <td align="left" rowspan="1" colspan="1">2</td>
                    <td align="left" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">C-STRAND</td>
                    <td align="left" rowspan="1" colspan="1">31â38</td>
                    <td align="left" rowspan="1" colspan="1">8</td>
                    <td align="left" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">CD-TURN</td>
                    <td align="left" rowspan="1" colspan="1">39â41</td>
                    <td align="left" rowspan="1" colspan="1">3 (or 1<xref ref-type="table-fn" rid="tfn28"><sup>g</sup></xref>)</td>
                    <td align="left" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">D-STRAND</td>
                    <td align="left" rowspan="1" colspan="1">42â49</td>
                    <td align="left" rowspan="1" colspan="1">8</td>
                    <td align="left" rowspan="1" colspan="1">49.1â49.5</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">HELIX</td>
                    <td align="left" rowspan="1" colspan="1">50â92</td>
                    <td align="left" rowspan="1" colspan="1">43 (or less or more)</td>
                    <td align="left" rowspan="1" colspan="1">54A, 61A, 61B, 72A, CYS-74, 92A</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="tfn22">
                  <p><italic><sup>a</sup>IMGT<sup>Â®</sup> labels (concepts of description) are written in capital letters (no plural) (<xref rid="B60" ref-type="bibr">60</xref>)</italic>.</p>
                </fn>
                <fn id="tfn23">
                  <p><italic><sup>b</sup>Based on the IMGT unique numbering for G-domain (G-DOMAIN and G-LIKE-DOMAIN) (<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B66" ref-type="bibr">66</xref>)</italic>.</p>
                </fn>
                <fn id="tfn24">
                  <p><italic><sup>c</sup>In number of AA (or codons)</italic>.</p>
                </fn>
                <fn id="tfn25">
                  <p><italic><sup>d</sup>IMGT Residue@Position is a given residue (usually an AA) or a given conserved property AA class, at a given position in a domain, based on the IMGT unique numbering (<xref rid="B66" ref-type="bibr">66</xref>)</italic>.</p>
                </fn>
                <fn id="tfn26">
                  <p><italic><sup>e</sup>For details on additional positions, see Ref. (<xref rid="B8" ref-type="bibr">8</xref>)</italic>.</p>
                </fn>
                <fn id="tfn27">
                  <p><italic><sup>f</sup>Or 9 in some G-BETA (<xref rid="B8" ref-type="bibr">8</xref>)</italic>.</p>
                </fn>
                <fn id="tfn28">
                  <p><italic><sup>g</sup>Or 0 in some G-ALPHA2-LIKE (<xref rid="B8" ref-type="bibr">8</xref>)</italic>.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </sec>
          <sec id="S2-4-3-14">
            <title>Conserved AA</title>
            <p>Two conserved cysteines, CYS-11 (in the A-strand) and CYS-74 (in the helix) (Table <xref ref-type="table" rid="T7">7</xref>), are found in the G-ALPHA2, G-BETA, and G-ALPHA2-LIKE (Figure <xref ref-type="fig" rid="F5">5</xref>), where they form a disulfide bridge fixing the helix to the floor.</p>
          </sec>
          <sec id="S2-4-3-15">
            <title>Genomic delimitation</title>
            <p>In the IMGT<sup>Â®</sup> definitive system, the G-domains (G-DOMAIN and G-LIKE-DOMAIN) are delimited taking into account the exon delimitations, if appropriate. Alignment sequence comparison with previously identified genes is used when genomic data are not available, as recently done for the rainbow trout (<italic>Oncorhynchus mykiss</italic>) MH1 and MH2 [IMGT<sup>Â®</sup>, see footnote text 1, IMGT Repertoire (MH)â&gt;âProteins and allelesâ&gt;âProtein displays].</p>
          </sec>
        </sec>
        <sec id="S2-4-4">
          <title>IMGT/Collier-de-Perles tool</title>
          <p>The IMGT/Collier-de-Perles tool (<xref rid="B29" ref-type="bibr">29</xref>), on the IMGT<sup>Â®</sup> Web site at <uri xlink:type="simple" xlink:href="http://www.imgt.org">http://www.imgt.org</uri>, is a generic tool, which allows the users to draw IMGT Colliers de Perles (<xref rid="B67" ref-type="bibr">67</xref>â<xref rid="B70" ref-type="bibr">70</xref>) starting from their own domain AA sequences [sequences already gapped according to the IMGT unique numbering, using for example IMGT/DomainGapAlign (<xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B27" ref-type="bibr">27</xref>, <xref rid="B28" ref-type="bibr">28</xref>)] (Table <xref ref-type="table" rid="T8">8</xref>). IMGT Collier de Perles can be obtained for V and C-domains (on one or two layers) and for G-domains (with one or the two domains of the groove). IMGT/Collier-de-Perles tool online can be customized to display the IG and TR CDR-IMGT according to the IMGT color menu and the AA according to their hydropathy or volume, or to the 11 IMGT physicochemical classes (<xref rid="B31" ref-type="bibr">31</xref>).</p>
          <table-wrap id="T8" position="float">
            <label>Table 8</label>
            <caption>
              <p><bold>IMGT<sup>Â®</sup> tools and databases for the analysis of the IG, TR, and MH domains (<uri xlink:type="simple" xlink:href="http://www.imgt.org">http://www.imgt.org</uri>)</bold>.</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th align="left" rowspan="1" colspan="1">IMGT<sup>Â®</sup> tools</th>
                  <th align="left" rowspan="1" colspan="1">Results for V, C, or G-domains<xref ref-type="table-fn" rid="tfn29"><sup>a</sup></xref></th>
                  <th align="left" rowspan="1" colspan="1">Entry types and protocol references</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left" rowspan="1" colspan="1">IMGT/Collier-de-Perles (<xref rid="B29" ref-type="bibr">29</xref>)</td>
                  <td align="left" rowspan="1" colspan="1">Graphical 2D representation of IMGT Colliers de Perles (<xref rid="B67" ref-type="bibr">67</xref>â<xref rid="B70" ref-type="bibr">70</xref>)</td>
                  <td align="left" rowspan="1" colspan="1">User âIMGT gappedâ V, C, or G-domain amino acid (AA) sequences (one sequence per representation, two possible for G) (<xref rid="B29" ref-type="bibr">29</xref>)</td>
                </tr>
                <tr>
                  <td align="left" colspan="3" style="background-color:DarkGray;" rowspan="1">
                    <bold>IG AND TR REPERTOIRE ANALYSIS</bold>
                  </td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">IMGT/V-QUEST (<xref rid="B15" ref-type="bibr">15</xref>â<xref rid="B20" ref-type="bibr">20</xref>)</td>
                  <td align="left" rowspan="1" colspan="1">1. Introduction of IMGT gaps</td>
                  <td align="left" rowspan="1" colspan="1">User nucleotide sequences of V-DOMAIN (1â50 sequences per analysis, and 1â10 sequences with the option âSearch for insertions and deletionsâ) (<xref rid="B19" ref-type="bibr">19</xref>)</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">2. Identification of the closest V, D, and J genes and alleles</td>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">3. IMGT/JunctionAnalysis results (<xref rid="B21" ref-type="bibr">21</xref>, <xref rid="B22" ref-type="bibr">22</xref>)</td>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">4. Description of mutations and AA changes</td>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"><italic>Applications:</italic> somatic mutations in chronic lymphocytic leukemia (CLL) prognostic</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">5. Identification of indels and their correction (<xref rid="B19" ref-type="bibr">19</xref>) (option)</td>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">6. IMGT/Automat annotation (<xref rid="B23" ref-type="bibr">23</xref>, <xref rid="B24" ref-type="bibr">24</xref>)</td>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">7. IMGT Colliers de Perles (<xref rid="B29" ref-type="bibr">29</xref>)</td>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">IMGT/HighV-QUEST (<xref rid="B20" ref-type="bibr">20</xref>, <xref rid="B25" ref-type="bibr">25</xref>, <xref rid="B26" ref-type="bibr">26</xref>)</td>
                  <td align="left" rowspan="1" colspan="1">1. Introduction of IMGT gaps</td>
                  <td align="left" rowspan="1" colspan="1">User NGS long (e.g., from 454) nucleotide sequences of V-DOMAIN (up to 500,000 sequences per run<xref ref-type="table-fn" rid="tfn30"><sup>b</sup></xref>)<xref ref-type="table-fn" rid="tfn31"><sup>c</sup></xref> (<xref rid="B25" ref-type="bibr">25</xref>, <xref rid="B26" ref-type="bibr">26</xref>)</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">2. Identification of indels and their correction (<xref rid="B19" ref-type="bibr">19</xref>) (by default)</td>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">3. Identification of the closest V, D, and J genes and alleles</td>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"><italic>Applications:</italic> IG and TR immune repertoires and clonotypes in NGS</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">4. IMGT/JunctionAnalysis results (<xref rid="B21" ref-type="bibr">21</xref>, <xref rid="B22" ref-type="bibr">22</xref>)</td>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">5. Description of mutations and AA changes</td>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">6. IMGT/Automat annotation (<xref rid="B23" ref-type="bibr">23</xref>, <xref rid="B24" ref-type="bibr">24</xref>)</td>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">7. Statistical analysis (<xref rid="B25" ref-type="bibr">25</xref>)</td>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">8. Characterization of the IMGT clonotypes (AA) (<xref rid="B26" ref-type="bibr">26</xref>)</td>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" colspan="3" style="background-color:DarkGray;" rowspan="1">
                    <bold>IG, TR, MH DOMAIN AA SEQUENCE ANALYSIS</bold>
                  </td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">IMGT/DomainGapAlign (<xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B27" ref-type="bibr">27</xref>, <xref rid="B28" ref-type="bibr">28</xref>)</td>
                  <td align="left" rowspan="1" colspan="1">1. Introduction of IMGT gaps</td>
                  <td align="left" rowspan="1" colspan="1">User AA sequences of V, C, and G-domains (one to several sequences of same domain type) (<xref rid="B27" ref-type="bibr">27</xref>, <xref rid="B28" ref-type="bibr">28</xref>)</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">2. Identification of the closest genes and alleles</td>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">3. Delimitation of the domains</td>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">4. Description of AA changes</td>
                  <td align="left" rowspan="1" colspan="1"><italic>Applications:</italic> IMGT antibody engineering and humanization for V and C</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">5. IMGT Colliers de Perles (<xref rid="B67" ref-type="bibr">67</xref>â<xref rid="B70" ref-type="bibr">70</xref>) with highlighted AA changes (pink circles online)</td>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" colspan="3" style="background-color:DarkGray;" rowspan="1">
                    <bold>IMGT<sup>Â®</sup> DATABASES</bold>
                  </td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">IMGT/3Dstructure-DB (<xref rid="B11" ref-type="bibr">11</xref>â<xref rid="B13" ref-type="bibr">13</xref>)</td>
                  <td align="left" rowspan="1" colspan="1">1. Identification of the closest genes and alleles</td>
                  <td align="left" rowspan="1" colspan="1">2,290 structure entries (1,987 IG, including 852 IG/Ag complexes, 151 TR, and 542 MH including 84 TR/pMH complexes)<xref ref-type="table-fn" rid="tfn30"><sup>b</sup></xref></td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">2. IMGT/DomainGapAlign results (<xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B27" ref-type="bibr">27</xref>, <xref rid="B28" ref-type="bibr">28</xref>)</td>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">3. IMGT Collier de Perles (<xref rid="B67" ref-type="bibr">67</xref>â<xref rid="B70" ref-type="bibr">70</xref>) (on two layers with hydrogen bonds for V and C or with pMH contact sites for G)</td>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"><italic>Applications:</italic> identification of the paratope and epitope in IG/AG and TR/pMH complexes and pMH contacts</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">4. Contact analysis between a pair of domains or between a domain and a ligand</td>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">5. Renumbered IMGT files</td>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">6. IMGT numbering comparison</td>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">IMGT/2Dstructure-DB (<xref rid="B13" ref-type="bibr">13</xref>)*</td>
                  <td align="left" rowspan="1" colspan="1">1. Identification of the closest genes and alleles</td>
                  <td align="left" rowspan="1" colspan="1">512 AA sequence entries<xref ref-type="table-fn" rid="tfn30"><sup>b</sup></xref> (of which 506 IG)*</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">2. IMGT/DomainGapAlign results (<xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B27" ref-type="bibr">27</xref>, <xref rid="B28" ref-type="bibr">28</xref>)</td>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"><italic>Applications:</italic> from gene to structures in the absence of 3D</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">3. IMGT Collier de Perles (<xref rid="B67" ref-type="bibr">67</xref>â<xref rid="B70" ref-type="bibr">70</xref>)</td>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">4. Renumbered IMGT files</td>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <p><italic>An asterisk (*) indicates that parts of the protocol dealing with 3D structures (hydrogen bonds in IMGT Colliers de Perles on two layers, Contact analysis) are not relevant, otherwise all other queries and results are similar to IMGT/3Dstructure-DB</italic>.</p>
              <fn id="tfn29">
                <p><italic><sup>a</sup>V: V-domain (includes V-DOMAIN of IG and TR and V-LIKE-DOMAIN of IgSF other than IG and TR) (<xref rid="B64" ref-type="bibr">64</xref>). C: C-domain (includes C-DOMAIN of IG and TR and C-LIKE-DOMAIN of IgSF other than IG and TR) (<xref rid="B65" ref-type="bibr">65</xref>). G: G-domain (G-DOMAIN of MH and G-LIKE-DOMAIN of MhSF other than MH) (<xref rid="B8" ref-type="bibr">8</xref>)</italic>.</p>
              </fn>
              <fn id="tfn30">
                <p><italic><sup>b</sup>In November 2013</italic>.</p>
              </fn>
              <fn id="tfn31">
                <p><italic><sup>c</sup>In November 2013, more than 1.4 billions of sequences analyzed by IMGT/HighV-QUEST, by 702 users from 40 countries (43% users from USA, 38% from EU, 19% from the remaining world)</italic>.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p>IMGT color menu for the CDR-IMGT of a V-DOMAIN indicates the type of rearrangement VâJ or VâDâJ (<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B3" ref-type="bibr">3</xref>). Thus, the IMGT color menu for CDR1-IMGT, CDR2-IMGT, and CDR3-IMGT is red, orange, and purple for the IG VH and for the TR V-BETA or V-DELTA (encoded by a VâDâJ-REGION resulting from a VâDâJ rearrangement), and blue, green, and greenblue for the IG V-KAPPA or V-LAMBDA and for the TR V-ALPHA or V-GAMMA (encoded by a VâJ-REGION resulting from a VâJ rearrangement). Arbitrarily the red, orange, and purple is used for the BC, Câ²Câ³ and FG loops of the V-domain of IgSF other than IG or TR.</p>
          <p>The IMGT/Collier-de-Perles tool is integrated in IMGT/ DomainGapAlign (<xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B27" ref-type="bibr">27</xref>, <xref rid="B28" ref-type="bibr">28</xref>) (users start from V, C, or G AA sequences) and in IMGT/V-QUEST (<xref rid="B15" ref-type="bibr">15</xref>â<xref rid="B20" ref-type="bibr">20</xref>) (users start from IG and TR V-DOMAIN nucleotide sequences) (Table <xref ref-type="table" rid="T8">8</xref>). IMGT Colliers de Perles for V, C, and G-domains are provided in IMGT/2Dstructure-DB (for AA sequences in the database), and in IMGT/3Dstructure-DB (on two layers with hydrogen bonds for the V or C-domains or with the pMH contact sites for the G-domains, for 3D structures in the database) (<xref rid="B11" ref-type="bibr">11</xref>â<xref rid="B13" ref-type="bibr">13</xref>) (Table <xref ref-type="table" rid="T8">8</xref>).</p>
        </sec>
      </sec>
    </sec>
    <sec id="S3">
      <title>IMGT<sup>Â®</sup> Tools for IG, TR, and MH Domain Analysis</title>
      <sec id="S3-5">
        <title>IMGT/V-QUEST</title>
        <sec id="S3-5-5">
          <title>IMGT/V-QUEST for IG and TR V-domain analysis</title>
          <p>IMGT/V-QUEST (<xref rid="B15" ref-type="bibr">15</xref>â<xref rid="B20" ref-type="bibr">20</xref>) is the IMGT<sup>Â®</sup> online tool for the analysis of nucleotide sequences of the IG and TR V-DOMAIN (Table <xref ref-type="table" rid="T8">8</xref>). IMGT/V-QUEST identifies the variable (V), diversity (D), and junction (J) genes in rearranged IG and TR sequences and, for the IG, the nucleotide (nt) mutations and AA changes resulting from somatic hypermutations by comparison with the IMGT/V-QUEST reference directory. The tool integrates IMGT/JunctionAnalysis (<xref rid="B21" ref-type="bibr">21</xref>, <xref rid="B22" ref-type="bibr">22</xref>) for the detailed characterization of the VâDâJ or VâJ junctions, IMGT/Automat (<xref rid="B23" ref-type="bibr">23</xref>, <xref rid="B24" ref-type="bibr">24</xref>) for a complete sequence annotation, and IMGT/ Collier-de-Perles (<xref rid="B29" ref-type="bibr">29</xref>).</p>
          <p>The IMGT/V-QUEST most important functionalities include: introduction of IMGT gaps in the user nucleotide sequences (and in its translation), alignments, and identification of the genes and alleles with the closest germline V, D, and J genes, analysis of the junctions, analysis of somatic hypermutations, and AA changes and, if the option âSearch for insertions and deletionsâ was selected, identification of insertions and deletions (indels) and their correction. Customized parameters and results provided by IMGT/V-QUEST and IMGT/JunctionAnalysis have been described elsewhere (<xref rid="B15" ref-type="bibr">15</xref>â<xref rid="B20" ref-type="bibr">20</xref>).</p>
        </sec>
        <sec id="S3-5-6">
          <title>IMGT/V-QUEST reference directory</title>
          <p>The IMGT/V-QUEST reference directory sets against which the IMGT/V-QUEST is running include IMGT reference sequences from all functional (F) genes and alleles, all ORF and all in-frame pseudogenes (P) alleles. By definition, the IMGT reference directory sets contain one sequence for each allele. By default, the user sequences are compared with all genes and alleles. However, the option âWith allele *01 onlyâ is useful for: (i) âDetailed view,â if the user sequences need to be compared with different genes, and (ii) âSynthesis view,â if the user sequences, which use the same gene need to be aligned together (independently of the allelic polymorphism) (<xref rid="B17" ref-type="bibr">17</xref>, <xref rid="B19" ref-type="bibr">19</xref>).</p>
          <p>The IMGT/V-QUEST reference directories have been set up for species, which have been extensively studied, such as human and mouse. This also holds for the other species or taxons with incomplete IMGT reference directory sets. In those cases, results should be interpreted considering the status of the IMGT reference directory (information on the updates on the IMGT<sup>Â®</sup> Web site). Links to the IMGT/V-QUEST reference directory sets are available from the IMGT/V-QUEST Welcome page (<xref rid="B17" ref-type="bibr">17</xref>, <xref rid="B19" ref-type="bibr">19</xref>).</p>
        </sec>
      </sec>
      <sec id="S3-6">
        <title>IMGT/HighV-QUEST</title>
        <sec id="S3-6-7">
          <title>NGS IG and TR V-domain analysis</title>
          <p>IMGT/HighV-QUEST (<xref rid="B25" ref-type="bibr">25</xref>), created in October 2010, is the high-throughput version of IMGT/V-QUEST. It is so far the only online tool available on the Web for the direct analysis of complete IG and TR domain sequences from NGS. It analyzes sequences obtained from the Roche 454 Life Sciences technology, without the need of computational read assembly (<xref rid="B25" ref-type="bibr">25</xref>, <xref rid="B26" ref-type="bibr">26</xref>). IMGT/HighV-QUEST analyses up to 500,000 sequences per run in November 2013 (<xref rid="B25" ref-type="bibr">25</xref>, <xref rid="B26" ref-type="bibr">26</xref>), with the same degree of resolution and high-quality results as IMGT/V-QUEST (<xref rid="B15" ref-type="bibr">15</xref>â<xref rid="B20" ref-type="bibr">20</xref>). IMGT/HighV-QUEST represents a major breakthrough for the analysis and the comparison of the antigen receptor V-DOMAIN repertoires and immunoprofilings of the adaptive immune response (<xref rid="B25" ref-type="bibr">25</xref>, <xref rid="B26" ref-type="bibr">26</xref>).</p>
          <p>The functionalities of IMGT/HighV-QUEST include: the introduction of IMGT gaps, the identification of indels and their correction (<xref rid="B19" ref-type="bibr">19</xref>) (by default), the identification of the closest V, D, and J genes and alleles, the IMGT/JunctionAnalysis results, the description of mutations and AA changes, the annotation by IMGT/Automat, the NGS statistical analysis, and the characterization of the IMGT clonotypes (AA) (<xref rid="B25" ref-type="bibr">25</xref>, <xref rid="B26" ref-type="bibr">26</xref>) (Table <xref ref-type="table" rid="T8">8</xref>). IMGT/HighV-QUEST provides results in different categories â1 copyâ and âMore than 1â to avoid redundancy of the analysis, âsingle alleleâ and âseveral alleles (or genes)â (with âsingle alleleâ sequences being usually longer than âseveral allelesâ) (<xref rid="B25" ref-type="bibr">25</xref>). These categories have been fundamental in the characterization of clonotypes for NGS (<xref rid="B26" ref-type="bibr">26</xref>).</p>
          <p>As for the other IMGT<sup>Â®</sup> databases and tools, IMGT/HighV-QUEST is freely available for academics. However, the IMGT/HighV-QUEST Welcome page requires user identification and provides, for new users, a link to register. User identification has been set to avoid non-relevant use and overload of the server, and to contact the user if needed. The user identification gives access to the IMGT/HighV-QUEST Search page.</p>
        </sec>
        <sec id="S3-6-8">
          <title>NGS IMGT<sup>Â®</sup> clonotype identification</title>
          <sec id="S3-6-8-16">
            <title>IMGT clonotype (AA) identification: clonal diversity</title>
            <p>In the literature, clonotypes are defined differently, depending on the experiment design (functional specificity) or available data. Thus, a clonotype may denote either a complete antigen receptor (e.g., IgG1-kappa), or only one of the two chains of the receptor (e.g., H or L), or one domain (e.g., VH), or the CDR3 sequence of a domain. Moreover the sequence can be at the AA or nucleotide (nt) level, and this is rarely specified. Therefore, IMGT<sup>Â®</sup> goal was first of all to define clonotypes and their properties, which could be identified and characterized by IMGT/HighV-QUEST, unambiguously (<xref rid="B26" ref-type="bibr">26</xref>).</p>
            <p>In IMGT<sup>Â®</sup>, the clonotype, designated as âIMGT clonotype (AA),â is defined by a unique V-(D)-J rearrangement (with IMGT gene and allele names determined by IMGT/HighV-QUEST at the nt level) and a unique CDR3-IMGT AA (in-frame) junction sequence (<xref rid="B26" ref-type="bibr">26</xref>). For identifying âIMGT clonotypes (AA)â in a given IMGT/HighV-QUEST dataset, the â1 copyâ are filtered to select for sequences with in-frame junction, conserved anchors 104 and 118 (âCâ is 2nd-CYS 104, and âFâ or âWâ is the J-PHE or J-TRP 118) and for V and J functional or ORF, and âsingle alleleâ (for V and J) (<xref rid="B26" ref-type="bibr">26</xref>).</p>
            <p>By essence, an âIMGT clonotype (AA)â is âuniqueâ for a given dataset. For that reason, each âIMGT clonotype (AA),â in a given dataset, has a unique set identifier (column âExp. IDâ) and, importantly, has a unique representative sequence (link in column âSequence IDâ) selected by IMGT/HighV-QUEST among the â1 copyâ âsingle alleleâ (for V and J), based on the highest percent of identity of the V-REGION (âV%â) compared to that of the closest germline, and/or on the sequence length (thus the most complete V-REGION) (<xref rid="B26" ref-type="bibr">26</xref>).</p>
          </sec>
          <sec id="S3-6-8-17">
            <title>Sequences assigned to IMGT clonotypes (AA): clonal expression</title>
            <p>Clonal expression is the number of sequences that can be assigned to each IMGT clonotype (AA). In our procedure, the high-quality and specific characterization of the âIMGT clonotype (AA)â (<xref rid="B26" ref-type="bibr">26</xref>) remains unaltered whereas the total number of sequences assigned to each given âIMGT clonotype (AA)â is calculated stepwise by adding:
<list list-type="order"><list-item><p>The number of the â1 copyâ âsingle alleleâ sequences not selected as representative. These sequences differ from the representative sequence by a different (usually shorter) length, and/or by sequencing errors in the V-REGION (lower âV%â of identity) or in the J-REGION, and/or by nt differences in the CDR3-IMGT. Sequences with nt differences in the CDR3-IMGT are identified as âIMGT clonotypes (nt),â the nt differences resulting from sequencing errors or, if this can be proven experimentally, from molecular convergence. For a given âIMGT clonotype (AA),â the number (nb) of different CDR3-IMGT (nt) or âIMGT clonotypes (nt),â the CDR3-IMGT sequence (nt) and the nb of different nt in the CDR3-IMGT are reported in the results (<xref rid="B26" ref-type="bibr">26</xref>).</p></list-item><list-item><p>The number of the â1 copyâ âseveral alleles (or genes)â sequences that have the same V and J allele as the IMGT clonotype (AA), among their IMGT/HighV-QUEST results.</p></list-item><list-item><p>The number of âMore than 1â (including those of the IMGT representative sequence) for each retained â1 copyâ of steps 1 and 2 (<xref rid="B25" ref-type="bibr">25</xref>).</p></list-item></list></p>
            <p>For the first time for NGS antigen receptor data analysis, the IMGT<sup>Â®</sup> standardized approach allows a clear distinction and accurate evaluation between the clonal diversity [nb of âIMGT clonotypes (AA)â], and the clonal expression [total nb of sequences assigned, unambiguously, to a given âIMGT clonotype (AA)â] (<xref rid="B26" ref-type="bibr">26</xref>). These assignments are clearly described and visualized in detail so the user always has the means of checking clonotypes individually. Indeed, the sequences of each â1 copyâ assigned to a given âIMGT clonotype (AA)â are available in âSequences fileâ (<xref rid="B26" ref-type="bibr">26</xref>). The user can easily perform an analysis of these sequences online with IMGT/V-QUEST (up to 10 sequences, selecting âSynthesis view displayâ and the option âSearch for insertions and deletionsâ) and/or with IMGT/JunctionAnalysis (up to 5,000 junction sequences), which provide a visual representation familiar to the IMGT<sup>Â®</sup> users.</p>
            <p>Clonal diversity is also visualized in the online results with histograms, which represent the number of IMGT clonotypes (AA) per V, D (for IGH, TRB or TRD), and J genes (in pink) (<xref rid="B26" ref-type="bibr">26</xref>). Clonal expression is visualized with histograms, which represent the number of sequences assigned to IMGT clonotypes (AA) per V (in green), D (in red), and J (in yellow) genes (<xref rid="B26" ref-type="bibr">26</xref>). Values are normalized, respectively, for 10,000 IMGT clonotypes (AA) to represent IG diversity immunoprofiles per V, D (for IGH, TRB or TRD), and J genes, and for 10,000 sequences assigned to IMGT clonotypes (AA) to represent IG expression immunoprofiles per V, D (for IGH, TRB or TRD), and J genes (<xref rid="B26" ref-type="bibr">26</xref>). These normalized values allow comparative analysis studies performed with the same IMGT/HighV-QUEST standards (<xref rid="B26" ref-type="bibr">26</xref>).</p>
          </sec>
        </sec>
      </sec>
      <sec id="S3-7">
        <title>IMGT/DomainGapAlign</title>
        <sec id="S3-7-9">
          <title>V, C, and G-domain analysis of IG, TR, and MH</title>
          <p>IMGT/DomainGapAlign (<xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B27" ref-type="bibr">27</xref>, <xref rid="B28" ref-type="bibr">28</xref>) is the IMGT<sup>Â®</sup> online tool for the analysis of AA sequences and 2D structures of V and C-domains (for IG, TR, and other IgSF) and of G-domains (for MH and other MhSF) (Table <xref ref-type="table" rid="T8">8</xref>). It analyzes domain AA sequences by comparison with the IMGT domain reference directory sets (translation of the germline V and J genes and of the C gene domains for IG and TR, AA domain sequences of MH and conventional genes). IMGT/DomainGapAlign functionalities include: introduction of IMGT gaps in the user AA sequences, alignments, and identification of the genes and alleles by comparison with the closest domain(s), delimitation of the domain(s) (e.g., V, C, or G) in the user sequence, description of the AA changes and IMGT Collier de Perles.</p>
        </sec>
        <sec id="S3-7-10">
          <title>IMGT domain reference directory</title>
          <p>The IMGT domain reference directory is the IMGT reference directory for V, C, and G-domains. Sequences are from the IMGT Repertoire (<xref rid="B1" ref-type="bibr">1</xref>) and from IMGT/GENE-DB (<xref rid="B10" ref-type="bibr">10</xref>). Owing to the particularities of the V-DOMAIN synthesis (<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B3" ref-type="bibr">3</xref>), there is no V-DOMAIN in the IMGT reference directory. Instead, the directory comprises the translation of the IG and TR germline V and J genes (V-REGION and J-REGION, respectively). The IMGT domain reference directory provides the IMGT<sup>Â®</sup> âgeneâ and âalleleâ names. Data are comprehensive for human and mouse IG and TR whereas for other species and other IgSF and MhSF they are added progressively. The IMGT domain reference directory comprises domain sequences of functional (F), ORF, and in-frame pseudogene (P) genes. As IMGT<sup>Â®</sup> alleles are characterized at the nucleotide level, identical sequences at the AA level may therefore correspond to different alleles, in the IMGT domain reference directory. The sequences can be displayed by querying IMGT/DomainDisplay (see footnote text 1).</p>
        </sec>
      </sec>
    </sec>
    <sec id="S4">
      <title>IMGT<sup>Â®</sup> Databases for IG, TR, and MH Domain Analysis</title>
      <sec id="S4-8">
        <title>IMGT/3Dstructure-DB</title>
        <sec id="S4-8-11">
          <title>IMGT/3Dstructure-DB card</title>
          <p>IMGT/3Dstructure-DB (<xref rid="B11" ref-type="bibr">11</xref>â<xref rid="B13" ref-type="bibr">13</xref>), the IMGT<sup>Â®</sup> structure database, provides IMGT<sup>Â®</sup> annotation and contact analysis of IG, TR, MH, IgSf, and MhSF 3D structures, and paratope/epitope description of IG/antigen and TR/pMH complexes (Table <xref ref-type="table" rid="T8">8</xref>). There is one âIMGT/3Dstructure-DB cardâ per IMGT/3Dstructure-DB entry and this card provides access to all data related to that entry. The âPDB codeâ (four letters and/or numbers, e.g., 1n0x) is used as âIMGT entry IDâ for the 3D structures obtained from the Research Collaboratory for Structural Bioinformatics (RCSB) Protein Data Bank (PDB) (<xref rid="B100" ref-type="bibr">100</xref>). The IMGT/3Dstructure-DB card provides eight search/display options: âChain details,â âContact analysis,â âParatope and epitope,â â3D visualization Jmol or QuickPDB,â âRenumbered IMGT files,â âIMGT numbering comparison,â âReferences and links,â and âPrintable cardâ (<xref rid="B11" ref-type="bibr">11</xref>â<xref rid="B13" ref-type="bibr">13</xref>).</p>
        </sec>
        <sec id="S4-8-12">
          <title>IMGT chain and domain annotation</title>
          <p>The âChain detailsâ section comprises information first on the chain itself, then per domain (<xref rid="B11" ref-type="bibr">11</xref>â<xref rid="B13" ref-type="bibr">13</xref>). Chain and domain annotation includes the IMGT gene and allele names (CLASSIFICATION), region and domain delimitations (DESCRIPTION) and domain AA positions according to the IMGT unique numbering (NUMEROTATION) (<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B62" ref-type="bibr">62</xref>â<xref rid="B66" ref-type="bibr">66</xref>). The closest IMGT<sup>Â®</sup> genes and alleles (found expressed in each domain of a chain) are identified with the integrated IMGT/DomainGapAlign (<xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B27" ref-type="bibr">27</xref>, <xref rid="B28" ref-type="bibr">28</xref>), which aligns the AA sequences of the 3D structures with the IMGT domain reference directory.</p>
        </sec>
        <sec id="S4-8-13">
          <title>Contact analysis</title>
          <p>âContact analysisâ gives access to a table with the different âDomain pair contactsâ of the 3D structure [this table is also accessed from âChain detailsâ by clicking on âDomain contact (overview)â]. âDomain pair contactsâ refer to contacts between a pair of domains or between a domain and a ligand. Clicking on âDomPairâ gives access to the contacts between AA for a given âDomain pair contacts.â Contacts between VH and the Ligand (antigen, Ag) and the V-KAPPA and the Ligand (Ag) of an IG/Ag complex are shown in Figure <xref ref-type="fig" rid="F6">6</xref>. These contact analysis representations are important as they demonstrate that most contacts with the ligand, if not all, involve the AA of the CDR-IMGT. They definitively confirmed the CDR-IMGT delimitations as the official reference standards (<xref rid="B66" ref-type="bibr">66</xref>, <xref rid="B70" ref-type="bibr">70</xref>, <xref rid="B93" ref-type="bibr">93</xref>).</p>
          <fig id="F6" position="float">
            <label>Figure 6</label>
            <caption>
              <p><bold>IMGT/3Dstructure-DB Domain pair contacts between VH and V-KAPPA and the ligand from an IG/Ag complex</bold>. The IG/Ag complex structure is 1n0x from IMGT/3Dstructure-DB (<uri xlink:type="simple" xlink:href="http://www.imgt.org">http://www.imgt.org</uri>) (<xref rid="B11" ref-type="bibr">11</xref>â<xref rid="B13" ref-type="bibr">13</xref>). The ligand is a synthetic peptide. <bold>(A)</bold> Domain pair contacts between VH and the ligand. The Summary shows that there are a total of 106 atom pair contacts (10 polar including 1 hydrogen bond and 96 non-polar) for 17 pair contacts between the VH (1n0x_H) and the ligand (1n0x_P). Seven amino acids (AA) of the VH interact with the ligand. The list of the pair contacts show that three of them belong to the CDR2-IMGT (orange color online) and two of them to the CDR3-IMGT (purple color online), and together contribute to 81 atom pair contacts (including the hydrogen bond). The VH binds the ligand primarily by the N64 of the CDR2-IMGT and the P112.3 and Q112.2 of the CDR3-IMGT that are localized next to the top of the loops (Figure <xref ref-type="fig" rid="F3">3</xref>). The only two positions of the FR-IMGT that have contacts with the ligand are the anchors 55 and 66 of the CDR2-IMGT. In that structure, there is no contact of the CDR1-IMGT. <bold>(B)</bold> Domain pair contacts between V-KAPPA and the ligand. The Summary shows that there are a total of 195 atom pair contacts (32 polar including 3 hydrogen bonds and 163 non-polar) for 24 pair contacts between the V-KAPPA (1n0x_L) and the ligand (1n0x_P). Twelve AA of the VH interact with the ligand. The list of the pair contacts show that seven of them belong to the CDR1-IMGT (blue color online) and three of them to the CDR3-IMGT (greenblue color online) and together contribute to 174 atom pair contacts (including the three hydrogen bonds). The only two positions of the FR-IMGT that have contacts with the ligand are the positions 1 and 2 of the strand A of the FR1-IMGT. In that structure, there is no contact with the CDR2-IMGT.</p>
            </caption>
            <graphic xlink:href="fimmu-05-00022-g006"/>
          </fig>
          <p>In IMGT/3Dstructure-DB, all contacts are described as atom pair contacts. Atom pair contacts are obtained by a local program in which atoms are considered to be in contact when no water molecule can take place between them (<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B12" ref-type="bibr">12</xref>). Atom pair contacts are provided by atom contact types (noncovalent, polar, hydrogen bond, nonpolar, covalent, disulfide) and/or atom contact categories [(BB) backbone/backbone, (SS) side chain/side chain, (BS) backbone/side chain, (SB) side chain/backbone] (<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B90" ref-type="bibr">90</xref>, <xref rid="B91" ref-type="bibr">91</xref>).</p>
          <p>Clicking on âR@Pâ gives access to the IMGT identity card of a given residue (usually an AA) at a given position or Residue@Position. The IMGT R@P card can also be accessed from the AA sequences of the IMGT/3Dstructure-DB card or from the IMGT Colliers de Perles, by clicking on one AA. In an IMGT R@P card, the Residue@Position is defined by the IMGT position numbering in a domain, or if not characterized, in the chain, the AA name (three-letter and between parentheses one-letter abbreviations), the IMGT domain description and the IMGT chain ID, e.g., â103 â TYR (Y) â VH â 1hzh_Hâ (<xref rid="B11" ref-type="bibr">11</xref>â<xref rid="B13" ref-type="bibr">13</xref>). The IMGT R@P card includes (i) general information (PDB file numbering, IMGT file numbering, residue full name and formula), (ii) structural information âIMGT LocalStructure@Positionâ [secondary structure, Phi and Psi angles (in degrees) and accessible surface area (ASA) (in square angstrom)] and (iii) detailed contact analysis with AA of other domains (<xref rid="B11" ref-type="bibr">11</xref>â<xref rid="B13" ref-type="bibr">13</xref>).</p>
        </sec>
        <sec id="S4-8-14">
          <title>Paratope and epitope</title>
          <p>In an IG/Ag complex, the AA in contact at the interface between the IG and the Ag constitute the paratope on the IG V-DOMAIN surface, and the epitope on the Ag surface. Similarly, in an TR/pMH complex, the AA in contact at the interface between the TR and the pMH constitute the paratope on the TR V-DOMAIN surface, and the epitope on the pMH surface. For IG/Ag and TR/pMH, the paratope and epitope are displayed in Contact analysis, but for each V-domain, separately. Clicking on the âParatope and epitopeâ tag (displayed in the IMGT/3Dstructure-DB card, only if relevant), gives access to âIMGT paratope and epitope detailsâ, which are described in a standardized way. Each AA that belongs to the paratope is defined by its position in a V-DOMAIN. Each AA that belongs to the epitope in an IG/Ag complex is defined by its position in the chain in the 3D structure or, if the antigen belongs to an IgSF or MhSF protein and if the epitope is part of a characterized V, C, or G-domain, by its position in the domain according to the IMGT unique numbering. The epitope in a TR/pMH complex includes AA of the peptide and of the two G-DOMAIN helices.</p>
        </sec>
        <sec id="S4-8-15">
          <title>Renumbered flat file and IMGT numbering comparison</title>
          <p>âRenumbered IMGT fileâ allows to view (or download) an IMGT coordinate file renumbered according to the IMGT unique numbering, and with added IMGT specific information on chains and domains (added in the âREMARK 410â lines (blue online), and identical to the âChain detailsâ annotation).</p>
          <p>âIMGT numbering comparisonâ provides, per domain, the IMGT DOMAIN numbering by comparison with the PDB numbering, and the residue (three-letter and one-letter names), which allows standardized IMGT representations using generic tools (Figures <xref ref-type="fig" rid="F3">3</xref>A and <xref ref-type="fig" rid="F4">4</xref>A).</p>
        </sec>
        <sec id="S4-8-16">
          <title>IMGT/3Dstructure-DB associated tools</title>
          <p>Tools associated to IMGT/3Dstructure-DB include IMGT/ StructuralQuery (<xref rid="B11" ref-type="bibr">11</xref>) and IMGT/DomainSuperimpose, available online. IMGT/StructuralQuery allows to retrieve the IMGT/3Dstructure-DB entries, based on specific structural characteristics of the intramolecular interactions: phi and psi angles, ASA, type of atom contacts, distance in angstrom between AA, IMGT Residue@Position contacts and, for V-DOMAIN, CDR-IMGT length or pattern (<xref rid="B11" ref-type="bibr">11</xref>). IMGT/DomainSuperimpose allows to superimpose the 3D structures of two domains from IMGT/3Dstructure-DB.</p>
        </sec>
      </sec>
      <sec id="S4-9">
        <title>IMGT/2Dstructure-DB</title>
        <p>IMGT/2Dstructure-DB was created as an extension of IMGT/3Dstructure-DB (<xref rid="B11" ref-type="bibr">11</xref>â<xref rid="B13" ref-type="bibr">13</xref>) to describe and analyze AA sequences of chains and domains for which no 3D structures were available (Table <xref ref-type="table" rid="T8">8</xref>). IMGT/2Dstructure-DB uses the IMGT/3Dstructure-DB informatics frame and interface, which allow one to analyze, manage, and query IG, TR, and MH, as well as other IgSF and MhSF and engineered proteins (FPIA, CPCA), as polymeric receptors made of several chains, in contrast to the IMGT/LIGM-DB sequence database that analyzes and manages sequences individually (<xref rid="B9" ref-type="bibr">9</xref>). The AA sequences are analyzed with the IMGT<sup>Â®</sup> criteria of standardized identification (<xref rid="B59" ref-type="bibr">59</xref>), description (<xref rid="B60" ref-type="bibr">60</xref>), nomenclature (<xref rid="B61" ref-type="bibr">61</xref>), and numerotation (<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B62" ref-type="bibr">62</xref>â<xref rid="B66" ref-type="bibr">66</xref>).</p>
        <p>The current IMGT/2Dstructure-DB entries include AA sequences of antibodies from Kabat (<xref rid="B94" ref-type="bibr">94</xref>) (those for which there were no available nucleotide sequences), and AA sequences of mAb and FPIA from the WHOâINN Programme (<xref rid="B14" ref-type="bibr">14</xref>, <xref rid="B50" ref-type="bibr">50</xref>, <xref rid="B51" ref-type="bibr">51</xref>). Queries can be made on an individual entry, using the Entry ID or the Molecule name. The same query interface is used for IMGT/2Dstructure-DB and IMGT/3Dstructure-DB. Thus a âtrastuzumabâ query in âMolecule nameâ allows to retrieve three results: two INN (âtrastuzumabâ and âtrastuzumab emtansineâ) from IMGT/2Dstructure-DB, and one 3D structure (â1nz8â) from IMGT/3Dstructure-DB.</p>
        <p>The IMGT/2Dstructure-DB cards provide standardized IMGT information on chains and domains and IMGT Colliers de Perles on one or two layers, identical to that provided for the sequence analysis in IMGT/3Dstructure-DB, however the information on experimental structural data (hydrogen bonds in IMGT Collier de Perles on two layers, Contact analysis) is only available in the corresponding IMGT/3Dstructure-DB cards, if the antibodies have been crystallized.</p>
      </sec>
    </sec>
    <sec id="S5">
      <title>IMGT<sup>Â®</sup> V and C-Domain for Antibody Humanization and Engineering</title>
      <sec id="S5-10">
        <title>CDR-IMGT delimitation for grafting</title>
        <p>The objective of antibody humanization is to graft at the DNA level the CDR of an antibody V-domain, from mouse (or other species) and of a given specificity, onto a human V-domain framework, thus preserving the specificity of the original (murine or other species) antibody while decreasing its immunogenicity (<xref rid="B101" ref-type="bibr">101</xref>). IMGT/DomainGapAlign (<xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B27" ref-type="bibr">27</xref>, <xref rid="B28" ref-type="bibr">28</xref>) is the reference tool for antibody humanization design based on CDR grafting. Indeed, it precisely defines the CDR-IMGT to be grafted and helps selecting the most appropriate human FR-IMGT by providing the alignment of the AA sequences between the mouse (or other species) and the closest human V-DOMAIN.</p>
        <p>Analyses performed on humanized therapeutic antibodies underline the importance of a correct delimitation of the CDR and FR. As an example, two AA changes were required in the first version of the humanized VH of alemtuzumab, in order to restore the specificity and affinity of the original rat antibody. The positions of these AA changes (S28â&gt;âF and S35â&gt;âF) are now known to be located in the CDR1-IMGT and should have been directly grafted, but at the time of this mAb humanization they were considered as belonging to the FR according to the Kabat numbering (<xref rid="B94" ref-type="bibr">94</xref>). In contrast, positions 66â74 were, at the same time, considered as belonging to the CDR according to the Kabat numbering, whereas they clearly belong to the FR2-IMGT and the corresponding sequence should have been âhumanâ instead of being grafted from the âratâ sequence (IMGT<sup>Â®</sup>, see footnote text 1, The IMGT Biotechnology pageâ&gt;âAntibody humanizationâ&gt;âAlemtuzumab).</p>
      </sec>
      <sec id="S5-11">
        <title>IGHG1 alleles and G1m allotypes</title>
        <p>Allotypes are polymorphic markers of an IG subclass that correspond to AA changes and are detected serologically by antibody reagents (<xref rid="B76" ref-type="bibr">76</xref>). In therapeutic antibodies (human, humanized, or chimeric) (<xref rid="B14" ref-type="bibr">14</xref>), allotypes may represent potential immunogenic residues (<xref rid="B75" ref-type="bibr">75</xref>), as demonstrated by the presence of antibodies in individuals immunized against these allotypes (<xref rid="B76" ref-type="bibr">76</xref>). The allotypes of the human heavy gamma chains of the IgG are designated as Gm (for gamma marker).</p>
        <p>The allotypes G1m, G2m, and G3m are carried by the constant region of the gamma1, gamma2, and gamma3 chains, encoded by the IGHG1, IGHG2, and IGHG3 genes, respectively (<xref rid="B76" ref-type="bibr">76</xref>). The gamma1 chains may express four G1m alleles (combinations of G1m allotypes): G1m3, G1m3,1, G1m17,1, and G1m17,1,2 (and in Negroid populations two additional G1m alleles, Gm17,1,28 and Gm17,1,27,28) (<xref rid="B76" ref-type="bibr">76</xref>) (Table <xref ref-type="table" rid="T9">9</xref>). The C-region of the G1m3,1, G1m17,1, and G1m17,1,2 chains differ from that of the G1m3 chains by two, three, and four AA, respectively (<xref rid="B76" ref-type="bibr">76</xref>). The correspondence between the G1m alleles and IGHG1 alleles is shown in Table <xref ref-type="table" rid="T9">9</xref>. Thus, IGHG1*01 and IGHG1*02 are G1m17,1, IGHG1*03 is G1m3, IGHG1*04 is G1m17,1,2 and IGHG1*05 is G1m3,1.</p>
        <table-wrap id="T9" position="float">
          <label>Table 9</label>
          <caption>
            <p><bold>Correspondence between the IGHG1 alleles and G1m alleles</bold>.</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th align="left" rowspan="1" colspan="1">IGHG1 alleles</th>
                <th align="center" colspan="2" rowspan="1">G1m alleles<xref ref-type="table-fn" rid="tfn32"><sup>a</sup></xref><hr/></th>
                <th align="center" colspan="5" rowspan="1">IMGT amino acid (AA) positions<xref ref-type="table-fn" rid="tfn33"><sup>b</sup></xref><hr/></th>
                <th align="left" rowspan="1" colspan="1">Populations (<xref rid="B76" ref-type="bibr">76</xref>)</th>
              </tr>
              <tr>
                <th align="left" rowspan="1" colspan="1"/>
                <th align="left" rowspan="1" colspan="1">Allotypes</th>
                <th align="left" rowspan="1" colspan="1">Isoallotypes<xref ref-type="table-fn" rid="tfn34"><sup>c</sup></xref></th>
                <th align="center" colspan="2" rowspan="1">CH1<hr/></th>
                <th align="center" colspan="3" rowspan="1">CH3<hr/></th>
              </tr>
              <tr>
                <th align="left" rowspan="1" colspan="1"/>
                <th align="left" rowspan="1" colspan="1"/>
                <th align="left" rowspan="1" colspan="1"/>
                <th align="center" rowspan="1" colspan="1">
                  <bold>103</bold>
                </th>
                <th align="center" rowspan="1" colspan="1">120</th>
                <th align="center" rowspan="1" colspan="1">12</th>
                <th align="center" rowspan="1" colspan="1">14</th>
                <th align="center" rowspan="1" colspan="1">110</th>
                <th align="left" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <th align="left" rowspan="1" colspan="1"/>
                <th align="left" rowspan="1" colspan="1"/>
                <th align="left" rowspan="1" colspan="1"/>
                <th align="left" rowspan="1" colspan="1">
                  <hr/>
                </th>
                <th align="left" rowspan="1" colspan="1">
                  <hr/>
                </th>
                <th align="left" colspan="2" rowspan="1">
                  <hr/>
                </th>
                <th align="left" rowspan="1" colspan="1">
                  <hr/>
                </th>
                <th align="left" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <th align="left" rowspan="1" colspan="1"/>
                <th align="left" rowspan="1" colspan="1"/>
                <th align="left" rowspan="1" colspan="1"/>
                <th align="center" rowspan="1" colspan="1">G1m3<xref ref-type="table-fn" rid="tfn35"><sup>d</sup></xref></th>
                <th align="center" rowspan="1" colspan="1">G1m17/nG1m1</th>
                <th align="center" colspan="2" rowspan="1">G1m1/nG1m1</th>
                <th align="center" rowspan="1" colspan="1">G1m2/-</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" rowspan="1" colspan="1">IGHG1*01<xref ref-type="table-fn" rid="tfn36"><sup>e</sup></xref></td>
                <td align="left" rowspan="1" colspan="1">G1m17,1</td>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="center" rowspan="1" colspan="1">I</td>
                <td align="center" rowspan="1" colspan="1">
                  <bold>K</bold>
                </td>
                <td align="center" rowspan="1" colspan="1">
                  <bold>D</bold>
                </td>
                <td align="center" rowspan="1" colspan="1">
                  <bold>L</bold>
                </td>
                <td align="center" rowspan="1" colspan="1">A</td>
                <td align="left" rowspan="1" colspan="1">Caucasoid Negroid</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">IGHG1*02<xref ref-type="table-fn" rid="tfn36"><sup>e</sup></xref></td>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="center" rowspan="1" colspan="1"/>
                <td align="center" rowspan="1" colspan="1"/>
                <td align="center" rowspan="1" colspan="1"/>
                <td align="center" rowspan="1" colspan="1"/>
                <td align="center" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">Mongoloid</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">IGHG1*03</td>
                <td align="left" rowspan="1" colspan="1">G1m3</td>
                <td align="left" rowspan="1" colspan="1"><italic>nG1m1</italic>, <italic>nG1m17</italic></td>
                <td align="center" rowspan="1" colspan="1">
                  <bold>I</bold>
                </td>
                <td align="center" rowspan="1" colspan="1">
                  <bold>R</bold>
                </td>
                <td align="center" rowspan="1" colspan="1">E</td>
                <td align="center" rowspan="1" colspan="1">M</td>
                <td align="center" rowspan="1" colspan="1">A</td>
                <td align="left" rowspan="1" colspan="1">Caucasoid</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">IGHG1*04<xref ref-type="table-fn" rid="tfn37"><sup>f</sup></xref></td>
                <td align="left" rowspan="1" colspan="1">G1m17,1,2</td>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="center" rowspan="1" colspan="1">I</td>
                <td align="center" rowspan="1" colspan="1">
                  <bold>K</bold>
                </td>
                <td align="center" rowspan="1" colspan="1">
                  <bold>D</bold>
                </td>
                <td align="center" rowspan="1" colspan="1">
                  <bold>L</bold>
                </td>
                <td align="center" rowspan="1" colspan="1">
                  <bold>G</bold>
                </td>
                <td align="left" rowspan="1" colspan="1">Caucasoid</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="center" rowspan="1" colspan="1"/>
                <td align="center" rowspan="1" colspan="1"/>
                <td align="center" rowspan="1" colspan="1"/>
                <td align="center" rowspan="1" colspan="1"/>
                <td align="center" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">Mongoloid</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">IGHG1*05<xref ref-type="table-fn" rid="tfn37"><sup>f</sup></xref></td>
                <td align="left" rowspan="1" colspan="1">G1m3,1</td>
                <td align="left" rowspan="1" colspan="1">
                  <italic>nG1m17</italic>
                </td>
                <td align="center" rowspan="1" colspan="1">
                  <bold>I</bold>
                </td>
                <td align="center" rowspan="1" colspan="1">
                  <bold>R</bold>
                </td>
                <td align="center" rowspan="1" colspan="1">
                  <bold>D</bold>
                </td>
                <td align="center" rowspan="1" colspan="1">
                  <bold>L</bold>
                </td>
                <td align="center" rowspan="1" colspan="1">A</td>
                <td align="left" rowspan="1" colspan="1">Mongoloid</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="tfn32">
              <p><italic><sup>a</sup>In Negroid populations, the G1m17,1 allele frequently includes G1m27 and G1m28, leading to two additional G1m alleles, G1m17,1,27 and G1m17,1,27,28 (<xref rid="B76" ref-type="bibr">76</xref>)</italic>.</p>
            </fn>
            <fn id="tfn33">
              <p><italic><sup>b</sup>AA corresponding to G1m allotypes are shown in bold</italic>.</p>
            </fn>
            <fn id="tfn34">
              <p><italic><sup>c</sup>The nG1m1 and nG1m17 isoallotypes present on the Gm1-negative and Gm17-negative gamma1 chains (and on other gamma chains) are shown in italics</italic>.</p>
            </fn>
            <fn id="tfn35">
              <p><italic><sup>d</sup>The presence of R120 is detected by anti-nG1m17 antibodies whereas the simultaneous presence of I103 and R120 in the gamma1 chains is detected by anti-Gm3 antibodies (<xref rid="B76" ref-type="bibr">76</xref>)</italic>.</p>
            </fn>
            <fn id="tfn36">
              <p><italic><sup>e</sup>The IGHG1*01 and IGHG1*02 alleles only differ at the nucleotide level (codon 85.1 in CH2)</italic>.</p>
            </fn>
            <fn id="tfn37">
              <p><italic><sup>f</sup>IGHG1*04 and IGHG1*05 AA are expected (<xref rid="B76" ref-type="bibr">76</xref>) but not yet sequenced at the nucleotide level and therefore the IGHG1*04 and IGHG1*05 alleles are not shown in IMGT Repertoire, Alignments of alleles: <italic>Homo sapiens</italic> IGHG1 (<uri xlink:type="simple" xlink:href="http://www.imgt.org">http://www.imgt.org</uri>)</italic>.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>In the IGHG1 CH1, the lysine at position 120 (K120) in strand G corresponds to the G1m17 allotype (<xref rid="B76" ref-type="bibr">76</xref>) (Figure <xref ref-type="fig" rid="F4">4</xref>D). The isoleucine I103 (strand F) is specific of the gamma1 chain isotype. If an arginine is expressed at position 120 (R120), the simultaneous presence of R120 and I103 corresponds to the expression of the G1m3 allotype (<xref rid="B76" ref-type="bibr">76</xref>). For the gamma3 and gamma4 isotypes (which also have R120 but T in 103), R120 only corresponds to the expression of the nG1m17 isoallotype (an isoallotype or nGm is detected by antibody reagents that identify this marker as an allotype in one IgG subclass and as an isotype for other subclasses) (<xref rid="B76" ref-type="bibr">76</xref>).</p>
        <p>In the IGHG1 CH3, the aspartate D12 and leucine L14 (strand A) correspond to G1m1, whereas glutamate E12 and methionine M14 correspond to the nG1m1 isoallotype (<xref rid="B76" ref-type="bibr">76</xref>) (Table <xref ref-type="table" rid="T9">9</xref>). A glycine at position 110 corresponds to G1m2, whereas an alanine does not correspond to any allotype (G1m2-negative chain) (Table <xref ref-type="table" rid="T9">9</xref>). Therapeutic antibodies are most frequently of the IgG1 isotype, and to avoid a potential immunogenicity, the constant region of the gamma1 chains are often engineered to replace the G1m3 allotype by the less immunogenic G1m17 (CH1 R120â&gt;âK) (G1m17 is more extensively found in different populations) (<xref rid="B76" ref-type="bibr">76</xref>).</p>
      </sec>
    </sec>
    <sec sec-type="conclusions" id="S6">
      <title>Conclusion</title>
      <p>IMGT-ONTOLOGY and the IMGT<sup>Â®</sup> information system, which are at the origin of immunoinformatics, have provided the concepts, the knowledge environment, and the informatics frame for a standardized and integrated analysis of IG, TR, and MH, extended to other IgSF (<xref rid="B102" ref-type="bibr">102</xref>â<xref rid="B106" ref-type="bibr">106</xref>) and MhSF (<xref rid="B96" ref-type="bibr">96</xref>, <xref rid="B97" ref-type="bibr">97</xref>), from gene to structure and function (<xref rid="B32" ref-type="bibr">32</xref>â<xref rid="B47" ref-type="bibr">47</xref>). IG and TR repertoire analysis, antibody humanization, IG and TR engineering for immunotherapy, paratope/epitope characterization represent major current fields of immunoinformatics at the forefront of basic, clinical, and pharmaceutical research owing to major methodological advances and medical implications.</p>
      <p>The IMGT<sup>Â®</sup> standards are used in clinical applications. Thus, IMGT/V-QUEST is frequently used by clinicians for the analysis of IG somatic hypermutations in leukemia, lymphoma, and myeloma, and more particularly in chronic lymphocytic leukemia (CLL) (<xref rid="B18" ref-type="bibr">18</xref>, <xref rid="B72" ref-type="bibr">72</xref>â<xref rid="B74" ref-type="bibr">74</xref>) in which the percentage of mutations of the rearranged IGHV gene in the VH of the leukemic clone has a prognostic value for the patients. For this evaluation, IMGT/V-QUEST is the standard recommended by the European Research Initiative on CLL (ERIC) for comparative analysis between laboratories (<xref rid="B72" ref-type="bibr">72</xref>). The sequences of the Vâ(D)âJ junctions determined by IMGT/JunctionAnalysis (<xref rid="B21" ref-type="bibr">21</xref>, <xref rid="B22" ref-type="bibr">22</xref>) are also used in the characterization of stereotypic patterns in CLL (<xref rid="B73" ref-type="bibr">73</xref>, <xref rid="B74" ref-type="bibr">74</xref>) and for the synthesis of probes specific of the junction for the detection and follow-up of minimal residual diseases (MRD) in leukemias and lymphomas. A new era is opening in hemato-oncology with the use of NGS for analysis of the clonality and MRD identification, making IMGT<sup>Â®</sup> standards use more needed as ever. More generally, the IMGT/HighV-QUEST web portal is a paradigm for identification of IMGT clonotype diversity and expression in NGS immune repertoire analysis of the adaptive immune response in infectious diseases, in vaccination, and for next-generation repertoire immunoprofiling (<xref rid="B26" ref-type="bibr">26</xref>).</p>
      <p>The therapeutic monoclonal antibody engineering field represents the most promising potential in medicine. A standardized analysis of IG genomic and expressed sequences, structures, and interactions is crucial for a better molecular understanding and comparison of the mAb specificity, affinity, half-life, Fc effector properties, and potential immunogenicity. IMGT-ONTOLOGY concepts have become a necessity for IG loci description of newly sequenced genomes, antibody structure/function characterization, antibody engineering [single chain Fragment variable (scFv), phage displays, combinatorial libraries] and antibody humanization (chimeric, humanized, and human antibodies) (<xref rid="B35" ref-type="bibr">35</xref>, <xref rid="B42" ref-type="bibr">42</xref>, <xref rid="B44" ref-type="bibr">44</xref>, <xref rid="B46" ref-type="bibr">46</xref>, <xref rid="B75" ref-type="bibr">75</xref>â<xref rid="B77" ref-type="bibr">77</xref>, <xref rid="B82" ref-type="bibr">82</xref>). IMGT<sup>Â®</sup> standardization allows repertoire analysis and antibody humanization studies to move to novel high-throughput methodologies with the same high-quality criteria. The CDR-IMGT lengths are now required for mAb INN applications and are included in the WHOâINN definitions (<xref rid="B51" ref-type="bibr">51</xref>), bringing a new level of standardized information in the comparative analysis of therapeutic antibodies.</p>
    </sec>
    <sec id="S7">
      <title>Availability and Citation</title>
      <p>Authors who use IMGT<sup>Â®</sup> databases and tools are encouraged to cite this article and to quote the IMGT<sup>Â®</sup> Home page, <uri xlink:type="simple" xlink:href="http://www.imgt.org">http://www.imgt.org</uri>. Online access to IMGT<sup>Â®</sup> databases and tools are freely available for academics and under licenses and contracts for companies.</p>
    </sec>
    <sec id="S8">
      <title>Conflict of Interest Statement</title>
      <p>The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
    </sec>
  </body>
  <back>
    <ack>
      <p>I am grateful to GÃ©rard Lefranc and Sophia Kossida for helpful discussion, Patrice Duroux, VÃ©ronique Giudicelli, Joumana Jabado-Michaloud, and GÃ©raldine Folch for developing and managing the IMGT<sup>Â®</sup> system, Eltaf Alamyar for IMGT/HighV-QUEST developments, Safa Aouinti, Emilie Carillon, Hugo Duverney, Denis Moreno, Typhaine Paysan-Lafosse, SaÃ¯da Saljoki, Souphatta Sasorith, Caroline Tournier for their invaluable current contribution, and all the previous members of the IMGT<sup>Â®</sup> team, for their expertise and constant motivation. We thank Cold Spring Harbor Protocol Press for the pdf of the IMGT Booklet available in IMGT references. IMGT<sup>Â®</sup> is a registered trademark of CNRS. IMGT<sup>Â®</sup> is member of the International Medical Informatics Association (IMIA). IMGT<sup>Â®</sup> was funded in part by the BIOMED1 (BIOCT930038), Biotechnology BIOTECH2 (BIO4CT960037), Fifth PCRDT Quality of Life and Management of Living Resources (QLG2-2000-01287), and Sixth PCRDT Information Science and Technology (ImmunoGrid, FP6 IST-028069) programs of the European Union (EU). IMGT<sup>Â®</sup> is currently supported by the Centre National de la Recherche Scientifique (CNRS), the MinistÃ¨re de lâEnseignement SupÃ©rieur et de la Recherche (MESR), the University Montpellier 2, the Agence Nationale de la Recherche (ANR) Labex MabImprove (ANR-10-LABX-53-01), BioCampus Montpellier, the RÃ©gion Languedoc-Roussillon (Grand Plateau Technique pour la Recherche (GPTR). This work was granted access to the HPC resources of CINES under the allocation 036029 (2010â2014) made by GENCI (Grand Equipement National de Calcul Intensif).</p>
    </ack>
    <fn-group>
      <fn id="fn1">
        <p>
          <sup>1</sup>
          <uri xlink:type="simple" xlink:href="http://www.imgt.org">http://www.imgt.org</uri>
        </p>
      </fn>
      <fn id="fn2">
        <p>
          <sup>2</sup>
          <uri xlink:type="simple" xlink:href="http://bioportal.bioontology.org/ontologies/1491">http://bioportal.bioontology.org/ontologies/1491</uri>
        </p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="B1">
        <label>1</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lefranc</surname><given-names>M-P</given-names></name><name><surname>Giudicelli</surname><given-names>V</given-names></name><name><surname>Ginestoux</surname><given-names>C</given-names></name><name><surname>Jabado-Michaloud</surname><given-names>J</given-names></name><name><surname>Folch</surname><given-names>G</given-names></name><name><surname>Bellahcene</surname><given-names>F</given-names></name><etal/></person-group>
<article-title>IMGT<sup>Â®</sup>, the international ImMunoGeneTics information system<sup>Â®</sup></article-title>. <source>Nucleic Acids Res</source> (<year>2009</year>) <volume>37</volume>:<fpage>D1006</fpage>â<lpage>12</lpage><pub-id pub-id-type="doi">10.1093/nar/gkn838</pub-id><pub-id pub-id-type="pmid">18978023</pub-id></mixed-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Lefranc</surname><given-names>M-P</given-names></name><name><surname>Lefranc</surname><given-names>G</given-names></name></person-group>
<source>The Immunoglobulin FactsBook</source>. <publisher-loc>London</publisher-loc>: <publisher-name>Academic Press</publisher-name> (<year>2001</year>).</mixed-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Lefranc</surname><given-names>M-P</given-names></name><name><surname>Lefranc</surname><given-names>G</given-names></name></person-group>
<source>The T Cell Receptor FactsBook</source>. <publisher-loc>London</publisher-loc>: <publisher-name>Academic Press</publisher-name> (<year>2001</year>).</mixed-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Lefranc</surname><given-names>M-P</given-names></name></person-group>
<article-title>Nomenclature of the human immunoglobulin genes</article-title>. In: <person-group person-group-type="editor"><name><surname>Coligan</surname><given-names>JE</given-names></name><name><surname>Bierer</surname><given-names>BE</given-names></name><name><surname>Margulies</surname><given-names>DE</given-names></name><name><surname>Shevach</surname><given-names>EM</given-names></name><name><surname>Strober</surname><given-names>W</given-names></name></person-group>, editors. <source>Current Protocols in Immunology</source>. <publisher-loc>Hoboken NJ</publisher-loc>: <publisher-name>John Wiley and Sons</publisher-name> (<year>2000</year>). p. <fpage>A.11</fpage>â<lpage>137</lpage></mixed-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Lefranc</surname><given-names>M-P</given-names></name></person-group>
<article-title>Nomenclature of the human T cell receptor genes</article-title>. In: <person-group person-group-type="editor"><name><surname>Coligan</surname><given-names>JE</given-names></name><name><surname>Bierer</surname><given-names>BE</given-names></name><name><surname>Margulies</surname><given-names>DE</given-names></name><name><surname>Shevach</surname><given-names>EM</given-names></name><name><surname>Strober</surname><given-names>W</given-names></name></person-group>, editors. <source>Current Protocols in Immunology</source>. <publisher-loc>Hoboken NJ</publisher-loc>: <publisher-name>John Wiley and Sons</publisher-name> (<year>2000</year>). p. <fpage>A.1O.1</fpage>â<lpage>A.10.23</lpage></mixed-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>KA</given-names></name></person-group>
<article-title>Toward a molecular understanding of adaptive immunity: a chronology, part I</article-title>. <source>Front Immunol</source> (<year>2012</year>) <volume>3</volume>:<fpage>369</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2012.00369</pub-id><?supplied-pmid 23230443?><pub-id pub-id-type="pmid">23230443</pub-id></mixed-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>KA</given-names></name></person-group>
<article-title>Toward a molecular understanding of adaptive immunity: a chronology, part II</article-title>. <source>Front Immunol</source> (<year>2012</year>) <volume>3</volume>:<fpage>364</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2012.00364</pub-id><?supplied-pmid 23230441?><pub-id pub-id-type="pmid">23230441</pub-id></mixed-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lefranc</surname><given-names>M-P</given-names></name><name><surname>Duprat</surname><given-names>E</given-names></name><name><surname>Kaas</surname><given-names>Q</given-names></name><name><surname>Tranne</surname><given-names>M</given-names></name><name><surname>Thiriot</surname><given-names>A</given-names></name><name><surname>Lefranc</surname><given-names>G</given-names></name></person-group>
<article-title>IMGT unique numbering for MHC groove G-DOMAIN and MHC superfamily (MhcSF) G-LIKE-DOMAIN</article-title>. <source>Dev Comp Immunol</source> (<year>2005</year>) <volume>29</volume>:<fpage>917</fpage>â<lpage>38</lpage><pub-id pub-id-type="doi">10.1016/j.dci.2005.03.003</pub-id><?supplied-pmid 15936075?><pub-id pub-id-type="pmid">15936075</pub-id></mixed-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giudicelli</surname><given-names>V</given-names></name><name><surname>Duroux</surname><given-names>P</given-names></name><name><surname>Ginestoux</surname><given-names>C</given-names></name><name><surname>Folch</surname><given-names>G</given-names></name><name><surname>Jabado-Michaloud</surname><given-names>J</given-names></name><name><surname>Chaume</surname><given-names>D</given-names></name><etal/></person-group>
<article-title>IMGT/LIGM-DB, the IMGT<sup>Â®</sup> comprehensive database of immunoglobulin and T cell receptor nucleotide sequences</article-title>. <source>Nucleic Acids Res</source> (<year>2006</year>) <volume>34</volume>:<fpage>D781</fpage>â<lpage>4</lpage><pub-id pub-id-type="doi">10.1093/nar/gkj088</pub-id><?supplied-pmid 16381979?><pub-id pub-id-type="pmid">16381979</pub-id></mixed-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giudicelli</surname><given-names>V</given-names></name><name><surname>Chaume</surname><given-names>D</given-names></name><name><surname>Lefranc</surname><given-names>M-P</given-names></name></person-group>
<article-title>IMGT/GENE-DB: a comprehensive database for human and mouse immunoglobulin and T cell receptor genes</article-title>. <source>Nucleic Acids Res</source> (<year>2005</year>) <volume>33</volume>:<fpage>D256</fpage>â<lpage>61</lpage><pub-id pub-id-type="doi">10.1093/nar/gki010</pub-id><?supplied-pmid 15608191?><pub-id pub-id-type="pmid">15608191</pub-id></mixed-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaas</surname><given-names>Q</given-names></name><name><surname>Ruiz</surname><given-names>M</given-names></name><name><surname>Lefranc</surname><given-names>M-P</given-names></name></person-group>
<article-title>IMGT/3Dstructure-DB and IMGT/ StructuralQuery, a database and a tool for immunoglobulin, T cell receptor and MHC structural data</article-title>. <source>Nucleic Acids Res</source> (<year>2004</year>) <volume>32</volume>:<fpage>D208</fpage>â<lpage>10</lpage><pub-id pub-id-type="doi">10.1093/nar/gkh042</pub-id><?supplied-pmid 14681396?><pub-id pub-id-type="pmid">14681396</pub-id></mixed-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ehrenmann</surname><given-names>F</given-names></name><name><surname>Kaas</surname><given-names>Q</given-names></name><name><surname>Lefranc</surname><given-names>M-P</given-names></name></person-group>
<article-title>IMGT/3Dstructure-DB and IMGT/DomainGapAlign: a database and a tool for immunoglobulins or antibodies, T cell receptors, MHC, IgSF and MhcSF</article-title>. <source>Nucleic Acids Res</source> (<year>2010</year>) <volume>38</volume>:<fpage>D301</fpage>â<lpage>7</lpage><pub-id pub-id-type="doi">10.1093/nar/gkp946</pub-id><?supplied-pmid 19900967?><pub-id pub-id-type="pmid">19900967</pub-id></mixed-citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ehrenmann</surname><given-names>F</given-names></name><name><surname>Lefranc</surname><given-names>M-P</given-names></name></person-group>
<article-title>IMGT/3Dstructure-DB: querying the IMGT database for 3D structures in immunology and immunoinformatics (IG or antibodies, TR, MH, RPI, and FPIA)</article-title>. <source>Cold Spring Harb Protoc</source> (<year>2011</year>) <volume>6</volume>:<fpage>750</fpage>â<lpage>61</lpage><pub-id pub-id-type="doi">10.1101/pdb.prot5637</pub-id><pub-id pub-id-type="pmid">21632774</pub-id></mixed-citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <mixed-citation publication-type="webpage"><person-group person-group-type="author"><name><surname>Poiron</surname><given-names>C</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Ginestoux</surname><given-names>C</given-names></name><name><surname>Ehrenmann</surname><given-names>F</given-names></name><name><surname>Duroux</surname><given-names>P</given-names></name><name><surname>Lefranc</surname><given-names>M-P</given-names></name></person-group>
<article-title><italic>IMGT/mAb-DB: The IMGT<sup>Â®</sup> Database for Therapeutic Monoclonal Antibodies, 11<sup>Ã¨mes</sup> JournÃ©es Ouvertes de Biologie</italic>, Informatique et MathÃ©matiques (JOBIM)</article-title>. <source>Montpellier</source> (<year>2010</year>). Poster 13, Available from: <uri xlink:type="simple" xlink:href="http://www.jobim2010.fr/indexe662.html?q=en/node/56">http://www.jobim2010.fr/indexe662.html?q=en/node/56</uri></mixed-citation>
      </ref>
      <ref id="B15">
        <label>15</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giudicelli</surname><given-names>V</given-names></name><name><surname>Chaume</surname><given-names>D</given-names></name><name><surname>Lefranc</surname><given-names>M-P</given-names></name></person-group>
<article-title>IMGT/V-QUEST, an integrated software for immunoglobulin and T cell receptor V-J and V-D-J rearrangement analysis</article-title>. <source>Nucleic Acids Res</source> (<year>2004</year>) <volume>32</volume>:<fpage>W435</fpage>â<lpage>40</lpage><pub-id pub-id-type="doi">10.1093/nar/gkh412</pub-id><?supplied-pmid 15215425?><pub-id pub-id-type="pmid">15215425</pub-id></mixed-citation>
      </ref>
      <ref id="B16">
        <label>16</label>
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Giudicelli</surname><given-names>V</given-names></name><name><surname>Lefranc</surname><given-names>M-P</given-names></name></person-group>
<article-title>Interactive IMGT on-line tools for the analysis of immunoglobulin and T cell receptor repertoires</article-title>. In: <person-group person-group-type="editor"><name><surname>Veskler</surname><given-names>BA</given-names></name></person-group>, editor. <source>New Research on Immunology</source>. <publisher-loc>New York</publisher-loc>: <publisher-name>Nova Science Publishers Inc</publisher-name> (<year>2005</year>). p. <fpage>77</fpage>â<lpage>105</lpage></mixed-citation>
      </ref>
      <ref id="B17">
        <label>17</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brochet</surname><given-names>X</given-names></name><name><surname>Lefranc</surname><given-names>M-P</given-names></name><name><surname>Giudicelli</surname><given-names>V</given-names></name></person-group>
<article-title>IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis</article-title>. <source>Nucleic Acids Res</source> (<year>2008</year>) <volume>36</volume>:<fpage>W503</fpage>â<lpage>8</lpage><pub-id pub-id-type="doi">10.1093/nar/gkn316</pub-id><?supplied-pmid 18503082?><pub-id pub-id-type="pmid">18503082</pub-id></mixed-citation>
      </ref>
      <ref id="B18">
        <label>18</label>
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Giudicelli</surname><given-names>V</given-names></name><name><surname>Lefranc</surname><given-names>M-P</given-names></name></person-group>
<article-title>IMGT<sup>Â®</sup> standardized analysis of immunoglobulin rearranged sequences</article-title>. In: <person-group person-group-type="editor"><name><surname>Ghia</surname><given-names>P</given-names></name><name><surname>Rosenquist</surname><given-names>R</given-names></name><name><surname>Davi</surname><given-names>F</given-names></name></person-group>, editors. <source>Immunoglobulin Gene Analysis in Chronic Lymphocytic Leukemia</source>. <publisher-loc>Italy</publisher-loc>: <publisher-name>Wolters Kluwer Health</publisher-name> (<year>2008</year>). p. <fpage>33</fpage>â<lpage>52</lpage></mixed-citation>
      </ref>
      <ref id="B19">
        <label>19</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giudicelli</surname><given-names>V</given-names></name><name><surname>Brochet</surname><given-names>X</given-names></name><name><surname>Lefranc</surname><given-names>M-P</given-names></name></person-group>
<article-title>IMGT/V-QUEST: IMGT standardized analysis of the immunoglobulin (IG) and T cell receptor (TR) nucleotide sequences</article-title>. <source>Cold Spring Harb Protoc</source> (<year>2011</year>) <volume>6</volume>:<fpage>695</fpage>â<lpage>715</lpage><pub-id pub-id-type="doi">10.1101/pdb.prot5633</pub-id><pub-id pub-id-type="pmid">21632778</pub-id></mixed-citation>
      </ref>
      <ref id="B20">
        <label>20</label>
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Alamyar</surname><given-names>E</given-names></name><name><surname>Duroux</surname><given-names>P</given-names></name><name><surname>Lefranc</surname><given-names>M-P</given-names></name><name><surname>Giudicelli</surname><given-names>V</given-names></name></person-group>
<article-title>IMGT<sup>Â®</sup> tools for the nucleotide analysis of immunoglobulin (IG) and T cell receptor (TR) V-(D)-J repertoires, polymorphisms, and IG mutations: IMGT/V-QUEST and IMGT/HighV-QUEST for NGS</article-title>. In: <person-group person-group-type="editor"><name><surname>Christiansen</surname><given-names>F</given-names></name><name><surname>Tait</surname><given-names>B</given-names></name></person-group>, editors. <source>Methods Mol Biol</source>. <publisher-loc>New York</publisher-loc>: <publisher-name>Humana Press, Springer</publisher-name> (<year>2012</year>) <volume>882</volume>:<fpage>569</fpage>â<lpage>604</lpage><pub-id pub-id-type="doi">10.1007/978-1-61779-842-9_32</pub-id></mixed-citation>
      </ref>
      <ref id="B21">
        <label>21</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yousfi Monod</surname><given-names>M</given-names></name><name><surname>Giudicelli</surname><given-names>V</given-names></name><name><surname>Chaume</surname><given-names>D</given-names></name><name><surname>Lefranc</surname><given-names>M-P</given-names></name></person-group>
<article-title>IMGT/ JunctionAnalysis: the first tool for the analysis of the immunoglobulin and T cell receptor complex V-J and V-D-J JUNCTIONs</article-title>. <source>Bioinformatics</source> (<year>2004</year>) <volume>20</volume>:<fpage>i379</fpage>â<lpage>85</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bth945</pub-id><?supplied-pmid 15262823?><pub-id pub-id-type="pmid">15262823</pub-id></mixed-citation>
      </ref>
      <ref id="B22">
        <label>22</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giudicelli</surname><given-names>V</given-names></name><name><surname>Lefranc</surname><given-names>M-P</given-names></name></person-group>
<article-title>IMGT/JunctionAnalysis: IMGT standardized analysis of the V-J and V-D-J junctions of the rearranged immunoglobulins (IG) and T cell receptors (TR)</article-title>. <source>Cold Spring Harb Protoc</source> (<year>2011</year>) <volume>6</volume>:<fpage>716</fpage>â<lpage>25</lpage><pub-id pub-id-type="doi">10.1101/pdb.prot5634</pub-id><pub-id pub-id-type="pmid">21632777</pub-id></mixed-citation>
      </ref>
      <ref id="B23">
        <label>23</label>
        <mixed-citation publication-type="confproc"><person-group person-group-type="author"><name><surname>Giudicelli</surname><given-names>V</given-names></name><name><surname>Protat</surname><given-names>C</given-names></name><name><surname>Lefranc</surname><given-names>M-P</given-names></name></person-group>
<article-title>The IMGT strategy for the automatic annotation of IG and TR cDNA sequences: IMGT/Automat</article-title>. In: <conf-name>Proceedings of the European Conference on Computational Biology (ECCB 2003),â Data and Knowledge Bases, Poster DKB_31, ECCB</conf-name>
<conf-loc>Paris</conf-loc>: <conf-sponsor>Institut National de Recherche en Informatique et en Automatique</conf-sponsor> (<year>2003</year>). pp. <fpage>103</fpage>â<lpage>104</lpage></mixed-citation>
      </ref>
      <ref id="B24">
        <label>24</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giudicelli</surname><given-names>V</given-names></name><name><surname>Chaume</surname><given-names>D</given-names></name><name><surname>Jabado-Michaloud</surname><given-names>J</given-names></name><name><surname>Lefranc</surname><given-names>M-P</given-names></name></person-group>
<article-title>Immunogenetics sequence annotation: the strategy of IMGT based on IMGT-ONTOLOGY</article-title>. <source>Stud Health Technol Inform</source> (<year>2005</year>) <volume>116</volume>:<fpage>3</fpage>â<lpage>8</lpage><?supplied-pmid 16160227?><pub-id pub-id-type="pmid">16160227</pub-id></mixed-citation>
      </ref>
      <ref id="B25">
        <label>25</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alamyar</surname><given-names>E</given-names></name><name><surname>Giudicelli</surname><given-names>V</given-names></name><name><surname>Shuo</surname><given-names>L</given-names></name><name><surname>Duroux</surname><given-names>P</given-names></name><name><surname>Lefranc</surname><given-names>M-P</given-names></name></person-group>
<article-title>IMGT/HighV-QUEST: the IMGT<sup>Â®</sup> web portal for immunoglobulin (IG) or antibody and T cell receptor (TR) analysis from NGS high throughput and deep sequencing</article-title>. <source>Immunome Res</source> (<year>2012</year>) <volume>8</volume>(<issue>1</issue>):<fpage>26</fpage><pub-id pub-id-type="doi">10.1007/978-1-61779-842-9_32</pub-id><?supplied-pmid 22665256?><pub-id pub-id-type="pmid">22665256</pub-id></mixed-citation>
      </ref>
      <ref id="B26">
        <label>26</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Lefranc</surname><given-names>M-P</given-names></name><name><surname>Miles</surname><given-names>JJ</given-names></name><name><surname>Alamyar</surname><given-names>E</given-names></name><name><surname>Giudicelli</surname><given-names>V</given-names></name><name><surname>Duroux</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>IMGT/HighV-QUEST paradigm for T cell receptor IMGT clonotype diversity and next generation repertoire immunoprofiling</article-title>. <source>Nat Commun</source> (<year>2013</year>) <volume>4</volume>:<fpage>2333</fpage><pub-id pub-id-type="doi">10.1038/ncomms3333</pub-id><?supplied-pmid 23995877?><pub-id pub-id-type="pmid">23995877</pub-id></mixed-citation>
      </ref>
      <ref id="B27">
        <label>27</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ehrenmann</surname><given-names>F</given-names></name><name><surname>Lefranc</surname><given-names>M-P</given-names></name></person-group>
<article-title>IMGT/DomainGapAlign: IMGT standardized analysis of amino acid sequences of variable, constant, and groove domains (IG, TR, MH, IgSF, MhSF)</article-title>. <source>Cold Spring Harb Protoc</source> (<year>2011</year>) <volume>6</volume>:<fpage>737</fpage>â<lpage>49</lpage><pub-id pub-id-type="doi">10.1101/pdb.prot5636</pub-id><pub-id pub-id-type="pmid">21632775</pub-id></mixed-citation>
      </ref>
      <ref id="B28">
        <label>28</label>
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Ehrenmann</surname><given-names>F</given-names></name><name><surname>Lefranc</surname><given-names>M-P</given-names></name></person-group>
<article-title>IMGT/DomainGapAlign: the IMGT<sup>Â®</sup> tool for the analysis of IG, TR, MHC, IgSF and MhcSF domain amino acid polymorphism</article-title>. In: <person-group person-group-type="editor"><name><surname>Christiansen</surname><given-names>F</given-names></name><name><surname>Tait</surname><given-names>B</given-names></name></person-group>, editors. <source>Methods Mol Biol</source>. <publisher-loc>New York</publisher-loc>: <publisher-name>Humana Press, Springer</publisher-name> (<year>2012</year>) <volume>882</volume>:<fpage>605</fpage>â<lpage>33</lpage><pub-id pub-id-type="doi">10.1007/978-1-61779-842-9_33</pub-id></mixed-citation>
      </ref>
      <ref id="B29">
        <label>29</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ehrenmann</surname><given-names>F</given-names></name><name><surname>Giudicelli</surname><given-names>V</given-names></name><name><surname>Duroux</surname><given-names>P</given-names></name><name><surname>Lefranc</surname><given-names>M-P</given-names></name></person-group>
<article-title>IMGT/Collier de Perles: IMGT standardized representation of domains (IG, TR, and IgSF variable and constant domains, MH and MhSF groove domains)</article-title>. <source>Cold Spring Harb Protoc</source> (<year>2011</year>) <volume>6</volume>:<fpage>726</fpage>â<lpage>36</lpage><pub-id pub-id-type="doi">10.1101/pdb.prot5635</pub-id><pub-id pub-id-type="pmid">21632776</pub-id></mixed-citation>
      </ref>
      <ref id="B30">
        <label>30</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lane</surname><given-names>J</given-names></name><name><surname>Duroux</surname><given-names>P</given-names></name><name><surname>Lefranc</surname><given-names>M-P</given-names></name></person-group>
<article-title>From IMGT-ONTOLOGY to IMGT/LIGMotif: the IMGT<sup>Â®</sup> standardized approach for immunoglobulin and T cell receptor gene identification and description in large genomic sequences</article-title>. <source>BMC Bioinformatics</source> (<year>2010</year>) <volume>11</volume>:<fpage>223</fpage><pub-id pub-id-type="doi">10.1186/1471-2105-11-223</pub-id><?supplied-pmid 20433708?><pub-id pub-id-type="pmid">20433708</pub-id></mixed-citation>
      </ref>
      <ref id="B31">
        <label>31</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>PommiÃ©</surname><given-names>C</given-names></name><name><surname>Levadoux</surname><given-names>S</given-names></name><name><surname>Sabatier</surname><given-names>R</given-names></name><name><surname>Lefranc</surname><given-names>G</given-names></name><name><surname>Lefranc</surname><given-names>M-P</given-names></name></person-group>
<article-title>IMGT standardized criteria for statistical analysis of immunoglobulin V-REGION amino acid properties</article-title>. <source>J Mol Recognit</source> (<year>2004</year>) <volume>17</volume>:<fpage>17</fpage>â<lpage>32</lpage><pub-id pub-id-type="doi">10.1002/jmr.647</pub-id><?supplied-pmid 14872534?><pub-id pub-id-type="pmid">14872534</pub-id></mixed-citation>
      </ref>
      <ref id="B32">
        <label>32</label>
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Lefranc</surname><given-names>M-P</given-names></name></person-group>
<article-title>IMGT, the international ImMunoGeneTics information system</article-title>. In: <person-group person-group-type="editor"><name><surname>Bock</surname><given-names>G</given-names></name><name><surname>Goode</surname><given-names>J</given-names></name></person-group> editors. <source>âImmunoinformatics: Bioinformatic Strategies for Better Understanding of Immune Functionâ Novartis Foundation Symposium</source>, Vol. <volume>254</volume>
<publisher-loc>Chichester</publisher-loc>: <publisher-name>John Wiley and Sons</publisher-name> (<year>2003</year>). pp. <fpage>126</fpage>â<lpage>126</lpage>; discussion 136â142, 216â222, 250â252.</mixed-citation>
      </ref>
      <ref id="B33">
        <label>33</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lefranc</surname><given-names>M-P</given-names></name><name><surname>Giudicelli</surname><given-names>V</given-names></name><name><surname>Ginestoux</surname><given-names>C</given-names></name><name><surname>Chaume</surname><given-names>D</given-names></name></person-group>
<article-title>IMGT, the international ImMunoGeneTics information system: the reference in immunoinformatics</article-title>. <source>Stud Health Technol Inform</source> (<year>2003</year>) <volume>95</volume>:<fpage>74</fpage>â<lpage>9</lpage><?supplied-pmid 14663966?><pub-id pub-id-type="pmid">14663966</pub-id></mixed-citation>
      </ref>
      <ref id="B34">
        <label>34</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lefranc</surname><given-names>M-P</given-names></name></person-group>
<article-title>IMGT databases, web resources and tools for immunoglobulin and T cell receptor sequence analysis</article-title>. <source>Leukemia</source> (<year>2003</year>) <volume>17</volume>(<issue>1</issue>):<fpage>260</fpage>â<lpage>6</lpage><pub-id pub-id-type="doi">10.1038/sj.leu.2402637</pub-id><?supplied-pmid 12529691?><pub-id pub-id-type="pmid">12529691</pub-id></mixed-citation>
      </ref>
      <ref id="B35">
        <label>35</label>
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Lefranc</surname><given-names>M-P</given-names></name></person-group>
<article-title>IMGT, the international ImMunoGenetics information system<sup>Â®</sup></article-title>. <edition>2nd ed</edition> In: <person-group person-group-type="editor"><name><surname>Lo</surname><given-names>BKC</given-names></name></person-group>, editor. <source>Methods Mol Biol</source>. <publisher-loc>Totowa, NJ</publisher-loc>: <publisher-name>Humana Press</publisher-name> (<year>2004</year>) <volume>248</volume>:<fpage>27</fpage>â<lpage>49</lpage></mixed-citation>
      </ref>
      <ref id="B36">
        <label>36</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lefranc</surname><given-names>M-P</given-names></name></person-group>
<article-title>IMGT-ONTOLOGY and IMGT databases, tools and Web resources for immunogenetics and immunoinformatics</article-title>. <source>Mol Immunol</source> (<year>2004</year>) <volume>40</volume>(<issue>10</issue>):<fpage>647</fpage>â<lpage>60</lpage><pub-id pub-id-type="doi">10.1016/j.molimm.2003.09.006</pub-id><?supplied-pmid 14644091?><pub-id pub-id-type="pmid">14644091</pub-id></mixed-citation>
      </ref>
      <ref id="B37">
        <label>37</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lefranc</surname><given-names>M-P</given-names></name></person-group>
<article-title>IMGT, the international ImMunoGeneTics information system: a standardized approach for immunogenetics and immunoinformatics</article-title>. <source>Immunome Res</source> (<year>2005</year>) <volume>1</volume>:<fpage>3</fpage><pub-id pub-id-type="doi">10.1186/1745-7580-1-3</pub-id><pub-id pub-id-type="pmid">16305737</pub-id></mixed-citation>
      </ref>
      <ref id="B38">
        <label>38</label>
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Lefranc</surname><given-names>M-P</given-names></name></person-group>
<article-title>IMGT<sup>Â®</sup>, the international ImMunoGeneTics information system<sup>Â®</sup> for immunoinformatics. Methods for querying IMGT<sup>Â®</sup> databases, tools and Web resources in the context of immunoinformatics</article-title>. In: <person-group person-group-type="editor"><name><surname>Flower</surname><given-names>DR</given-names></name></person-group>, editor. <source>Methods Mol Biol</source>. <publisher-loc>Totowa, NJ</publisher-loc>: <publisher-name>Humana Press, Springer</publisher-name> (<year>2007</year>) <volume>409</volume>:<fpage>19</fpage>â<lpage>42</lpage><pub-id pub-id-type="doi">10.1007/978-1-60327-118-9_2</pub-id></mixed-citation>
      </ref>
      <ref id="B39">
        <label>39</label>
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Lefranc</surname><given-names>M-P</given-names></name></person-group>
<article-title>IMGT-ONTOLOGY, IMGT<sup>Â®</sup> databases, tools and Web resources for immunoinformatics</article-title>. In: <person-group person-group-type="author"><name><surname>Schoenbach</surname><given-names>C</given-names></name><name><surname>Ranganathan</surname><given-names>S</given-names></name><name><surname>Brusic</surname><given-names>V</given-names></name></person-group> editors. <source>Immunoinformatics, Immunomics Reviews, Series of Springer Science and Business Media LLC</source>, Vol. <volume>1</volume>
<publisher-loc>New York</publisher-loc>: <publisher-name>Springer</publisher-name> (<year>2008</year>). pp. <fpage>1</fpage>â<lpage>18</lpage></mixed-citation>
      </ref>
      <ref id="B40">
        <label>40</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lefranc</surname><given-names>M-P</given-names></name><name><surname>Giudicelli</surname><given-names>V</given-names></name><name><surname>Regnier</surname><given-names>L</given-names></name><name><surname>Duroux</surname><given-names>P</given-names></name></person-group>
<article-title>IMGT<sup>Â®</sup>, a system and an ontology that bridge biological and computational spheres in bioinformatics</article-title>. <source>Brief Bioinform</source> (<year>2008</year>) <volume>9</volume>:<fpage>263</fpage>â<lpage>75</lpage><pub-id pub-id-type="doi">10.1093/bib/bbn014</pub-id><?supplied-pmid 18424816?><pub-id pub-id-type="pmid">18424816</pub-id></mixed-citation>
      </ref>
      <ref id="B41">
        <label>41</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lefranc</surname><given-names>M-P</given-names></name></person-group>
<article-title>IMGT<sup>Â®</sup>, the international ImMunoGeneTics information system<sup>Â®</sup> for immunoinformatics. Methods for querying IMGT<sup>Â®</sup> databases, tools and Web resources in the context of immunoinformatics</article-title>. <source>Mol Biotechnol</source> (<year>2008</year>) <volume>40</volume>:<fpage>101</fpage>â<lpage>11</lpage><pub-id pub-id-type="doi">10.1007/s12033-008-9062-7</pub-id><pub-id pub-id-type="pmid">18463990</pub-id></mixed-citation>
      </ref>
      <ref id="B42">
        <label>42</label>
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Lefranc</surname><given-names>M-P</given-names></name></person-group>
<article-title>Antibody databases and tools: the IMGT<sup>Â®</sup> experience</article-title>. In: <person-group person-group-type="editor"><name><surname>An</surname><given-names>Z</given-names></name></person-group>, editor. <source>Therapeutic Monoclonal Antibodies: From Bench to Clinic</source>. <publisher-loc>Hoboken NJ</publisher-loc>: <publisher-name>John Wiley and Sons</publisher-name> (<year>2009</year>). p. <fpage>91</fpage>â<lpage>114</lpage></mixed-citation>
      </ref>
      <ref id="B43">
        <label>43</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lefranc</surname><given-names>M-P</given-names></name></person-group>
<article-title>Antibody databases: IMGT<sup>Â®</sup>, a French platform of world-wide interest [in French]. Bases de donnÃ©es anticorps: IMGT<sup>Â®</sup>, une plate-forme franÃ§aise dâintÃ©rÃªt mondial</article-title>. <source>Med Sci (Paris)</source> (<year>2009</year>) <volume>25</volume>:<fpage>1020</fpage>â<lpage>3</lpage><pub-id pub-id-type="doi">10.1051/medsci/200925121020</pub-id><?supplied-pmid 20035673?><pub-id pub-id-type="pmid">20035673</pub-id></mixed-citation>
      </ref>
      <ref id="B44">
        <label>44</label>
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Ehrenmann</surname><given-names>F</given-names></name><name><surname>Duroux</surname><given-names>P</given-names></name><name><surname>Giudicelli</surname><given-names>V</given-names></name><name><surname>Lefranc</surname><given-names>M-P</given-names></name></person-group>
<article-title>Standardized sequence and structure analysis of antibody using IMGT<sup>Â®</sup></article-title>. In: <person-group person-group-type="editor"><name><surname>Kontermann</surname><given-names>R</given-names></name><name><surname>DÃ¼bel</surname><given-names>S</given-names></name></person-group>, editors. <source>Antibody Engineering</source> Vol. <volume>2</volume>
<publisher-loc>Berlin</publisher-loc>: <publisher-name>Springer-Verlag</publisher-name> (<year>2010</year>). pp. <fpage>11</fpage>â<lpage>31</lpage></mixed-citation>
      </ref>
      <ref id="B45">
        <label>45</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lefranc</surname><given-names>M-P</given-names></name></person-group>
<article-title>IMGT, the international ImMunoGeneTics information system</article-title>. <source>Cold Spring Harb Protoc</source> (<year>2011</year>) <volume>6</volume>:<fpage>595</fpage>â<lpage>603</lpage><pub-id pub-id-type="doi">10.1101/pdb.top115</pub-id><pub-id pub-id-type="pmid">21632786</pub-id></mixed-citation>
      </ref>
      <ref id="B46">
        <label>46</label>
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Lefranc</surname><given-names>M-P</given-names></name><name><surname>Ehrenmann</surname><given-names>F</given-names></name><name><surname>Ginestoux</surname><given-names>C</given-names></name><name><surname>Duroux</surname><given-names>P</given-names></name><name><surname>Giudicelli</surname><given-names>V</given-names></name></person-group>
<article-title>Use of IMGT<sup>Â®</sup> databases and tools for antibody engineering and humanization</article-title>. <source>Methods Mol Biol</source>. <publisher-loc>New York</publisher-loc>: <publisher-name>Humana Press, Springer</publisher-name> (<year>2012</year>) <volume>907</volume>:<fpage>3</fpage>â<lpage>37</lpage><pub-id pub-id-type="pmid">22907343</pub-id></mixed-citation>
      </ref>
      <ref id="B47">
        <label>47</label>
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Lefranc</surname><given-names>M-P</given-names></name></person-group>
<article-title>IMGT<sup>Â®</sup> information system</article-title>. In: <person-group person-group-type="editor"><name><surname>Dubitzky</surname><given-names>W</given-names></name><name><surname>Wolkenhauer</surname><given-names>O</given-names></name><name><surname>Cho</surname><given-names>K-H</given-names></name><name><surname>Yokota</surname><given-names>H</given-names></name></person-group>, editors. <source>Encyclopedia of Systems Biology</source>. <publisher-loc>New York</publisher-loc>: <publisher-name>Springer Science+Business Media</publisher-name> (<year>2013</year>). p. <fpage>959</fpage>â<lpage>64</lpage><pub-id pub-id-type="doi">10.1007/978-1-4419-9863-7</pub-id></mixed-citation>
      </ref>
      <ref id="B48">
        <label>48</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lefranc</surname><given-names>M-P</given-names></name></person-group>
<article-title>WHO-IUIS Nomenclature Subcommittee for immunoglobulins and T cell receptors report</article-title>. <source>Immunogenetics</source> (<year>2007</year>) <volume>59</volume>:<fpage>899</fpage>â<lpage>902</lpage><pub-id pub-id-type="doi">10.1007/s00251-007-0260-4</pub-id><pub-id pub-id-type="pmid">18046549</pub-id></mixed-citation>
      </ref>
      <ref id="B49">
        <label>49</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lefranc</surname><given-names>M-P</given-names></name></person-group>
<article-title>WHO-IUIS Nomenclature Subcommittee for immunoglobulins and T cell receptors report August 2007, 13th International Congress of Immunology, Rio de Janeiro, Brazil</article-title>. <source>Dev Comp Immunol</source> (<year>2008</year>) <volume>32</volume>:<fpage>461</fpage>â<lpage>3</lpage><pub-id pub-id-type="doi">10.1016/j.dci.2007.09.008</pub-id><pub-id pub-id-type="pmid">18036660</pub-id></mixed-citation>
      </ref>
      <ref id="B50">
        <label>50</label>
        <mixed-citation publication-type="webpage"><collab>World Health Organization</collab>
<source>International Nonproprietary Names (INN) for Biological and Biotechnological Substances (A Review). INN Working Document 05.179</source>. (<year>2012</year>). Available from: <uri xlink:type="simple" xlink:href="http://www.who.int/medicines/services/inn/BioRev2012.pdf">http://www.who.int/medicines/services/inn/BioRev2012.pdf</uri></mixed-citation>
      </ref>
      <ref id="B51">
        <label>51</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lefranc</surname><given-names>M-P</given-names></name></person-group>
<article-title>Antibody nomenclature: from IMGT-ONTOLOGY to INN definition</article-title>. <source>MAbs</source> (<year>2011</year>) <volume>3</volume>(<issue>1</issue>):<fpage>1</fpage>â<lpage>2</lpage><pub-id pub-id-type="doi">10.4161/mabs.3.1.14151</pub-id><pub-id pub-id-type="pmid">21099347</pub-id></mixed-citation>
      </ref>
      <ref id="B52">
        <label>52</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giudicelli</surname><given-names>V</given-names></name><name><surname>Lefranc</surname><given-names>M-P</given-names></name></person-group>
<article-title>Ontology for immunogenetics: IMGT- ONTOLOGY</article-title>. <source>Bioinformatics</source> (<year>1999</year>) <volume>15</volume>:<fpage>1047</fpage>â<lpage>54</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/15.12.1047</pub-id><?supplied-pmid 10745995?><pub-id pub-id-type="pmid">10745995</pub-id></mixed-citation>
      </ref>
      <ref id="B53">
        <label>53</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giudicelli</surname><given-names>V</given-names></name><name><surname>Lefranc</surname><given-names>M-P</given-names></name></person-group>
<article-title>IMGT-ONTOLOGY 2012</article-title>. <source>Front Genet</source> (<year>2012</year>) <volume>3</volume>:<fpage>79</fpage> eCollection 2012,<pub-id pub-id-type="doi">10.3389/fgene.2012.00079</pub-id><pub-id pub-id-type="pmid">22654892</pub-id></mixed-citation>
      </ref>
      <ref id="B54">
        <label>54</label>
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Giudicelli</surname><given-names>V</given-names></name><name><surname>Lefranc</surname><given-names>M-P</given-names></name></person-group>
<article-title>IMGT-ONTOLOGY</article-title>. In: <person-group person-group-type="editor"><name><surname>Dubitzky</surname><given-names>W</given-names></name><name><surname>Wolkenhauer</surname><given-names>O</given-names></name><name><surname>Cho</surname><given-names>K-H</given-names></name><name><surname>Yokota</surname><given-names>H</given-names></name></person-group>, editors. <source>Encyclopedia of Systems Biology</source>. <publisher-loc>New York</publisher-loc>: <publisher-name>Springer Science+Business Media</publisher-name> (<year>2013</year>). p. <fpage>964</fpage>â<lpage>72</lpage><pub-id pub-id-type="doi">10.1007/978-1-4419-9863-7</pub-id></mixed-citation>
      </ref>
      <ref id="B55">
        <label>55</label>
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Giudicelli</surname><given-names>V</given-names></name><name><surname>Lefranc</surname><given-names>M-P</given-names></name></person-group>
<article-title>IMGT-ONTOLOGY: gestion et dÃ©couverte de connaissances au sein dâIMGT</article-title>. In: <person-group person-group-type="editor"><name><surname>Hacid</surname><given-names>M-S</given-names></name><name><surname>Kodratoff</surname><given-names>Y</given-names></name><name><surname>Boulanger</surname><given-names>D</given-names></name></person-group> editors. <source>Extraction et gestion des connaissances (EGCâ2003), Actes des troisiÃ¨mes journÃ©es, Lyon, France, 22-24 janvier 2003. Revue des Sciences et Technologies de lâInformation, RSTI, sÃ©rie Revue dâIntelligence Artificielle â Extraction des Connaissances et Apprentissage (RIA-ECA)</source>, <publisher-loc>Paris</publisher-loc>: <publisher-name>HermÃ¨s Science Publications</publisher-name> (<year>2003</year>). pp. <fpage>13</fpage>â<lpage>23</lpage></mixed-citation>
      </ref>
      <ref id="B56">
        <label>56</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lefranc</surname><given-names>M-P</given-names></name><name><surname>Giudicelli</surname><given-names>V</given-names></name><name><surname>Ginestoux</surname><given-names>C</given-names></name><name><surname>Bosc</surname><given-names>N</given-names></name><name><surname>Folch</surname><given-names>G</given-names></name><name><surname>Guiraudou</surname><given-names>D</given-names></name><etal/></person-group>
<article-title>IMGT-ONTOLOGY for immunogenetics and immunoinformatics</article-title>. <source>In silico Biol</source> (<year>2004</year>) <volume>4</volume>:<fpage>17</fpage>â<lpage>29</lpage><pub-id pub-id-type="pmid">15089751</pub-id></mixed-citation>
      </ref>
      <ref id="B57">
        <label>57</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lefranc</surname><given-names>M-P</given-names></name><name><surname>ClÃ©ment</surname><given-names>O</given-names></name><name><surname>Kaas</surname><given-names>Q</given-names></name><name><surname>Duprat</surname><given-names>E</given-names></name><name><surname>Chastellan</surname><given-names>P</given-names></name><name><surname>Coelho</surname><given-names>I</given-names></name><etal/></person-group>
<article-title>IMGT-choreography for immunogenetics and immunoinformatics</article-title>. <source>In silico Biol</source> (<year>2005</year>) <volume>5</volume>:<fpage>45</fpage>â<lpage>60</lpage><?supplied-pmid 15972004?><pub-id pub-id-type="pmid">15972004</pub-id></mixed-citation>
      </ref>
      <ref id="B58">
        <label>58</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duroux</surname><given-names>P</given-names></name><name><surname>Kaas</surname><given-names>Q</given-names></name><name><surname>Brochet</surname><given-names>X</given-names></name><name><surname>Lane</surname><given-names>J</given-names></name><name><surname>Ginestoux</surname><given-names>C</given-names></name><name><surname>Lefranc</surname><given-names>M-P</given-names></name><etal/></person-group>
<article-title>IMGT-Kaleidoscope, the formal IMGT-ONTOLOGY paradigm</article-title>. <source>Biochimie</source> (<year>2008</year>) <volume>90</volume>:<fpage>570</fpage>â<lpage>83</lpage><pub-id pub-id-type="doi">10.1016/j.biochi.2007.09.003</pub-id><?supplied-pmid 17949886?><pub-id pub-id-type="pmid">17949886</pub-id></mixed-citation>
      </ref>
      <ref id="B59">
        <label>59</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lefranc</surname><given-names>M-P</given-names></name></person-group>
<article-title>From IMGT-ONTOLOGY IDENTIFICATION Axiom to IMGT standardized keywords: for immunoglobulins (IG), T cell receptors (TR), and conventional genes</article-title>. <source>Cold Spring Harb Protoc</source> (<year>2011</year>) <volume>6</volume>:<fpage>604</fpage>â<lpage>13</lpage><pub-id pub-id-type="doi">10.1101/pdb.ip82</pub-id><pub-id pub-id-type="pmid">21632792</pub-id></mixed-citation>
      </ref>
      <ref id="B60">
        <label>60</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lefranc</surname><given-names>M-P</given-names></name></person-group>
<article-title>From IMGT-ONTOLOGY DESCRIPTION axiom to IMGT standardized labels: for immunoglobulin (IG) and T cell receptor (TR) sequences and structures</article-title>. <source>Cold Spring Harb Protoc</source> (<year>2011</year>) <volume>6</volume>:<fpage>614</fpage>â<lpage>26</lpage><pub-id pub-id-type="doi">10.1101/pdb.ip83</pub-id><pub-id pub-id-type="pmid">21632791</pub-id></mixed-citation>
      </ref>
      <ref id="B61">
        <label>61</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lefranc</surname><given-names>M-P</given-names></name></person-group>
<article-title>From IMGT-ONTOLOGY CLASSIFICATION axiom to IMGT standardized gene and allele nomenclature: for immunoglobulins (IG) and T cell receptors (TR)</article-title>. <source>Cold Spring Harb Protoc</source> (<year>2011</year>) <volume>6</volume>:<fpage>627</fpage>â<lpage>32</lpage><pub-id pub-id-type="doi">10.1101/pdb.ip84</pub-id><pub-id pub-id-type="pmid">21632790</pub-id></mixed-citation>
      </ref>
      <ref id="B62">
        <label>62</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lefranc</surname><given-names>M-P</given-names></name></person-group>
<article-title>Unique database numbering system for immunogenetic analysis</article-title>. <source>Immunol Today</source> (<year>1997</year>) <volume>18</volume>:<fpage>509</fpage><pub-id pub-id-type="doi">10.1016/S0167-5699(97)01163-8</pub-id><pub-id pub-id-type="pmid">9386342</pub-id></mixed-citation>
      </ref>
      <ref id="B63">
        <label>63</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lefranc</surname><given-names>M-P</given-names></name></person-group>
<article-title>The IMGT unique numbering for immunoglobulins, T cell receptors and Ig-like domains</article-title>. <source>Immunologist</source> (<year>1999</year>) <volume>7</volume>:<fpage>132</fpage>â<lpage>6</lpage><pub-id pub-id-type="doi">10.1093/bfgp/elm032</pub-id><?supplied-pmid 18208865?><pub-id pub-id-type="pmid">18208865</pub-id></mixed-citation>
      </ref>
      <ref id="B64">
        <label>64</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lefranc</surname><given-names>M-P</given-names></name><name><surname>PommiÃ©</surname><given-names>C</given-names></name><name><surname>Ruiz</surname><given-names>M</given-names></name><name><surname>Giudicelli</surname><given-names>V</given-names></name><name><surname>Foulquier</surname><given-names>E</given-names></name><name><surname>Truong</surname><given-names>L</given-names></name><etal/></person-group>
<article-title>IMGT unique numbering for immunoglobulin and T cell receptor variable domains and Ig superfamily V-like domains</article-title>. <source>Dev Comp Immunol</source> (<year>2003</year>) <volume>27</volume>:<fpage>55</fpage>â<lpage>77</lpage><pub-id pub-id-type="doi">10.1016/S0145-305X(02)00039-3</pub-id><?supplied-pmid 12477501?><pub-id pub-id-type="pmid">12477501</pub-id></mixed-citation>
      </ref>
      <ref id="B65">
        <label>65</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lefranc</surname><given-names>M-P</given-names></name><name><surname>PommiÃ©</surname><given-names>C</given-names></name><name><surname>Kaas</surname><given-names>Q</given-names></name><name><surname>Duprat</surname><given-names>E</given-names></name><name><surname>Bosc</surname><given-names>N</given-names></name><name><surname>Guiraudou</surname><given-names>D</given-names></name><etal/></person-group>
<article-title>IMGT unique numbering for immunoglobulin and T cell receptor constant domains and Ig superfamily C-like domains</article-title>. <source>Dev Comp Immunol</source> (<year>2005</year>) <volume>29</volume>:<fpage>185</fpage>â<lpage>203</lpage><pub-id pub-id-type="doi">10.1016/j.dci.2004.07.003</pub-id><?supplied-pmid 15572068?><pub-id pub-id-type="pmid">15572068</pub-id></mixed-citation>
      </ref>
      <ref id="B66">
        <label>66</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lefranc</surname><given-names>M-P</given-names></name></person-group>
<article-title>IMGT unique numbering for the variable (V), constant (C), and groove (G) domains of IG, TR, MH, IgSF, and MhSF</article-title>. <source>Cold Spring Harb Protoc</source> (<year>2011</year>) <volume>6</volume>:<fpage>633</fpage>â<lpage>42</lpage><pub-id pub-id-type="doi">10.1101/pdb.ip85</pub-id><pub-id pub-id-type="pmid">21632789</pub-id></mixed-citation>
      </ref>
      <ref id="B67">
        <label>67</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruiz</surname><given-names>M</given-names></name><name><surname>Lefranc</surname><given-names>M-P</given-names></name></person-group>
<article-title>IMGT gene identification and Colliers de Perles of human immunoglobulins with known 3D structures</article-title>. <source>Immunogenetics</source> (<year>2002</year>) <volume>53</volume>:<fpage>857</fpage>â<lpage>83</lpage><pub-id pub-id-type="doi">10.1007/s00251-001-0408-6</pub-id><?supplied-pmid 11862387?><pub-id pub-id-type="pmid">11862387</pub-id></mixed-citation>
      </ref>
      <ref id="B68">
        <label>68</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaas</surname><given-names>Q</given-names></name><name><surname>Lefranc</surname><given-names>M-P</given-names></name></person-group>
<article-title>IMGT Colliers de Perles: standardized sequence-structure representations of the IgSF and MhcSF superfamily domains</article-title>. <source>Curr Bioinform</source> (<year>2007</year>) <volume>2</volume>:<fpage>21</fpage>â<lpage>30</lpage><pub-id pub-id-type="doi">10.1093/bfgp/elm032</pub-id><?supplied-pmid 18208865?><pub-id pub-id-type="pmid">18208865</pub-id></mixed-citation>
      </ref>
      <ref id="B69">
        <label>69</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaas</surname><given-names>Q</given-names></name><name><surname>Ehrenmann</surname><given-names>F</given-names></name><name><surname>Lefranc</surname><given-names>M-P</given-names></name></person-group>
<article-title>IG, TR and IgSf, MHC and MhcSF: what do we learn from the IMGT Colliers de Perles?</article-title>
<source>Brief Funct Genomic Proteomic</source> (<year>2007</year>) <volume>6</volume>:<fpage>253</fpage>â<lpage>64</lpage><pub-id pub-id-type="doi">10.1093/bfgp/elm032</pub-id><?supplied-pmid 18208865?><pub-id pub-id-type="pmid">18208865</pub-id></mixed-citation>
      </ref>
      <ref id="B70">
        <label>70</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lefranc</surname><given-names>M-P</given-names></name></person-group>
<article-title>IMGT Collier de Perles for the variable (V), constant (C), and groove (G) domains of IG, TR, MH, IgSF, and MhSF</article-title>. <source>Cold Spring Harb Protoc</source> (<year>2011</year>) <volume>6</volume>:<fpage>643</fpage>â<lpage>51</lpage><pub-id pub-id-type="doi">10.1101/pdb.ip86</pub-id><pub-id pub-id-type="pmid">21632788</pub-id></mixed-citation>
      </ref>
      <ref id="B71">
        <label>71</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robert</surname><given-names>R</given-names></name><name><surname>Lefranc</surname><given-names>M-P</given-names></name><name><surname>Ghochikyan</surname><given-names>A</given-names></name><name><surname>Agadjanyan</surname><given-names>MG</given-names></name><name><surname>Cribbs</surname><given-names>DH</given-names></name><name><surname>Van Nostrand</surname><given-names>WE</given-names></name><etal/></person-group>
<article-title>Restricted V gene usage and VH/VL pairing of mouse humoral response against the N-terminal immunodominant epitope of the amyloid Î² peptide</article-title>. <source>Mol Immunol</source> (<year>2010</year>) <volume>48</volume>(<issue>1â3</issue>):<fpage>59</fpage>â<lpage>72</lpage><pub-id pub-id-type="doi">10.1016/j.molimm.2010.09.012</pub-id><?supplied-pmid 20970857?><pub-id pub-id-type="pmid">20970857</pub-id></mixed-citation>
      </ref>
      <ref id="B72">
        <label>72</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghia</surname><given-names>P</given-names></name><name><surname>Stamatopoulos</surname><given-names>K</given-names></name><name><surname>Belessi</surname><given-names>C</given-names></name><name><surname>Moreno</surname><given-names>C</given-names></name><name><surname>Stilgenbauer</surname><given-names>S</given-names></name><name><surname>Stevenson</surname><given-names>FI</given-names></name><etal/></person-group>
<article-title>ERIC recommendations on IGHV gene mutational status analysis in chronic lymphocytic leukemia</article-title>. <source>Leukemia</source> (<year>2007</year>) <volume>21</volume>:<fpage>1</fpage>â<lpage>3</lpage><pub-id pub-id-type="doi">10.1038/sj.leu.2404457</pub-id><pub-id pub-id-type="pmid">17167526</pub-id></mixed-citation>
      </ref>
      <ref id="B73">
        <label>73</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agathangelidis</surname><given-names>A</given-names></name><name><surname>Darzentas</surname><given-names>N</given-names></name><name><surname>Hadzidimitriou</surname><given-names>A</given-names></name><name><surname>Brochet</surname><given-names>X</given-names></name><name><surname>Murray</surname><given-names>F</given-names></name><name><surname>Yan</surname><given-names>XJ</given-names></name><etal/></person-group>
<article-title>Stereotyped B-cell receptors in one third of chronic lymphocytic leukemia: towards a molecular classification with implications for targeted therapeutic interventions</article-title>. <source>Blood</source> (<year>2012</year>) <volume>119</volume>(<issue>19</issue>):<fpage>4467</fpage>â<lpage>75</lpage><pub-id pub-id-type="doi">10.1182/blood-2011-11-393694</pub-id><?supplied-pmid 22415752?><pub-id pub-id-type="pmid">22415752</pub-id></mixed-citation>
      </ref>
      <ref id="B74">
        <label>74</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kostareli</surname><given-names>E</given-names></name><name><surname>Gounari</surname><given-names>M</given-names></name><name><surname>Janus</surname><given-names>A</given-names></name><name><surname>Murray</surname><given-names>F</given-names></name><name><surname>Brochet</surname><given-names>X</given-names></name><name><surname>Giudicelli</surname><given-names>V</given-names></name><etal/></person-group>
<article-title>Antigen receptor stereotypy across B-cell lymphoproliferations: the case of IGHV4-59/IGKV3-20 receptors with rheumatoid factor activity</article-title>. <source>Leukemia</source> (<year>2012</year>) <volume>26</volume>(<issue>5</issue>):<fpage>1127</fpage>â<lpage>31</lpage><pub-id pub-id-type="doi">10.1038/leu.2011.311</pub-id><pub-id pub-id-type="pmid">22051533</pub-id></mixed-citation>
      </ref>
      <ref id="B75">
        <label>75</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jefferis</surname><given-names>R</given-names></name><name><surname>Lefranc</surname><given-names>M-P</given-names></name></person-group>
<article-title>Human immunoglobulin allotypes: possible implications for immunogenicity</article-title>. <source>MAbs</source> (<year>2009</year>) <volume>1</volume>(<issue>4</issue>):<fpage>332</fpage>â<lpage>8</lpage><pub-id pub-id-type="doi">10.4161/mabs.1.4.9122</pub-id><pub-id pub-id-type="pmid">20073133</pub-id></mixed-citation>
      </ref>
      <ref id="B76">
        <label>76</label>
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Lefranc</surname><given-names>M-P</given-names></name><name><surname>Lefranc</surname><given-names>G</given-names></name></person-group>
<article-title>Human Gm, Km and Am allotypes and their molecular characterization: a remarkable demonstration of polymorphism</article-title>. In: <person-group person-group-type="editor"><name><surname>Christiansen</surname><given-names>F</given-names></name><name><surname>Tait</surname><given-names>B</given-names></name></person-group>, editors. <source>Methods Mol Biol</source>. <publisher-loc>New York</publisher-loc>: <publisher-name>Humana Press, Springer</publisher-name> (<year>2012</year>) <volume>882</volume>:<fpage>635</fpage>â<lpage>80</lpage><pub-id pub-id-type="doi">10.1007/978-1-61779-842-9_34</pub-id></mixed-citation>
      </ref>
      <ref id="B77">
        <label>77</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dechavanne</surname><given-names>C</given-names></name><name><surname>Guillonneau</surname><given-names>F</given-names></name><name><surname>Chiappetta</surname><given-names>G</given-names></name><name><surname>Sago</surname><given-names>L</given-names></name><name><surname>LÃ©vy</surname><given-names>P</given-names></name><name><surname>Salnot</surname><given-names>V</given-names></name><etal/></person-group>
<article-title>Mass spectrometry detection of G3m and IGHG3 alleles and follow-up of differential mother and neonate IgG3</article-title>. <source>PLoS One</source> (<year>2012</year>) <volume>7</volume>(<issue>9</issue>):<fpage>e46097</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0046097</pub-id><?supplied-pmid 23049948?><pub-id pub-id-type="pmid">23049948</pub-id></mixed-citation>
      </ref>
      <ref id="B78">
        <label>78</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magdelaine-Beuzelin</surname><given-names>C</given-names></name><name><surname>Kaas</surname><given-names>Q</given-names></name><name><surname>Wehbi</surname><given-names>V</given-names></name><name><surname>Ohresser</surname><given-names>M</given-names></name><name><surname>Jefferis</surname><given-names>R</given-names></name><name><surname>Lefranc</surname><given-names>M-P</given-names></name><etal/></person-group>
<article-title>Structure-function relationships of the variable domains of monoclonal antibodies approved for cancer treatment</article-title>. <source>Crit Rev Oncol Hematol</source> (<year>2007</year>) <volume>64</volume>:<fpage>210</fpage>â<lpage>25</lpage><pub-id pub-id-type="doi">10.1016/j.critrevonc.2007.04.011</pub-id><?supplied-pmid 17624800?><pub-id pub-id-type="pmid">17624800</pub-id></mixed-citation>
      </ref>
      <ref id="B79">
        <label>79</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pelat</surname><given-names>T</given-names></name><name><surname>Bedouelle</surname><given-names>H</given-names></name><name><surname>Rees</surname><given-names>AR</given-names></name><name><surname>Crennell</surname><given-names>SJ</given-names></name><name><surname>Lefranc</surname><given-names>M-P</given-names></name><name><surname>Thullier</surname><given-names>P</given-names></name></person-group>
<article-title>Germline humanization of a non-human Primate antibody that neutralizes the anthrax toxin, by in vitro and in silico engineering</article-title>. <source>J Mol Biol</source> (<year>2008</year>) <volume>384</volume>:<fpage>1400</fpage>â<lpage>7</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2008.10.033</pub-id><?supplied-pmid 18976662?><pub-id pub-id-type="pmid">18976662</pub-id></mixed-citation>
      </ref>
      <ref id="B80">
        <label>80</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pelat</surname><given-names>T</given-names></name><name><surname>Hust</surname><given-names>M</given-names></name><name><surname>Hale</surname><given-names>M</given-names></name><name><surname>Lefranc</surname><given-names>M-P</given-names></name><name><surname>DÃ¼bel</surname><given-names>S</given-names></name><name><surname>Thullier</surname><given-names>P</given-names></name></person-group>
<article-title>Isolation of a human-like antibody fragment (scFv) that neutralizes ricin biological activity</article-title>. <source>BMC Biotechnol</source> (<year>2009</year>) <volume>9</volume>:<fpage>60</fpage><pub-id pub-id-type="doi">10.1186/1472-6750-9-60</pub-id><?supplied-pmid 19563687?><pub-id pub-id-type="pmid">19563687</pub-id></mixed-citation>
      </ref>
      <ref id="B81">
        <label>81</label>
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Alamyar</surname><given-names>E</given-names></name><name><surname>Giudicelli</surname><given-names>V</given-names></name><name><surname>Duroux</surname><given-names>P</given-names></name><name><surname>Lefranc</surname><given-names>M-P</given-names></name></person-group>
<article-title>Antibody V and C domain sequence, structure and interaction analysis with special reference to IMGT<sup>Â®</sup></article-title>. <edition>2nd ed</edition> In: <person-group person-group-type="editor"><name><surname>Ossipow</surname><given-names>V</given-names></name><name><surname>Fisher</surname><given-names>A</given-names></name></person-group>, editors. <source>Monoclonal Antibodies: Methods and Protocols</source>. <publisher-loc>New York</publisher-loc>: <publisher-name>Humana Press, Springer Science+Business Media</publisher-name> (<year>2014</year>) (in press).</mixed-citation>
      </ref>
      <ref id="B82">
        <label>82</label>
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Lefranc</surname><given-names>M-P</given-names></name></person-group>
<article-title>How to use IMGT<sup>Â®</sup> for therapeutic antibody engineering</article-title>. <edition>2nd ed</edition> In: <person-group person-group-type="editor"><name><surname>DÃ¼bel</surname><given-names>S</given-names></name><name><surname>Reichert</surname><given-names>J</given-names></name></person-group>, editors. <source>Handbook of Therapeutic Antibodies</source>. <publisher-name>Wiley</publisher-name> (<year>2014</year>) (in press).</mixed-citation>
      </ref>
      <ref id="B83">
        <label>83</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wain</surname><given-names>HM</given-names></name><name><surname>Bruford</surname><given-names>EA</given-names></name><name><surname>Lovering</surname><given-names>RC</given-names></name><name><surname>Lush</surname><given-names>MJ</given-names></name><name><surname>Wright</surname><given-names>MW</given-names></name><name><surname>Povey</surname><given-names>S</given-names></name></person-group>
<article-title>Guidelines for human gene nomenclature</article-title>. <source>Genomics</source> (<year>2002</year>) <volume>79</volume>:<fpage>464</fpage>â<lpage>70</lpage><pub-id pub-id-type="doi">10.1006/geno.2002.6748</pub-id><pub-id pub-id-type="pmid">11944974</pub-id></mixed-citation>
      </ref>
      <ref id="B84">
        <label>84</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruford</surname><given-names>EA</given-names></name><name><surname>Lush</surname><given-names>MJ</given-names></name><name><surname>Wright</surname><given-names>MW</given-names></name><name><surname>Sneddon</surname><given-names>TP</given-names></name><name><surname>Povey</surname><given-names>S</given-names></name><name><surname>Birney</surname><given-names>E</given-names></name></person-group>
<article-title>The HGNC database in 2008: a resource for the human genome</article-title>. <source>Nucleic Acids Res</source> (<year>2008</year>) <volume>36</volume>:<fpage>D445</fpage>â<lpage>8</lpage><pub-id pub-id-type="doi">10.1093/nar/gkm881</pub-id><?supplied-pmid 17984084?><pub-id pub-id-type="pmid">17984084</pub-id></mixed-citation>
      </ref>
      <ref id="B85">
        <label>85</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Letovsky</surname><given-names>SI</given-names></name><name><surname>Cottingham</surname><given-names>RW</given-names></name><name><surname>Porter</surname><given-names>CJ</given-names></name><name><surname>Li</surname><given-names>PW</given-names></name></person-group>
<article-title>GDB: the human genome database</article-title>. <source>Nucleic Acids Res</source> (<year>1998</year>) <volume>26</volume>(<issue>1</issue>):<fpage>94</fpage>â<lpage>9</lpage><pub-id pub-id-type="doi">10.1093/nar/26.1.94</pub-id><pub-id pub-id-type="pmid">9399808</pub-id></mixed-citation>
      </ref>
      <ref id="B86">
        <label>86</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maglott</surname><given-names>DR</given-names></name><name><surname>Katz</surname><given-names>KS</given-names></name><name><surname>Sicotte</surname><given-names>H</given-names></name><name><surname>Pruitt</surname><given-names>KD</given-names></name></person-group>
<article-title>NCBIâs LocusLink and RefSeq</article-title>. <source>Nucleic Acids Res</source> (<year>2000</year>) <volume>28</volume>(<issue>1</issue>):<fpage>126</fpage>â<lpage>8</lpage><pub-id pub-id-type="doi">10.1093/nar/28.1.126</pub-id><pub-id pub-id-type="pmid">10592200</pub-id></mixed-citation>
      </ref>
      <ref id="B87">
        <label>87</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maglott</surname><given-names>D</given-names></name><name><surname>Ostell</surname><given-names>J</given-names></name><name><surname>Pruitt</surname><given-names>KD</given-names></name><name><surname>Tatusova</surname><given-names>T</given-names></name></person-group>
<article-title>Entrez Gene: gene-centered information at NCBI</article-title>. <source>Nucleic Acids Res</source> (<year>2007</year>) <volume>35</volume>:<fpage>D26</fpage>â<lpage>31</lpage><pub-id pub-id-type="doi">10.1093/nar/gkl993</pub-id><?supplied-pmid 17148475?><pub-id pub-id-type="pmid">17148475</pub-id></mixed-citation>
      </ref>
      <ref id="B88">
        <label>88</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stabenau</surname><given-names>A</given-names></name><name><surname>McVicker</surname><given-names>G</given-names></name><name><surname>Melsopp</surname><given-names>C</given-names></name><name><surname>Proctor</surname><given-names>G</given-names></name><name><surname>Clamp</surname><given-names>M</given-names></name><name><surname>Birney</surname><given-names>E</given-names></name></person-group>
<article-title>The Ensembl core software libraries</article-title>. <source>Genome Res</source> (<year>2004</year>) <volume>14</volume>:<fpage>929</fpage>â<lpage>33</lpage><pub-id pub-id-type="doi">10.1101/gr.1857204</pub-id><?supplied-pmid 15123588?><pub-id pub-id-type="pmid">15123588</pub-id></mixed-citation>
      </ref>
      <ref id="B89">
        <label>89</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilming</surname><given-names>LG</given-names></name><name><surname>Gilbert</surname><given-names>JG</given-names></name><name><surname>Howe</surname><given-names>K</given-names></name><name><surname>Trevanion</surname><given-names>S</given-names></name><name><surname>Hubbard</surname><given-names>T</given-names></name><name><surname>Harrow</surname><given-names>JL</given-names></name></person-group>
<article-title>The vertebrate genome annotation (Vega) database</article-title>. <source>Nucleic Acids Res</source> (<year>2008</year>) <volume>36</volume>:<fpage>D753</fpage>â<lpage>60</lpage><pub-id pub-id-type="doi">10.1093/nar/gkm987</pub-id><?supplied-pmid 18003653?><pub-id pub-id-type="pmid">18003653</pub-id></mixed-citation>
      </ref>
      <ref id="B90">
        <label>90</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaas</surname><given-names>Q</given-names></name><name><surname>Lefranc</surname><given-names>M-P</given-names></name></person-group>
<article-title>T cell receptor/peptide/MHC molecular characterization and standardized pMHC contact sites in IMGT/3Dstructure-DB</article-title>. <source>In silico Biol</source> (<year>2005</year>) <volume>5</volume>:<fpage>505</fpage>â<lpage>28</lpage><?supplied-pmid 16268793?><pub-id pub-id-type="pmid">16268793</pub-id></mixed-citation>
      </ref>
      <ref id="B91">
        <label>91</label>
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Kaas</surname><given-names>Q</given-names></name><name><surname>Duprat</surname><given-names>E</given-names></name><name><surname>Tourneur</surname><given-names>G</given-names></name><name><surname>Lefranc</surname><given-names>M-P</given-names></name></person-group>
<article-title>IMGT standardization for molecular characterization of the T cell receptor/peptide/MHC complexes</article-title>. In: <person-group person-group-type="editor"><name><surname>Schoenbach</surname><given-names>C</given-names></name><name><surname>Ranganathan</surname><given-names>S</given-names></name><name><surname>Brusic</surname><given-names>V</given-names></name></person-group>, editors. <source>Immunoinformatics</source>, <publisher-loc>New York</publisher-loc>: <publisher-name>Springer</publisher-name> (<year>2008</year>). p. <fpage>19</fpage>â<lpage>49</lpage></mixed-citation>
      </ref>
      <ref id="B92">
        <label>92</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vlachakis</surname><given-names>D</given-names></name><name><surname>Feidakis</surname><given-names>C</given-names></name><name><surname>Megalooikonomou</surname><given-names>V</given-names></name><name><surname>Kossida</surname><given-names>S</given-names></name></person-group>
<article-title>IMGT/Collier-de-Perles: a two-dimensional visualization tool for amino acid domain sequences</article-title>. <source>Theor Biol Med Model</source> (<year>2013</year>) <volume>10</volume>:<fpage>14</fpage><pub-id pub-id-type="doi">10.1186/1742-4682-10-14</pub-id><?supplied-pmid 23432825?><pub-id pub-id-type="pmid">23432825</pub-id></mixed-citation>
      </ref>
      <ref id="B93">
        <label>93</label>
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Lefranc</surname><given-names>M-P</given-names></name></person-group>
<article-title>Immunoinformatics of the V, C and G domains: IMGT<sup>Â®</sup> definitive system for IG, TR and IgSF, MH and MhSF</article-title>. <edition>2nd ed</edition> In: <person-group person-group-type="editor"><name><surname>De</surname><given-names>RK</given-names></name><name><surname>Tomar</surname><given-names>N</given-names></name></person-group>, editors. <source>Immunoinformatics: From Biology to Informatics</source>. <publisher-name>Humana Press</publisher-name> (<year>2014</year>) (in press).</mixed-citation>
      </ref>
      <ref id="B94">
        <label>94</label>
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Kabat</surname><given-names>EA</given-names></name><name><surname>Wu</surname><given-names>TT</given-names></name><name><surname>Perry</surname><given-names>HM</given-names></name><name><surname>Gottesman</surname><given-names>KS</given-names></name><name><surname>Foeller</surname><given-names>C</given-names></name></person-group>
<source>Sequences of Proteins of Immunological Interest</source>. <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>U.S. Department of Health and Human Services (USDHHS), National Institute of Health NIH Publication</publisher-name> (<year>1991</year>). p. <fpage>91</fpage>â<lpage>3242</lpage></mixed-citation>
      </ref>
      <ref id="B95">
        <label>95</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chothia</surname><given-names>C</given-names></name><name><surname>Lesk</surname><given-names>AM</given-names></name></person-group>
<article-title>Canonical structures for the hypervariable regions of immunoglobulins</article-title>. <source>Mol Biol</source> (<year>1987</year>) <volume>196</volume>(<issue>4</issue>):<fpage>901</fpage>â<lpage>17</lpage><pub-id pub-id-type="doi">10.1016/0022-2836(87)90412-8</pub-id></mixed-citation>
      </ref>
      <ref id="B96">
        <label>96</label>
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Frigoul</surname><given-names>A</given-names></name><name><surname>Lefranc</surname><given-names>M-P</given-names></name></person-group>
<article-title>MICA: standardized IMGT allele nomenclature, polymorphisms and diseases</article-title>. In: <person-group person-group-type="editor"><name><surname>Pandalai</surname><given-names>SG</given-names></name></person-group>, editor. <source>Recent Research Developments in Human Genetics</source>, Vol. <volume>3</volume>
<publisher-loc>Trivandrum</publisher-loc>: <publisher-name>Research Signpost</publisher-name> (<year>2005</year>). p. <fpage>95</fpage>â<lpage>145</lpage></mixed-citation>
      </ref>
      <ref id="B97">
        <label>97</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duprat</surname><given-names>E</given-names></name><name><surname>Lefranc</surname><given-names>M-P</given-names></name><name><surname>Gascuel</surname><given-names>O</given-names></name></person-group>
<article-title>A simple method to predict protein binding from aligned sequences â application to MHC superfamily and beta2-microglobulin</article-title>. <source>Bioinformatics</source> (<year>2006</year>) <volume>22</volume>:<fpage>453</fpage>â<lpage>9</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bti826</pub-id><?supplied-pmid 16352655?><pub-id pub-id-type="pmid">16352655</pub-id></mixed-citation>
      </ref>
      <ref id="B98">
        <label>98</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hischenhuber</surname><given-names>B</given-names></name><name><surname>Frommlet</surname><given-names>F</given-names></name><name><surname>Schreiner</surname><given-names>W</given-names></name><name><surname>Knapp</surname><given-names>B</given-names></name></person-group>
<article-title>MH2c: characterization of major histocompatibility Î±-helices â an information criterion approach</article-title>. <source>Comput Phys Commun</source> (<year>2012</year>) <volume>183</volume>(<issue>7</issue>):<fpage>1481</fpage>â<lpage>90</lpage><pub-id pub-id-type="doi">10.1016/j.cpc.2012.02.008</pub-id><?supplied-pmid 23564964?><pub-id pub-id-type="pmid">23564964</pub-id></mixed-citation>
      </ref>
      <ref id="B99">
        <label>99</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hischenhuber</surname><given-names>B</given-names></name><name><surname>Havlicek</surname><given-names>H</given-names></name><name><surname>Todoric</surname><given-names>J</given-names></name><name><surname>HÃ¶llrigl-Binder</surname><given-names>S</given-names></name><name><surname>Schreiner</surname><given-names>W</given-names></name><name><surname>Knapp</surname><given-names>B</given-names></name></person-group>
<article-title>Differential geometric analysis of alterations in MH Î±-helices</article-title>. <source>J Comput Chem</source> (<year>2013</year>) <volume>34</volume>(<issue>21</issue>):<fpage>1862</fpage>â<lpage>79</lpage><pub-id pub-id-type="doi">10.1002/jcc.23328</pub-id><?supplied-pmid 23703160?><pub-id pub-id-type="pmid">23703160</pub-id></mixed-citation>
      </ref>
      <ref id="B100">
        <label>100</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rose</surname><given-names>PW</given-names></name><name><surname>Beran</surname><given-names>B</given-names></name><name><surname>Bi</surname><given-names>C</given-names></name><name><surname>Bluhm</surname><given-names>WF</given-names></name><name><surname>Dimitropoulos</surname><given-names>D</given-names></name><name><surname>Goodsell</surname><given-names>DS</given-names></name><etal/></person-group>
<article-title>The RCSB protein data bank: redesigned web site and web services</article-title>. <source>Nucleic Acids Res</source> (<year>2011</year>) <volume>39</volume>:<fpage>D392</fpage>â<lpage>401</lpage><pub-id pub-id-type="doi">10.1093/nar/gkq1021</pub-id><?supplied-pmid 21036868?><pub-id pub-id-type="pmid">21036868</pub-id></mixed-citation>
      </ref>
      <ref id="B101">
        <label>101</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riechmann</surname><given-names>L</given-names></name><name><surname>Clark</surname><given-names>M</given-names></name><name><surname>Waldmann</surname><given-names>H</given-names></name><name><surname>Winter</surname><given-names>G</given-names></name></person-group>
<article-title>Reshaping human antibodies for therapy</article-title>. <source>Nature</source> (<year>1988</year>) <volume>332</volume>:<fpage>323</fpage>â<lpage>7</lpage><pub-id pub-id-type="doi">10.1038/332323a0</pub-id><pub-id pub-id-type="pmid">3127726</pub-id></mixed-citation>
      </ref>
      <ref id="B102">
        <label>102</label>
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Duprat</surname><given-names>E</given-names></name><name><surname>Kaas</surname><given-names>Q</given-names></name><name><surname>Garelle</surname><given-names>V</given-names></name><name><surname>Lefranc</surname><given-names>G</given-names></name><name><surname>Lefranc</surname><given-names>M-P</given-names></name></person-group>
<article-title>IMGT standardization for alleles and mutations of the V-LIKE-DOMAINs and C-LIKE-DOMAINs of the immunoglobulin superfamily</article-title>. In: <person-group person-group-type="editor"><name><surname>Pandalai</surname><given-names>SG</given-names></name></person-group>, editor. <source>Recent Research Developments in Human Genetics</source>, Vol. <volume>2</volume>
<publisher-loc>Trivandrum, Kerala</publisher-loc>: <publisher-name>Research Signpost</publisher-name> (<year>2004</year>). p. <fpage>111</fpage>â<lpage>36</lpage></mixed-citation>
      </ref>
      <ref id="B103">
        <label>103</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bertrand</surname><given-names>G</given-names></name><name><surname>Duprat</surname><given-names>E</given-names></name><name><surname>Lefranc</surname><given-names>M-P</given-names></name><name><surname>Marti</surname><given-names>J</given-names></name><name><surname>Coste</surname><given-names>J</given-names></name></person-group>
<article-title>Characterization of human FCGR3B*02 (HNA-1b, NA2) cDNAs and IMGT standardized description of FCGR3B alleles</article-title>. <source>Tissue Antigens</source> (<year>2004</year>) <volume>64</volume>:<fpage>119</fpage>â<lpage>31</lpage><pub-id pub-id-type="doi">10.1111/j.1399-0039.2004.00259.x</pub-id><?supplied-pmid 15245367?><pub-id pub-id-type="pmid">15245367</pub-id></mixed-citation>
      </ref>
      <ref id="B104">
        <label>104</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernard</surname><given-names>D</given-names></name><name><surname>Hansen</surname><given-names>JD</given-names></name><name><surname>du Pasquier</surname><given-names>L</given-names></name><name><surname>Lefranc</surname><given-names>M-P</given-names></name><name><surname>Benmansour</surname><given-names>A</given-names></name><name><surname>Boudinot</surname><given-names>P</given-names></name></person-group>
<article-title>Costimulatory receptors in jawed vertebrates: conserved CD28, odd CTLA4 and multiple BTLAs</article-title>. <source>Dev Comp Immunol</source> (<year>2005</year>) <volume>31</volume>:<fpage>255</fpage>â<lpage>71</lpage><pub-id pub-id-type="doi">10.1016/j.dci.2006.06.003</pub-id><?supplied-pmid 16928399?><pub-id pub-id-type="pmid">16928399</pub-id></mixed-citation>
      </ref>
      <ref id="B105">
        <label>105</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garapati</surname><given-names>VP</given-names></name><name><surname>Lefranc</surname><given-names>M-P</given-names></name></person-group>
<article-title>IMGT Colliers de Perles and IgSF domain standardization for T cell costimulatory activatory (CD28, ICOS) and inhibitory (CTLA4, PDCD1 and BTLA) receptors</article-title>. <source>Dev Comp Immunol</source> (<year>2007</year>) <volume>31</volume>:<fpage>1050</fpage>â<lpage>72</lpage><pub-id pub-id-type="doi">10.1016/j.dci.2007.01.008</pub-id><?supplied-pmid 17391759?><pub-id pub-id-type="pmid">17391759</pub-id></mixed-citation>
      </ref>
      <ref id="B106">
        <label>106</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hansen</surname><given-names>JD</given-names></name><name><surname>Pasquier</surname><given-names>LD</given-names></name><name><surname>Lefranc</surname><given-names>M-P</given-names></name><name><surname>Lopez</surname><given-names>V</given-names></name><name><surname>Benmansour</surname><given-names>A</given-names></name><name><surname>Boudinot</surname><given-names>P</given-names></name></person-group>
<article-title>The B7 family of immunoregulatory receptors: a comparative and evolutionary perspective</article-title>. <source>Mol Immunol</source> (<year>2009</year>) <volume>46</volume>:<fpage>457</fpage>â<lpage>72</lpage><pub-id pub-id-type="doi">10.1016/j.molimm.2008.10.007</pub-id><?supplied-pmid 19081138?><pub-id pub-id-type="pmid">19081138</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record></GetRecord></OAI-PMH>